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1 
Abstract 
 
  
 Plants synthesise a diverse range of secondary metabolites that have a 
wide range of functions from pigmentation to plant defence.  Oxidosqualene 
cyclases (OSCs) catalyse the first committed step in triterpenoid secondary 
metabolite synthesis and cyclise 2,3-oxidosqualene to a number of cyclic 
products.  This work describes the characterisation of β-amyrin synthase from the 
diploid oat Avena strigosa (AsbAS1).  AsbAS1 catalyses the first committed step 
in synthesis of Avenacin A-1, an antimicrobial triterpene glycoside that confers 
broad spectrum disease resistance. To date, functional analysis of plant OSCs has 
been studied via site-directed mutagenesis in yeast and inhibitor studies.  This 
work describes the first set of OSC mutants isolated through a forward screen for 
loss of function.   
 A homology model of AsbAS1 was generated based on structural 
information from human lanosterol synthase (hOSC).  Each step of the cyclisation 
process was explored in detail and AsbAS1 was found to have conserved catalytic 
residues that are seen in all OSCs, as well as two amino acid residues, Trp257 
and Phe259, that are implicated in the formation of pentacyclic products.  AsbAS1 
contains catalytic regions that are unique to monocot triterpene OSCs suggesting 
that they have evolved separately to dicot triterpene OSCs. 
 Seventeen AsbAS1 (sad1) mutants identified from a forward screen for 
avenacin deficiency were characterised at the gene, transcript and protein level.  
All mutants contained single point mutations in the Sad1 gene which introduced 
predicted premature termination of translation codons, splicing errors or amino 
acid substitutions into the Sad1 coding sequence.  Only two sad1 mutants, #358 
and #384/#1023, produced full-length AsbAS1 protein and the mutations, both 
located in the active site, are likely to affect reaction initiation and D-ring 
stabilisation respectively.  The location of the substitution mutations implies that 
OSCs are very tolerant of mutations in areas of the enzyme that are not critical 
for function and only mutations that seriously affect enzyme expression or 
function result in premature termination of metabolic pathways.   
 To date, no triterpene OSCs have been purified on a large scale from 
heterologous expression.  AsbAS1 was cloned and heterologously expressed in 
Pichia pastoris. An in vitro assay was developed to screen for functional 
transformants and a purification strategy using metal affinity chromatography 
and gel filtration enabled partial purification of tagged AsbAS1. 
  
2 
Chapter 1 - Introduction 
1.1 Cereals and disease resistance 
1.1.1 The Gramineae: a family of the plant kingdom 
 The family Gramineae, also known as Poaceae, is part of the kingdom 
Plantae and is found in the subclass Liliopsida (monocots) of the flowering plants.  
Members of the Gramineae family, around 10,000 species, are commonly referred 
to as grasses and are found across all parts of the world in every kind of habitat.  
This widespread occurrence of grasses is due to their ability to adapt to a range of 
soil types and climates, to compete successfully with other plant types and to 
survive high levels of predation (1).  The grasses that are grown for human 
consumption are known as cereals.  In 2005 cereals provided 46% of the total 
worldwide calorie consumption and most of the worldwide carbohydrate either 
directly via cereal grain from crops such as wheat, rice, maize, barley, oats, 
sorghum and millet, or indirectly through animal feed.  Many parts of the world 
rely on cereals as their major food source, for example, rice in Asia and millet in 
Africa.  The three most common cereals produced throughout the world are maize 
(Zea mays), wheat (Triticum aestivum) and rice (Oryza sativa) and together they 
account for 86% of all grain production worldwide (2-4).   
 
1.1.2 Susceptibility of cereals to pathogenic fungi 
 Like all other plants, cereals are susceptible to colonisation by pathogenic 
fungi.  For example, Rhynchosporium secalis causes leaf scald, Tapesia yallundae 
causes eyespot and Claviceps purpurea causes ergot.  The fungus 
Gaeumannomyces graminis var. tritici, commonly known as the Take-all fungus, 
causes one of the most serious diseases of cereals and mainly affects wheat and 
barley (5).  Take-all is a large problem in the United Kingdom and currently the 
only option for control of the disease is crop rotation, as chemical treatments are 
unreliable and there is no good source of genetic resistance to Take-all in 
cultivated wheat.  In the United Kingdom it is estimated that over half of the 
wheat crop is affected and suffers losses of 5-20%, with up to 50% loss if the 
disease is severe.  The estimated loss to farmers is £60 million a year (6).  The 
plant can be infected throughout its growth and development but infection is 
usually most severe in the third or fourth successive cereal crop (7).  The fungus 
begins its infection from inoculums in the soil and then spreads along the root via  
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Figure 1.1: Colonisation of cereals by the Take-all fungus 
A. Shows the path of Take-all infection as the fungus spreads through cereal plants.  The fungus 
enters the plant through the cortical cells of the roots.  It travels upwards through the plant until it 
reaches the crown and from there it spreads up the main stems and tillers. Image adapted from 
http://www.ipm.ucdavis.edu.  B. The effect of Take-all on wheat roots.  Compared to healthy roots 
(above), diseased roots (below) have black lesions.  Images taken from Bateman et al. (2006) (6). 
 
runner hyphae.  It then enters the cortical cells of the root, stem and tillers of the 
plant, blocks the vascular system which cuts off the supply of nutrients and water 
causing death.  Phenotypes of the disease include stunted growth, fewer tillers, 
premature ear formation, bleached ears, blackened brittle roots and empty 
spikelets (7-8).   
 Whilst most cereals are susceptible to Take-all, oats (Avena spp.) have 
developed extreme resistance.  Oats are susceptible to the var. avenae strain of 
the fungus, but this strain is rare (6).  Biochemical characterisation has shown 
oats to contain secondary metabolites called saponins which have potent 
antimicrobial activity and have been implicated with a role in plant defence.  
Avenacin deficient mutants of oat are susceptible to infection by G. graminis var. 
tritici providing evidence to support a role for these compounds in disease 
resistance (9-10). 
 
1.1.3 Resistance mechanisms in plants 
 Despite fungi having developed many methods to invade and propagate 
within cereals and other plants, plants have evolved many unique strategies to 
evade and defend these attacks.  Unlike animals, plants cannot move to escape 
so they have developed defence mechanisms.  These defences can be split into 
two categories, preformed and induced.  Preformed defences are the first line of 
A B 
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attack against pathogens, but if these defences fail then the plant can activate 
induced defence mechanisms in order to survive (11).   
 Preformed defences are both structural and chemical.  The first barrier the 
fungus must overcome is the wax layer present on the leaf surface which 
together with leaf hairs prevent the formation of water droplets that are essential 
for fungal spore germination (11).  The layers below the cuticle are formed of 
fatty acids and cellulose woven into a high tensile fabric making entry into the 
plant very difficult (12).  The waxy cuticle protects against airborne spores, but 
spores can also enter the plant via the soil.  As the root tips elongate they are 
vulnerable to pathogen attack, so are guarded by root border cells which secrete 
anthocyanins and antimicrobial antibiotics to repel pathogens (11).  Plants also 
have a wide range of preformed antimicrobial compounds known as 
phytoanticipins.  Phytoanticipins are low molecular weight, antimicrobial 
compounds that are present in plants before invasion by microorganisms or are 
produced after infection solely from pre-existing constituents (13-14).  
Phytoanticipin distribution is usually tissue specific and these compounds are 
often found in the outer cell layers of healthy plants, sequestered in vacuoles or 
organelles.  Protective compounds of this kind include avenacins and other 
saponins, cyanogenic glycosides and phenolic compounds (14). 
 Induced defences can be activated by the presence of a fungus on an 
external plant surface whilst others are only switched on once the fungus has 
penetrated the cell wall.  Cytoskeletal rearrangements are one of the defences 
activated prior to fungal penetration, resulting in a build-up of cytoplasm and 
plant microtubules at the site of contact.  The inner surface of the cell wall is 
reinforced with compounds such as callose, extensin and lignin which form an 
insoluble barrier.  Peroxidase enzymes also act to strengthen the cell wall.  One of 
the first responses to be activated once penetration has occurred is the 
production of enzymes such as chitinases and glucanases which degrade fungal 
cell walls.  Another preliminary response is the oxidative burst that results in the 
production of hydrogen peroxide which is converted to reactive oxygen species 
(ROS) and leads to activation of signalling pathways for systemic defence 
responses.  Other chemical mediators of defence signalling pathways include 
salicylic acid, jasmonic acid, ethylene and nitric oxide.  The spread of pathogens 
can be blocked by the hypersensitive response in which there is localised death of 
plant cells surrounding the site of pathogen entry.  This restricts the spread of the 
fungus and prevents diffusion of fungal toxins (11-12, 14).  Plants have also 
evolved resistance (R) genes which provide gene-for-gene resistance against 
pathogens with the corresponding avirulence (Avr) genes.  This triggers signal 
Chapter 1 – Introduction 
 
 
5 
A B
C D
E
F
G
transduction pathways which activate defence responses such as the 
hypersensitivity response, synthesis of antimicrobial proteins and metabolites and 
cell wall thickening (15-16).  Plants can also induce the production of 
antimicrobial compounds known as phytoalexins which are defined as low 
molecular weight, antimicrobial compounds that are both synthesised by and 
accumulated in plants after exposure to microorganisms (17).  These compounds 
are synthesised by the isoprenoid and shikimic acid pathways which 
predominantly synthesise primary metabolic compounds, but can be diverted to 
form secondary metabolites phytoalexins such as terpenoids, phenolics and 
nitrogen and sulphur compounds (14). 
  
1.2 Secondary metabolites 
1.2.1 Secondary metabolites in plants 
 As mentioned in the previous section plants can synthesise a number of 
chemical compounds, both preformed and induced, and these may provide 
protection against attack from fungal pathogens.  These chemical compounds 
belong to a family known as secondary metabolites.  These compounds are not 
required for the growth and development of the plant and are not essential for 
survival, unlike primary metabolites, hence are termed ―secondary‖.  Although 
Figure 1.2: Groups of plant secondary metabolites 
Chemical diversity of natural products in plants.  A. Saponins – avenacin A-1 (Avena strigosa). B. 
Phenolics – resveratol (Vitus viniferis). C. Cyclic hydroxamic acids – DIMBOA (Zea mays). D. 
Cyanogenic glycosides – luteone (Lupinus albus). E. Sesquiterpenes – cadinene (Juniperus 
oxycedrus). F. Sulphur-containing indole derivatives – camalexin (Arabidopsis thaliana). 
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not crucial for plant survival under standard growth conditions, they may confer 
selective advantages in return, for example, through protection against disease 
and repressing neighbouring plant growth.  Many secondary metabolites also 
have antimicrobial properties so have been implicated with a role in plant defence 
(9, 18-20).  This family of compounds is chemically diverse and includes groups 
such as saponins, phenolics, cyclic hydroxamic acids, cyanogenic glycosides, 
isoflavonoids, sesquiterpenes, sulphur-containing indole derivatives and many 
others (Figure 1.2) (19).  The medical community has begun to refocus on 
natural products as sources of antimicrobial compounds.  Antibiotics isolated from 
microorganisms are rapidly becoming obsolete due to the appearance of resistant 
pathogen strains.  Laboratory designed antimicrobials can sometimes be toxic or 
have multiple side effects and therefore are not suitable for clinical use; so plant 
natural products are now one group of compounds at the forefront of antibiotic 
development.  Natural products provide a large diverse resource of compounds 
that are proven to be effective against bacteria and other pathogens, and by 
chemically and enzymatically modifying them, more potent antimicrobials that 
can combat resistant strains are being developed (21-22). 
 
1.2.2 Saponins and disease resistance 
 Saponins are a major family of secondary metabolites and are found in 
many plant species.  These compounds have surfactant properties and form soap-
like foams in aqueous solution, a characteristic that gave rise to the name 
saponin which is derived from the latin word for soap, sapo (23-24).  Saponins 
consist of glycosylated steroids, steroidal alkaloids and triterpenoids and each are 
found in distinct areas of the plant, often as complex mixtures (Figure 1.3).  The 
basic structure of these molecules consists of an aglycone, consisting of a 
triterpenoid 5-ring system, and an oligosaccharide chain at the C-3 position which 
is formed of up to five sugar molecules.  The aglycone can also be further 
modified by glycosylation, acylation or oxidation steps (24-26).  The saponin 
content in plants can be made up of a complex mixture and is dependent on a 
number of different factors – genetic background, tissue type, age, health and 
environment of the plant (25, 27).  Saponins have many different properties and 
have been utilised commercially by the biochemical industry as drugs and 
medicines, adjuvants, foaming agents, sweeteners, taste modifiers and cosmetics 
(24).  As mentioned previously, many saponins have antimicrobial activity so may 
protect plants against pathogen attack.  A number of studies have shown  
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Figure 1.3: Three classes of saponins 
Shows example structure from the three classes of saponins that are found in plants.  All have a 
triterpenoid ring system that is modified by glycosylation, acylation, and oxidation steps.  A. 
Triterpenoid saponins – Avenacin A-1 (from the roots of Avena strigosa). B. Glycosylated steroidal 
saponins – Gracillin (from the rhizomes of Costus speciosus). C. Steroidal alkaloid saponins – α-
Tomatine (stems, leaves and unripe fruit of Solanum lycopersicum). 
 
saponins to be biologically active against a range of plant, animal and human 
pathogens.  Recent examples include four saponins from the roots of Cephalaria 
ambrosioides (28), two saponins from the roots of Scrophularia ningpoensis (29) 
and two saponins from extracts of Tribulus terrestris (30).   
 One example of a saponin that has been characterised and shown to have 
antimicrobial activity is avenacin A-1 from oat roots.  Oats are immune to attack 
by the fungus Gaeumannomyces graminis var. tritici and this was thought to be 
due to the presence of the saponin avenacin in its roots.  One species of oats, 
Avena longiglumis lacks avenacin and was found to be susceptible to infection by 
the G. graminis, suggesting that presence of avenacin was the determining factor 
in fungal resistance (20).  Further evidence came from both gene-knockouts 
experiments in fungi and genetic analysis of oat mutants with increased 
susceptibility to disease (18, 31).  Oats, although immune to the var. tritici strain 
of the fungus Gaeumannomyces graminis, are susceptible to the var. avenae 
strain.  This strain is able to infect oats due to the presence of the enzyme 
avenacinase which detoxifies avenacin by removing the two glucose molecules 
from the oligosaccharide chain attached to C-3 of the aglycone.  Fungal gene-
knockout mutants that lacked the avenacinase enzyme lost pathogenicity on oats 
but were still pathogenic to wheat – which does not synthesise saponins (31).  
The second line of evidence came from chemical mutagenesis experiments carried 
out in the diploid oat Avena strigosa.  Out of the ten independent mutants 
A B
C
Avenacin A-1 Gracillin
α-Tomatine
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isolated, eight lacked avenacins and the remaining two had reduced avenacin 
levels.  When challenged with the G. graminis var. tritici fungus, all ten showed 
disease symptoms with the eight mutants lacking avenacins being more 
susceptible than the two with reduced avenacin levels (18).  Together these two 
experiments provided a clear link between saponins and disease resistance. 
 
1.2.3 Avenacins: Structure and function 
 The avenacins, avenacin A-1, B-1, A-2 and B-2 are a family of four 
structurally related triterpenoid saponins that are found in oat roots.  Avenacin A-
1 is the most abundant, comprising 70% of the total avenacin content in young 
oat roots (32).  The structure of the four avenacins is very similar with each 
consisting of a pentacyclic aglycone which is modified by β-1,2- and β-1,4-linked 
D-glucose molecules attached via L-arabinose to the aglycone at the C-3 carbon.  
Avenacins A-1 and B-1 have a fluorescent N-methyl anthranilate group attached 
to the aglycone via an ester bond to C-21 whereas avenacins A-2 and B-2 have a 
benzoic acid in the corresponding position which conversely emits little or no 
fluorescence.  In addition to the esterified groups avenacins A-1 and A-2 also 
have a hydroxide group at C-23 (24, 33) (Figure 1.4).  Avenacins are localised in 
the epidermal cells of young oat root tips, so are in an ideal position to provide 
protection against soil borne pathogens (20). 
Figure 1.4: Structure of avenacin 
Shows the common structural features of the four avenacins found in oat.  All four avenacins have a 
pentacyclic aglycone modified at a number of positions by oxidation, glycosylation and acylation.  All 
have an oligosaccharide sugar chain attached to the aglycone at C-3 and addition of an esterified 
group at C-21.  The identity of the esterified group at C-21 (R2) and the group attached to C-23 (R1) 
varies between each of the avenacins and is shown in the table above. 
  
 Avenacins confer their antifungal properties by forming complexes with 
sterols in fungal membranes.  The aglycone portion of the avenacin molecule 
inserts into the membrane where it binds a cholesterol molecule.  This triggers 
the formation of a transmembrane pore via aggregation of the sugar moieties on 
avenacin which initiates lipid bilayer rearrangements causing loss of membrane 
Avenacin A-1 R1 = OH   R2 = NHMe
Avenacin A-2 R1 = OH   R2 = H
Avenacin B-1 R1 = H     R2 = NHMe
Avenacin B-2 R1 = HO R2 = H3
23
21
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integrity and death of the fungus.  This process relies on the presence of a 
oligosaccharide chain attached to the aglycone at C-3 and removal of even a 
single sugar from this chain results in a large reduction in avenacin bioactivity 
(34).  In order to protect themselves from the permeabilising affects of these 
molecules, oats store avenacins in vacuoles (35).  Vacuole membranes of 
avenacin containing cells may have substituted sterols or a low sterol content to 
prevent the host cell from permeabilising its own membranes (24).  This 
compartmentalisation of avenacin to protect the cell from the toxic effects of the 
molecule is also seen for other toxic secondary metabolites produced in other 
plants (36-37).   
 
1.3 Pathway to avenacin production 
1.3.1 Primary and secondary metabolism in plants 
 Metabolism in plants is a complex process involving many enzymes.  Solar 
energy captured in chloroplasts is used for a wide range of metabolic processes to 
ensure the survival of the plant.  Together the complex reactions create metabolic 
pathways in which the precursor is converted to the product through a series of 
intermediates known as metabolites (38).  Plants synthesise a huge range of 
metabolites and one of the largest families is the isoprenoids (or terpenoids) 
consisting of over 30,000 members (39-40).  This family is split into two classes 
of compounds: primary and secondary metabolites.  Primary metabolites include 
hormones (gibberellins and brassinosteroids), photosynthetic pigments 
(carotenoids), membrane components (sterols) and electron carriers 
(chlorophylls), and are vital for the functioning of essential plant systems (41).  
Secondary metabolites, although not vital for plant survival, have functions such 
as insect attractants (essential oils and flower colours), antimicrobial compounds 
(phytoanticipins and phytoalexins) and defences against herbivores (antifeedants) 
(41).   
 
1.3.2 Sterol and triterpene synthesis: a branchpoint between primary and 
secondary metabolism 
 The isoprenoid family is classified according to the number of isoprene 
units in their structure, with one isoprene unit consisting of five carbon atoms and 
eight hydrogen atoms.  The major groups within the isoprenoid family are the 
monoterpenes (C10 – two isoprene units), sesquiterpenes (C15 – three isoprene 
units), diterpenes (C20 -  four isoprene units) and triterpenes (C40 – five isoprene 
units) (42).  Isoprenoid precursors in plants are synthesised by condensation of 
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isopentenyl diphosphate (IPP) with its isomer dimethylallyl diphosphate (DMAPP) 
and these two molecules can be synthesised via two different pathways: the 
mevalonate pathway in the cytosol which synthesises 2,3-oxidosqualene for 
sesquiterpene, triterpene and sterol formation (41, 43); and the 1-deoxy-D-
xylulose-5-phosphate (DXP) pathway in the plastid which synthesises 2,3-
oxidosqualene for monoterpene, diterpene, chlorophyll and carotenoid formation 
(44).   
 For triterpene and sterol biosynthesis IPP (C5) is added in a head-to-tail 
fashion with DMAPP (C5) to form geranyl diphosphate (GPP) (C10).  Further 
condensation of GPP with IPP forms the larger prenyl diphosphate, farnesyl 
diphosphate (FPP) (C15) which then dimerises to form squalene (C30) (41, 45).  
The enzyme squalene epoxidase adds an oxygen across the first carbon-carbon 
double bond of squalene to form the epoxide, 2,3-oxidosqualene (Figure 1.5) 
(46). It is at this stage that the sterol and triterpene biosynthetic pathways 
diverge, with the former producing membrane sterols and hormones (primary 
metabolites) and the latter producing a diverse range of triterpenes (secondary 
metabolites).  This divergence represents the branchpoint between primary and 
secondary metabolism and cyclisation of 2,3-oxidosqualene to distinct products is 
catalysed by the oxidosqualene cyclases (OSCs) (23).  OSC catalysis converts a 
linear molecule of 2,3-oxidosqualene to a polycyclic product. 
 Cyclisation of 2,3-oxidosqualene by the sterol OSCs, lanosterol synthase 
and cycloartenol synthase, result in production of the tetracyclic sterol precursors 
lanosterol and cycloartenol respectively (Figure 1.6).  Lanosterol is the precursor 
to the membrane sterols cholesterol and ergosterol, in animals and fungi 
respectively; cycloartenol is the precursor to a number of phytosterols in plants, 
for example sitosterol, sigmasterol and campesterol.   With this apparently clear 
distinction between animal, fungal and plant sterol precursors, it was previously 
thought that lanosterol synthases were restricted to animals and fungi and 
cycloartenol synthases to plants, but recent evidence has shown that functional 
lanosterol synthases also exist in plants and have arisen by convergent evolution 
from cycloartenol synthase (47-48).  The role that lanosterol plays in plant 
metabolism is currently not understood but the presence of a lanosterol synthase, 
in addition to a cycloartenol synthase that already provides a route to membrane 
sterols indicates that it may have an alternative role in plants, possibly in defence 
responses (47-48). 
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Figure 1.5: Synthesis of 2,3-oxidosqualene via the mevalonate pathway 
Pathway to 2,3-oxidosqualene, the sterol and triterpene precursor, via the mevalonate pathway.  
Mevalonate (MVA) is converted to isopentenyl diphosphate (IPP) which reacts with its isomer 
dimethylallyl diphosphate (DMAPP) to form geranyl diphosphate (GPP).  GPP reacts with another IPP 
molecule to form farnesyl diphosphate (FPP) which dimerises to form squalene.  Addition of an 
epoxide group across a carbon-carbon double bond forms 2,3-oxidosqualene which can then be 
cyclised to form sterol or triterpene precursors. 
   
 The triterpene OSC family has many more members than the sterol OSC 
family, therefore cyclisation of 2,3-oxidosqualene by the triterpene OSCs 
produces a wide range of cyclic products (Figure 1.6).  The two major groups of 
triterpene OSCs identified to date are the β-amyrin synthases and lupeol 
synthases and these synthesise the pentacyclic products β-amyrin and lupeol 
respectively.  These enzymes are found throughout a wide range of monocot and 
dicot plants and are precursors for a number of secondary metabolites, for 
example, avenacin – Avena strigosa (49); soyasaponin I – Lupinus angustifolius  
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Figure 1.6: Cyclisation of 2,3-oxidosqualene to sterols and triterpenes 
2,3-oxidosqualene is situated  at the branch point between primary and secondary metabolism.  For 
primary metabolism it is cyclised by the sterol oxidosqualene cyclases (OSCs) to lanosterol in animals 
and fungi and cycloartenol in plants.  Lanosterol has been found in some plants, but it is not thought 
to participate in primary metabolism (47).  Lanosterol and cycloartenol are then modified by a number 
of enzymes to form membrane sterols.  For secondary metabolism, 2,3-oxidosqualene is cyclised by 
the triterpene OSCs to a wide range of cyclic products.  Just a small number of the cyclic products that 
have been identified in plants are shown and the enzyme that catalyses each reaction is named as the 
synthase of the product formed, for example, lupeol is synthesised by lupeol synthase.  Products 
labelled with an asterisk are those that have only been observed in Arabidopsis thaliana. 
 
(50); and bourneioside A - Lonicera bournei (51).  Compared to the sterol OSCs,  
product specificity for triterpene OSCs is not as strict.  Many synthesise multiple 
triterpene products, usually one or two major triterpene products and a number 
of minor products (52-56).  With the recent advances in whole genome 
sequencing and genome mining, a number of new triterpene OSCs have been 
identified, mainly in Arabidopsis thaliana, that have novel cyclic products.  Some, 
like thalianol synthase (Arabidopsis thaliana) (57) are specific enzymes, but the 
majority are multifunctional and produce a wide range of cyclic products.  
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Examples include baccharis oxide synthase (Stevia rebaudiana), and from 
Arabidopsis thaliana, baurol synthase (58), marneral synthase (59) and arabidiol 
synthase (60).  As more whole genome sequences for plants become available, it 
is likely that many more new triterpene skeletons will be discovered.  
 After 2,3-oxidosqualene cyclisation the triterpene backbone undergoes a 
series of modification steps which can include oxidation, alkylation, glycosylation, 
and acylation.  Elaboration of the triterpene skeleton to produce the final product 
can take a large number of steps and the pathways enzymes involved are largely 
uncharacterised.  One well characterised pathway is the synthesis of avenacin in 
Avena strigosa.  The first step in avenacin synthesis is cyclisation of 2,3-
oxidosqualene by β-amyrin synthase.  The β-amyrin skeleton is then modified by 
hydroxylation by at least one cytochrome p450 (61), addition of sugars at C-3 by 
glucosyltransferases, and addition of an N-methyl anthranilate group by a 
combination of three enzymes, a glycosyltransferase, methyltransferase and a 
serine carboxypeptidase-like acyltransferase (62).   
 
1.3.3 Applications of characterising secondary metabolic pathways 
 The mechanism of 2,3-oxidosqualene cyclisation into sterol and triterpene 
precursors and their subsequent modification to primary and secondary 
metabolites has been a source of huge interest to both biochemists and the field 
of industry.  However the complexity of the pathway and the many enzymes that 
are involved have made this a difficult challenge.  Currently many research 
programmes are trying to identify the genes involved in triterpene biosynthesis, 
however DNA sequence information alone can make it hard to construct complex 
pathways (19).  The elucidation of the avenacin pathway was aided by the 
generation of a collection of avenacin-deficient mutants and the clustering of the 
pathway genes in the oat genome (63).  Genes for metabolic pathways are often 
found in clusters in bacterial and fungal genomes but clustering of biosynthetic 
genes in plants is rare, so elucidation of  biosynthetic pathway genes is not as 
simple (64).  To date, only a handful of plant biosynthetic gene clusters have 
been characterised, but with the continual advances in genetics, identification of 
biosynthetic pathways is becoming easier (65-67).   
 As the avenacin pathway appears to be unique to oats, an improved 
understanding of this complex pathway and transference of pathway genes from 
oat into other major cereal crops such as wheat, barley, maize and rice could 
improve disease resistance substantially (63).  Many crop plants have been 
subjected to many years of selective breeding and have therefore lost large 
numbers of natural products that still exist in their wild counterparts, so gene 
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transfer to provide disease resistance would appear to be a solution (68).  As well 
as being utilised in plants for disease resistance, triterpenes are also used by 
pharmaceutical companies as lead compounds for antifungal and cholesteremic 
drugs, so knowledge of the biosynthetic pathways could greatly enhance progress 
in this field (69).  However, whilst transferring pathway genes to other crops may 
seem like a simple solution and has been achieved for single resistance genes 
(70-73), transferring multiple pathway genes between plant species represents a 
substantial technical challenge.  The production of antimicrobial compounds relies 
on the coordinated involvement of many unrelated genes, so large numbers of 
genes would have to be transferred to ensure effective antimicrobial activity.  
How the pathways are regulated is also important, and to date this area is not 
well understood.  There is also the problem of pathogens developing resistance 
for the introduced antimicrobial compound (19).  Despite these potential 
stumbling blocks, elucidation of the pathway would be a major step forward in 
understanding the way in which plants fight disease. 
 
1.3.4 Elucidating biosynthetic pathways in plants 
 Despite the technological advantages that will come from elucidation of 
individual steps in metabolic pathways, with the exception of the first cyclisation 
step, the remainder of saponin biosynthetic pathways remain uncharacterised at 
the molecular level.  The first step in saponin and triterpenoid biosynthesis is 
cyclisation of 2,3-oxidosqualene which is catalysed by triterpene OSCs.  These 
enzymes synthesise the triterpene skeleton which is modified at various positions 
by subsequent enzymes in the pathway.  A large number of triterpene OSCs have 
been cloned from a wide range of plant species and this will be discussed in a 
later section. 
 The gap in knowledge comes at the latter stages of triterpenoid synthesis.  
A large number of triterpenoids have been isolated from plants and their 
structures have been determined by mass spectroscopy and NMR, which has 
allowed speculation about the enzymes that are involved in modifying the 
triterpene backbone.  However very few of these enzymes have been cloned and 
characterised from plants in comparison to enzymes involved in fungal and 
bacterial biosynthetic pathways.  Elucidation of pathways in fungi and bacteria 
has been aided by the genes for metabolic pathways being clustered in the 
genome, a phenomenon that is rarely seen in plants.  The spread of metabolic 
pathway genes throughout the plant genome makes elucidation of pathways 
more challenging.  Despite this, advances have been made identification of non-
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clustered genes involved in saponin biosynthesis in Medicago truncatula, Glycine 
max and Saponaria vaccaria.   
 Characterisation of the saponins found in Medicago truncatula found that 
2,3-oxidosqualene was cyclised to β-amyrin which was further modified by 
cytochrome P450s to generate five triterpenoid backbones that formed the core 
of the 37 saponins identified in M. truncatula.  Clustering analysis of transcript 
and metabolic profiles identified a candidate P450 for modification of β-amyrin 
and two glucosyltransferases which had activity against the five triterpenoid 
backbones (74-75).  Other enzymes that have been cloned and characterised 
include a P450 hydroxylase that modifies a β-amyrin backbone in Glycine max 
(76), and a glucosyltransferase that modifies a carboxylic acid β-amyrin 
derivative in Saponaria vaccaria (77). 
  
1.3.5 Identification of genes involved in avenacin biosynthesis in oats 
 As mentioned previously, clustering of biosynthetic genes in the genome 
has greatly aided the elucidation of metabolic pathways.  Work carried out by the 
Osbourn group at the John Innes Centre, Norwich has been focussed on the 
elucidation of the pathway to avenacin in oats.  As discussed previously in section 
1.2.2, the triterpenoid saponin avenacin found in oat roots was thought to confer 
resistance to the fungus Gaeumannomyces graminis var. tritici (32).  To 
investigate this hypothesis, avenacin-deficient mutants were generated in the 
diploid oat species Avena strigosa by mutagenising seeds with sodium azide.  The 
fluorescent phenotype of avenacin presence was then used to screen the 
mutagenised oats for avenacin-deficient plants followed by TLC and HPLC analysis 
of root extracts to quantify avenacin levels in each of the mutants.  Ten avenacin 
deficient mutants, termed sad mutants (saponin-deficient), were identified from 
the first screen.  Eight of them had no avenacin or trace amounts of avenacin 
present and the remaining two had reduced avenacin levels (Figure 1.7A).  Test 
crosses with the wild-type suggested that the mutations were recessive alleles of 
single genes and analysis of the F2 progeny found that the ten mutants fell into at 
least four complementation groups, named Sad1 to Sad4.  When inoculated with 
the pathogen G. graminis to which wild type oats are known to be resistant, all 
ten sad mutants developed lesions on their roots whereas the wild-type showed 
no visible signs of infection (Figure 1.7B).  The ten mutants were also susceptible 
to other fungal pathogens such as, Fusarium culmorum and Fusarium avenaceum 
which provided a clear link between saponin deficiency and compromised disease 
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Figure 1.7: Evidence for antimicrobial activity of avenacin A-1 
A. TLC analysis of partially purified methanolic root extracts from wild-type (S75) and the ten 
independent oat mutants using a chromogenic reagent to detect the four avenacins found in oat roots.  
Preparations enriched for each of the four avenacins are shown on the right.  Wild-type extract shows 
clear presence of avenacin, mutant nos. 791 and 9 have reduced avenacin levels and the remaining 
eight mutants have no detectable avenacin present.  B.  Oat roots inoculated with Gaeumannomyces 
graminis var. tritici.  Wild-type (S75) roots show no infection.  Mutant no. 791 (reduced avenacin 
levels) has some black lesions on the roots whereas mutant no. 1027 (no avenacin) has more severe 
disease symptoms.  Figure adapted from Papadopoulou et al. (1999) (18) 
resistance in oats (18).  Subsequent analysis of an extended collection of 92 oat 
mutants with reduced root fluorescence revealed an additional four loci (sad6 to 
sad9) that were involved in avenacin biosynthesis (61). 
 Further genetic analysis showed genetic linkage between the Sad1 locus 
and five of the six sad loci previously defined by mutation (18, 63).  Sad2, 6, 7 
and 8 were 0 cM from the Sad1 locus, with the Sad3 locus was less closely linked 
at 3.6 cM from the Sad1 locus.  Together these genes form a cluster around the 
Sad1 locus (63).  Subsequent detailed analysis of a bacterial artificial 
chromosome (BAC) contig that spanned the Sad1 locus and surrounding genes 
revealed that the Sad1 and Sad2 loci were 70 kb apart and the Sad1 and Sad7 
loci were 62 kb apart (Figure 1.8) (61-62).  It is known that Sad1, 2, 3 and 7 are  
Figure 1.8: Clustering of genes required for avenacin synthesis in the oat genome 
Extension of the bacterial artificial chromosome (BAC) contig upstream and downstream of the Sad1 
gene revealed loci for Sad2 and Sad7, both of which are involved in the avenacin  biosynthetic 
pathway.  Sad2 is located 69.5Kb upstream of the Sad1 gene and Sad7 is located 61.6Kb downstream 
of the Sad1 gene.  There are no open reading frames found in the regions between any of the loci.  
Figure adapted from Mugford et al. 2009 (62). 
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required for the synthesis of avenacin.  The enzymes that they encode are 
distinct and these genes are not tandem duplications (63).  Gene clusters of 
genes that share sequence relatedness are common in plants, for example, 
leucine rich receptor kinase genes required for specific disease resistance.  
Clusters which consist of unrelated genes acting in the same biosynthetic 
pathway, such as the Sad gene cluster in oats, are uncommon, but recently a 
number of functional gene clusters for metabolic pathways have been discovered.  
These are the cyclic hydroxamic acid (DIBOA) pathway in maize (66, 78-79), the 
triterpene thalianol pathway in Arabidopsis (65) and the diterpenoid momilactone 
and phytocassane pathways in rice (80-81).  As many of the genes found in 
eukaryotic metabolic pathways are generally unlinked, questions have been 
raised as to how these gene clusters originated and persisted in the genome.  
There are many advantages of clustering of genes belonging to a metabolic 
pathway, for example, by facilitating regulation and coordinated expression of the 
pathway genes; and promoting the inheritance of genes that confer a selective 
advantage to the plant.  Furthermore,  disruption of the cluster may lead not only 
to loss of the advantageous effect of the pathway but also in accumulation of 
deleterious intermediates which are detrimental to plant survival (82).  How these 
clusters have assembled in plants is currently not well understood, but is thought 
to have occurred through gene duplication, acquisition of new function, and 
genome reorganization rather than horizontal gene transfer from microbes (64-
65). 
 Currently three of the genes in the avenacin biosynthetic cluster have 
been cloned and characterised, Sad1, Sad2 and Sad7; and the Sad3 and Sad4 
loci have also been partly characterised (35, 49, 61-62).  This has allowed 
elucidation of the individual steps of the avenacin pathway and facilitated the 
search for gene clusters in cereals and other plants. 
 
1.3.5.1 Sad1 – β-amyrin synthase (AsbAS1) 
 The first gene from the oat pathway to be characterised was the gene for 
β-amyrin synthase.  Evidence showed that β-amyrin and avenacins are 
synthesised in the root tip and β-amyrin synthase activity was also observed 
there (26, 83).  Two cDNA libraries were constructed from the root tips of Avena 
strigosa and sequence analysis identified two putative OSC sequences.  One had 
high homology to cycloartenol synthases from other plants so was presumed to 
be the Avena strigosa cycloartenol synthase (AsCAS), but the other sequence was 
clearly distinct from AsCAS (55% homology) so was postulated to be the Avena 
strigosa β-amyrin synthase (AsbAS1) (49).  The putative β-amyrin synthase 
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cDNA sequence was cloned into the yeast expression vector pYES2 and 
transformed into the yeast strain GIL77 which accumulates 2,3-oxidosqualene 
due to a lack of lanosterol synthase (84).  HPLC analysis of the yeast cells 
expressing the putative AsbAS1 cDNA accumulated β-amyrin thus confirming that 
the cDNA encoded β-amyrin synthase.  Amino acid sequence analysis showed 
that AsbAS1 is distinct from other β-amyrin synthases and demonstrated closer 
homology to lanosterol synthases from animals and fungi than to other plant 
cyclases.  AsbAS1 was a novel enzyme and therefore defined in a new class of β-
amyrin synthases (49). 
 Further analysis found AsbAS1 to be synonymous with the Sad1 locus.  
Radiochemical feeding experiments on the original ten sad mutants identified two 
mutants (#109 and #610) that represented mutant alleles at a locus termed 
Figure 1.9: Characterisation of the Sad1 locus 
A. Identification and characterisation of sad1 mutants by GC analysis of root extracts from the wild-
type S75 and mutant #109.  Mutant #109 accumulates 2,3-oxidosqualene which was identified using 
MS data.  The vertical bar indicates relative mass abundance.  Figure adapted from Qi et al. (2006) 
(61). B. Northern blot analysis of RNA from roots of different cereals using oat cycloartenol synthase 
(CS) and oat β-amyrin synthase (βAS) probes.  RNA levels were monitored using methylene blue dye 
(MB).  Lane 1, A. strigosa S75; lane 2, A. longiglumis; lane 3, A. strigosa accession no. CI1994; lane 
4, A. strigosa accession no. CI13815; lane 5, Triticum aestivum (cultivar Riband); lane 6, Hordeum 
vulgare (cultivar Golden Promise); lane 7, Oryza sativa (accession M12); and lane 8, Zea mays 
(accession P10).  Figure adapted from Haralampidis et al. (2001) (49). 
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Sad1.  Both of these mutants accumulated 2,3-oxidosqualene and lacked β- 
amyrin and also had no detectable β-amyrin activity, which indicated that that 
they were likely to contain mutations in the β-amyrin synthase gene itself or a 
gene involved in regulation of its expression (Figure 1.9A).  Sequencing of the β-
amyrin synthase gene in both of the mutants found single point mutations which 
resulted in premature termination of translation codons being predicted.  These 
results together with single nucleotide polymorphism (SNP) analysis, which 
showed that the sad1 phenotype cosegregated absolutely with the mutations in 
the AsbAS1 gene, provided convincing evidence that Sad1 locus encoded AsbAS1 
(49, 83). 
 More detailed analysis of the Sad1 locus found that Sad1 mapped to a part 
of the oat genome named Oisu441 which is found on linkage group AswC (85).  
This region of the oat genome has overall synteny with chromosome six in the 
rice genome, however high homology sequences corresponding to Sad1 or 
Oisu441 are not observed.  Northern blot analysis of RNA from cereal root 
extracts confirmed that Sad1 transcripts are only present in oats whereas 
cycloartenol synthase expression was found in all cereals tested (Figure 1.9B).  
Together, this data showed that the β-amyrin synthase gene is found in a region 
of the oat genome which is not conserved in other cereals (49). 
 
1.3.5.2 Sad2 – cytochrome p450 sterol demethylase (AsCYP51H10) 
 In 2006, the second enzyme in the avenacin pathway was cloned from the 
oat cDNA library and found to be a cytochrome P450 monooxygenase.  The gene 
was identified by extension of the BAC contig surrounding the Sad1 gene and 
found to be homologous with cytochrome P450 monooxygenases, specifically  
obtusifoliol 14α-demethylase, and was named AsCYP51H10 according to 
cytochrome P450 nomenclature.  Sequence analysis placed AsCYP51H10 in the 
avenacin gene cluster, 66,828 base pairs downstream of Sad1 with no open 
reading frames (ORFs) between the two genes.  Cytochrome P450s have been 
implicated in avenacin biosynthesis and as AsCYP51H10 expression was only 
found in oat roots, in a similar to pattern to Sad1 expression, this suggested a 
role in avenacin biosynthesis (Figure 1.10A) (61). 
 Further analysis found AsCYP51H10 to be synonymous with the Sad2 
locus.  The AsCYP51H10 gene in each of the ten original sad mutants was 
sequenced to ascertain whether it corresponded to any of the loci defined by  
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Figure 1.10: Characterisation of the Sad2 locus 
A. In situ mRNA analysis of Sad1 and Sad2 transcripts in the root tips of A. strigosa.  Avenacin 
synthesis is restricted to the epidermal cell layer of the root tip and AsCYP51H10 expression is 
restricted to this location indicating that it is involved in avenacin synthesis.  B.  Identification and 
characterisation of sad2 mutants by GC analysis of root extracts from the wild-type S75 and mutant 
#791 and #1027.  Mutant #791 and #1027 both accumulate β-amyrin which was identified using MS 
data.  The vertical bar indicates relative mass abundance.  C. Modelling of the active site cavity of the 
oat sterol 14α-demethylase (left) and AsCYP51H10 (right).  AsCYP51H10 has a larger active site cavity 
than other sterol demethylases indicating acquisition of a different function.  All figures adapted from 
Qi et al. (2006) (61). 
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mutation.  Single point mutations were found in the coding region in two mutants 
(#791 and #1027) that represented mutant alleles at the Sad2 locus.  Previous 
radiochemical feeding experiments and GC-MS analysis had shown both of these 
mutants accumulated β-amyrin indicative of a block in the pathway after the 
AsbAS1 enzyme (Figure 1.10B).  Screening of the extended mutant collection 
revealed six additional sad2 mutants which accumulated β-amyrin and also had 
single point mutations in the AsCYP51H10 gene.  This evidence confirmed that 
AsCYP51H10 corresponded to the Sad2 locus. 
 Sad2 is a member of the CYP51 sterol demethylase family, an ancient and 
highly conserved family thought only to be involved in sterol synthesis.  Members 
of this family from bacteria, protozoa, fungi, animals and plants share 34 
conserved amino acid residues, however AsCYP51H10 shares only 28 of these 
conserved residues with the remaining six residues being divergent.  These six 
residues are found in conserved substrate recognition sites or regions important 
for enzyme structure and/or function.  Active site comparisons show the active 
site of AsCYP51H10 to be much larger than other demethylases and this, together 
with the sequence information indicates that AsCYP51H10 has acquired a different 
function from the other enzymes in the CYP51 class (Figure 1.10C).  Phylogenetic 
analysis also indicates that the CYP51H family to which AsCYP51H10 belongs has 
evolved from the conserved CYP51G family which is responsible for plant sterol 
biosynthesis (61).  This evidence parallels the evolution of the Sad1 gene which is 
predicted to have arisen from a primary sterol cycloartenol synthase-like gene 
ancestor (63).  These results show a connection between primary and secondary 
metabolism in plants as both Sad1 and Sad2 have been linked with two 
independent steps in the primary sterol pathway.  This indicates that enzymes 
involved in secondary metabolic pathways are likely to have been recruited from 
ancestral primary metabolic enzymes (61).  The specific function of AsCYP51H10 
is currently under investigation in the Osbourn lab and it is known that the 
enzyme is involved in at least one hydroxylation step to modify the β-amyrin 
product following AsbAS1 catalysis.  However there are a number of oxidation 
steps that modify the β-amyrin ring structure and it is unknown how many of 
these steps are catalysed by AsCYP51H10 (86). 
 
1.3.5.3 Sad 7 – Serine carboxypeptidase-like acyltransferase (AsSCPL1) 
 In 2009, the third enzyme in the avenacin pathway was cloned and 
characterised.  Two out of the ten original sad mutants (#376 and #616) 
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Figure 1.11: Characterisation of the Sad7 locus 
A. Structure of avenacin A-1 and des-acyl avenacin.  All four avenacins are esterified with N-methyl 
anthranilate at the C-21 position of the aglycone.  Des-acyl avenacins lack this esterified group and 
accumulate in sad7 mutants. Bi). RNA gel blot analysis of Sad1, Sad2 and SCPL1 transcripts in 
different oat tissues: root (R), shoots (S), leaves (L),  flowers (F).  RNA loading was monitored with 
methylene blue dye (MB).  ii). In situ mRNA analysis of Sad1 (left) and SCPL1 (right) transcripts in the 
root tips of A. strigosa.  In both i) and ii) SCPL1 shows an identical expression pattern to Sad1 and 
Sad2 indicating that it is involved in avenacin synthesis.  C. Identification and characterisation of sad2 
mutants by LC-MS analysis of root extracts from the wild-type S75 and mutant #376.  The wild-type 
accumulates avenacins whereas mutant #376 lacks avenacins and accumulates des-acyl avenacins.  
All figures adapted from Mugford et al. (2009) (62). 
 
Avenacin Des-acyl avenacin
R S L F
Sad1
Sad2
SCPL1
MB
Sad1 SCPL1
S75(WT)
#376 (sad7)R
e
la
ti
v
e
 i
n
te
n
s
it
y
 
(%
)
Retention time (min) 
Avenacin:  A2    A1  B1
Des-acyl avenacin:
A  B
A
B 
C
i) ii)
Chapter 1 – Introduction 
 
 
23 
were found to accumulate des-acyl avenacins (avenacin lacking the N-methyl 
anthranilate group at C-21).  This indicated that they were deficient in acylation, 
and so represented independent mutant alleles at a locus termed Sad7 and 
possibly lacked a functional acyltransferase (Figure 1.11A) (18, 63).  Genetic 
analysis had shown the Sad7 locus cosegregated with the Sad1 and Sad2 loci 
(63), therefore the BAC contig that spanned the Sad1 and Sad2 region was 
extended.  A third gene was discovered 62 kb upstream of the Sad1 gene and 
was found to encode a serine carboxypeptidase-like acyltransferase (AsSCPL1).  
Gel blot and in situ localisation analysis showed that the expression of AsSCPL1 
was restricted to the epidermal cells of the root tip which is an identical pattern to 
the other two members of the avenacin biosynthetic pathway, AsbAS1 and 
AsCYP51H10 (Figure 1.11B).  Sequencing of the AsSCPL1 gene in mutant nos. 
376 and 616 revealed single point mutations that were predicted to result in 
amino acid substitutions.  Another sad7 mutant (#19) was identified from the 
extended mutant collection that also accumulated des-acyl avenacins and that 
had a single point mutation in the AsSCPL1 gene (Figure 1.11C).  Together these 
data provide strong evidence that AsSCPL1 was encoded by the Sad7 locus and 
that it was likely to be involved in avenacin acylation (62). 
 The Sad7 gene encodes a 493 amino acid protein which has an N-terminal 
signal peptide, possibly for targeting to the vacuole where avenacins are known 
to accumulate (35).  Removal of the signal peptide results in a 51.4 kDa protein 
which is formed of a large and small subunit, 29 kDa and 19 kDa respectively, 
joined by a linker region.  To produce a functional protein product, the full-length 
protein is predicted to undergo cleavage in a two step process to remove the 
linker region and form a heterodimer from the large and small subunits.  Analysis 
of AsSCPL1 protein levels in the three sad7 mutants using an AsSCPL1 antibody 
show that no protein is present in mutant #616 and #19 whereas mutant #376 
has reduced protein levels.  The location of the mutation in mutant no. 376 was in 
a loop region in the active site so may affect protein activity, and the location of 
the mutations in mutant #616 and #19 are both in β-sheets which form part of 
the secondary structure of the protein so are likely to cause misfolded protein 
resulting in protein degradation (62).  
 Functional characterisation of the three sad7 mutants found that all three 
accumulated N-methyl anthraniloyl-O-glucose in the roots compared to the wild-
type which implied that AsSCPL1 uses an O-glucose ester as the acyl donor 
substrate.  To test this hypothesis, AsSCPL1 was expressed in Nicotiana 
benthamiana leaves using a virus-based system and an AsSCPL protein 
preparation was incubated with methanolic extracts from the roots of sad7 
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mutants (which contain des-acyl avenacins and the glucose ester N-methyl 
anthraniloyl-O-glucose, the presumed substrates for AsSCPL1).  The reaction 
products were analysed by LC-MS and resulted in production of all four avenacins 
(A-1, A-2, B-1 and B-2) which indicated that AsSCPL can catalyse the transfer of 
both N-methyl anthraniloyl and benzoyl groups onto des-acyl avenacins (62). 
 
1.3.5.4  Sad3 and Sad4 – glucosyltransferases? 
 In addition to modification of the β-amyrin triterpene skeleton by oxidation 
(Sad2) and acylation (Sad7), it is known that β-amyrin is also acted on by 
glucosyltransferases which add the branched sugar chain onto C-3 of the 
aglycone and also play a part in activation of the acyl group which is added at C-
21 by AsSCPL1 (18, 87).  Glycosylation at C-3 of the aglycone occurs late in the 
pathway and is critical for the antifungal activity of avenacin, as removal of even 
a single sugar results in loss of potency (88).  Mutants at two of the loci identified 
in the mutant screen, Sad3 and Sad4, accumulate monodeglucosyl avenacin A-1 
which lacks the β-1,4–linked D-glucose, indicating that both of these loci are 
involved in glucose addition possibly by encoding glucosyltransferases (GTs) or 
regulating their expression (Figure 1.12A) (83).  GTs are a large enzyme family 
that catalyse the transfer of sugars to a wide variety of acceptor molecules.  
There are 77 GT families of which GT Family 1 is the largest and is mainly 
responsible for transferring sugar molecules onto low molecular weight molecules 
such as avenacin A-1 (89).  Therefore it is likely that the GTs responsible for 
glycosylation of the aglycone are members of Family 1 GTs.  Analysis of the 
expressed sequence tag (EST) library constructed from oat root tips revealed 27 
sequences with similarity to Family 1 GTs.  A number of these candidate cDNA 
sequences have been cloned for heterologous expression in bacteria and it is 
hoped that functional analysis of these enzymes to determine their donor and 
acceptor profiles will enable the discovery of GTs that are involved in avenacin 
synthesis (90). 
 Further characterisation of sad3 and sad4 mutants revealed that as well as 
being deficient in avenacin synthesis, they also have stunted roots and reduced 
numbers of root hairs.  Further analysis using propidium iodide staining, 
calcofluor staining and electron microscopy revealed that membrane trafficking 
had been disrupted in root epidermal cells.  Calcofluor staining showed that 
accumulation of callose and other primary cell wall components disrupted the 
epidermal cell layer resulting in root hair deficiency (Figure 1.12B).  To ascertain  
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Figure 1.12: Characterisation of the Sad3 and Sad4 loci 
A.  Structure of avenacin A-1.  sad3 and sad4 mutants accumulate monodeglucosyl avenacin A-1 
which lacks the β-1,4–linked D-glucose at the position indicated by a black line.  B.  Calcofluor 
staining of oat meristematic root cross sections of wild type S75, sad3 and sad4 mutants.  Calcofluor 
staining aggregates (arrows) are seen in both sad3 and sad4 mutants. C, cortex; E, epidermis.  Bars 
= 50µm.  C.  Root phenotypes of 4-day old seedlings of sad1/sad1 sad4/sad4 double mutants.  sad4 
mutants in a wild type Sad1 background have a mutant root morphology whereas in a sad1 mutant 
background (where the avenacin pathway is blocked) normal root morphology is seen.  Similar results 
were seen for sad3 mutants.  All figures adapted from Mylona et al. (2008) (35). 
 
whether these root defects were a direct result of sad3 and sad4 mutations or as 
a result of additional mutations, both of the sad3 and sad4 mutations were 
introduced into a wild-type, heterozygous and homozygous Sad1 backgrounds.  
A
B
C
S75 (WT) sad3 (#1139) sad4 (#9)
Sad4 (#9) Sad1Sad1
sad4sad4
sad1sad1
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In the wild-type background, root defects are still observed, but in a homozygous 
sad1 mutant (where the avenacin pathway is blocked) root defects are 
suppressed (Figure 1.12C).  This implies that monodeglucosyl avenacin A-1, 
which accumulates in sad3 and sad4 mutants, causes the observed root defects.  
The results also indicated that Sad3, which is found in the avenacin gene cluster, 
has a specific role in avenacin synthesis whereas Sad4, which is unlinked, has a 
much broader function (35). 
1.4 Oxidosqualene cyclases in plants, animals and fungi 
 Even though the avenacin pathway is restricted to oats, the initial step of 
2,3-oxidosqualene cyclisation into lanosterol, cycloartenol, β-amyrin, lupeol and 
other sterol and triterpene precursors is observed in all plants.  Studying other 
triterpenoid synthase pathways has given great insights into the enzymes 
involved in triterpenoid production.  By studying homologous genes in other plant 
species, information relating to evolution of the pathways; enzyme structure and 
mechanism; product specificity and pathway regulation has enabled further 
understanding of triterpenoid synthesis and the origins of these fascinating and 
complex pathways. 
 
1.4.1 Cloning of oxidosqualene cyclases involved in sterol production 
 The first sterol OSC to be cloned from any organism was lanosterol 
synthase from Candida albicans by complementation of a Saccharomyces 
cerevisiae OSC mutant (erg7) which lacked lanosterol synthase activity (91-92).  
As lanosterol synthase is crucial for membrane sterol synthesis (ergosterol in 
fungi), erg7 mutants were unable to grow without exogenous ergosterol.  
Complementation of the ERG7 gene by the lanosterol synthase sequence in C. 
albicans confirmed that ERG7 encoded a lanosterol synthase (91).  PCR cloning 
using degenerate primers complementary to homologous regions from other 
cloned OSCs and complementation of the erg7 mutant has been used for cloning 
of seven lanosterol synthases from the fungi Schizosaccharomyces pombe (93), 
Saccharomyces cerevisiae (94), Pneumocystis carinii (95) and Cephalosporium 
caerulens (96); the parasitic protozoa Trypanosoma cruzi (95); animals Homo 
sapiens (97-98) and Rattus norvegicus (99); and the bacterium Methylococcus 
capsulatus (100).  Whole genome sequencing of a number of animals and fungi 
has resulted in identification of a number of putative lanosterol synthase 
sequences which are all targets for future cloning and functional characterisation. 
 In plants, cycloartenol synthase converts 2,3-oxidosqualene to 
cycloartenol, the major precursor for sterol synthesis.  Cloning of cycloartenol 
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synthases could not be done simply by complementation of the erg7 S. cerevisiae 
mutant as for the lanosterol synthases as yeast does not synthesise cycloartenol 
synthase.  The erg7 mutant was instead utilised for heterologous expression of 
putative cycloartenol synthase cDNA sequences and researchers took advantage 
of 2,3-oxidosqualene accumulation in the mutant which could be used by the 
expressed gene to generate a novel cyclisation product that was detected by TLC, 
HPLC or GC-MS analysis (101).  Subsequently the first cycloartenol synthase gene 
was cloned from Arabidopsis thaliana and subsequently over 20 cycloartenol 
synthases have been isolated from a wide variety of plant species by sequence 
homology.  To date, cycloartenol synthases have been cloned from dicots (102-
111), monocots (49, 53, 112), a gymnosperm (Abies magnifica) and a fern 
(Adiantum capillus-veneris) (113).  Functional cycloartenol synthases have also 
been cloned from a soil amoeba (Dictyostelium discoideum) (114) and a 
myxobacteria (Stigmatella aurantiaca) (115) which show approximately 50% 
homology to the plant cycloartenol synthases.  This implies that cycloartenol 
synthases from bacteria and plants are orthologous and represent a highly 
conserved and important class of OSCs that predates the emergence of plants 
(116). 
 Experiments carried out by Gibbons et al. in 1971 provided strong 
evidence that the precursor of sterols in plants and other photosynthetic 
organisms was cycloartenol, whereas in animals and fungi lanosterol was used 
(117).  However, studies in Euphorbia identified lanosterol in a non-polar fraction 
of the latex that could not be made via conversion of cycloartenol which 
suggested that plants may contain a lanosterol synthase (118-120).  A candidate 
lanosterol synthase protein sequence was found in Arabidopsis thaliana with 64% 
identity to the cycloartenol synthase protein sequence.  Complementation of a 
lanosterol synthase-deficient yeast and functional expression found the candidate 
sequence to be a functional lanosterol synthase and functional lanosterol 
synthases have since been cloned from Lotus japonicus (121) and Panax ginseng 
(120).  Phylogenetic analysis has shown lanosterol synthases to be widespread 
amongst dicots and to have a different evolutionary origin from animal and fungal 
lanosterol synthases (47). 
 
1.4.2 Cloning of oxidosqualene cyclases involved in triterpene production 
 For primary metabolism most organisms contain one sterol OSC, either a 
cycloartenol synthase or a lanosterol synthase, which synthesises a single sterol 
precursor, cycloartenol or lanosterol respectively.  Production of triterpenes by 
secondary metabolism can be catalysed by numerous enzymes in a single plant 
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species.  Compared to the sterol OSCs, collectively the triterpene OSCs produce 
many more cyclic products.  Some OSCs are specific, producing a single product, 
but many are promiscuous and produce numerous different products which add to 
the diversity of secondary metabolites found in plants.  Production of triterpenoids 
through secondary metabolism is a process that is mostly found in plants but is 
also seen in fungi and sea cucumbers (122), the only animals to produce 
triterpenoids.  Over the last twelve years, a wide variety of triterpene OSCs have 
been cloned from a number of plant species and one basidiomycete. 
 The first plant triterpene OSC to be cloned was a β-amyrin synthase from 
the roots of Panax ginseng using homology-based PCR methods (111).  A number 
of β-amyrin synthases have since been cloned from dicots and represent the 
largest group of plant triterpene OSCs (54, 56, 75, 77, 104, 109, 111, 123-128).  
β-amyrin synthase from the monocot Avena strigosa (AsbAS1) is the only 
triterpene OSC to be cloned from monocots to date and represents a novel class 
of β-amyrin synthases (49).  Triterpene OSCs show far less sequence 
conservation than their sterol synthase counterparts (approx. 50% compared to 
75%) and the large phylogenetic separation of dicot and monocot sequences 
suggests that the two groups evolved β-amyrin synthases separately (63). 
 The second largest group of triterpene OSCs are the lupeol synthases 
which cyclise 2,3-oxidosqualene to the pentacyclic product lupeol.  The first lupeol 
synthases to produce solely a lupeol product were cloned from Olea europaea and 
Taraxacum officinale in 1999 (105).  Other lupeol synthases have since been 
cloned from Betula platyphylla (104), Glycyrrhiza glabra (129), Lotus japonicus 
(109) and Bruguiera gymnorrhiza (56), with the latter forming a new branch of 
lupeol synthases.  These enzymes are phylogenetically distinct from other OSCs, 
but show 74-81% sequence homology to each other (116).  There are also two 
multifunctional triterpene OSCs which synthesise lupeol as their major product 
and these have been cloned from Arabidopsis thaliana (52, 130) and Ricinus 
communis (107). 
 The majority of single product enzymes that have been cloned are either 
β-amyrin synthases or lupeol synthase but over 90 different triterpene skeletons 
exist in nature so this implies that there are also more triterpene OSCs that have 
not yet been discovered.  Currently through homology based PCR methods, four 
novel triterpene OSCs have been cloned that synthesise pentacyclic or tetracyclic 
triterpenes; isomultiflorenol synthase (Luffa cylindrica), cucurbitadienol synthase 
(Cucurbita pepo) and dammarenediol-II synthase (Panax ginseng and Centella 
asiatica).  The remainder of the triterpene OSCs that have been cloned to date 
fall into the category of multifunctional triterpene OSCs, in that they synthesise 
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more than one triterpene product (53-56, 131-134).  The products that they 
produce include β-amyrin, α-amyrin, lupeol, taraxasterol, germanicol, 
butyrospermol and many others. 
 The only non-plant triterpene OSC to be cloned to date is clavarinone 
cyclase from the basidiomycete Hypholoma sublateritium which catalyses the 
conversion of 2,3-oxidosqualene to clavaric acid (135).     
 
1.4.3 Alternative strategies for cloning plant oxidosqualene cyclase genes 
 Most OSCs to date have either been cloned via functional complementation 
or sequence homology and their products identified by TLC, HPLC, GC-MS or 
natural product isolation.  Systematic analysis of fully sequenced plant genomes 
is now being used to identify new enzymes that are involved in natural product 
synthesis.  The technique requires a whole genome sequence of a particular 
organism from which protein-encoding regions are identified and functions are 
assigned to each of the regions based on their homology to other genes of known 
function (136-138).  As more plant genomes become fully sequenced, this will 
enable the whole OSC gene family to be uncovered.  It also allows more sensitive 
probing of plant genomes in order to identify new triterpenoids and by coupling 
this process to heterologous expression, may uncover new biosynthetic pathways 
and low-abundance natural products (57, 116). 
 Using this technique in Arabidopsis thaliana facilitated the cloning of a 
number of enzymes which generate new triterpenoid products including those 
with partially cyclised triterpene skeletons.  These enzymes include, a 
multifunctional triterpene OSC (139), thalianol synthase (57), marneral synthase 
(140), arabidiol synthase (60), camelliol synthase (141), baurol synthase (58) 
and β-amyrin synthase (128).  Many of these products were thought not to occur 
in nature, but recently, low levels of thalianol have been detected in Arabidopsis 
roots which matched the expression pattern of thalianol synthase (AtTHAS).  
Analysis of the genomic region surrounding the AtTHAS gene uncovered two 
cytochrome P450s and an acyltransferase.  Both of these enzyme classes have 
been implicated in secondary metabolism and mutational analysis revealed that 
both P450s modify the thalianol gene product and provided strong evidence for a 
novel biosynthetic pathway in Arabidopsis (65). 
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1.5 Structure-function relationships in plant OSCs 
1.5.1 Conserved features: vast product differences 
 One of the great mysteries surrounding OSCs is how one substrate can be 
converted to so many different products using only a handful of different 
enzymes.  One might think that these enzymes would be significantly different 
from each other, but sequence analysis has shown that they not only have highly 
homologous sequences but have also evolved from a common ancestor.  They 
also share common conserved features that identify them as OSCs. 
 OSC activity is generally associated with microsomes, and so OSCs were 
presumed to be membrane bound, but sequence analysis found no signal 
sequences or transmembrane domains.  Theories suggested the presence of a 
hydrophobic membrane-localising region which provided a different mechanism 
for OSCs to attach to the membrane (142).  This region has been observed on 
both the Alicyclobacillus acidocaldarius squalene cyclase (AaSHC) (143) and the 
Homo sapiens lanosterol synthase (hOSC) (144) crystal structures, thereby 
confirming that AaSHC and hOSC are monotopic membrane proteins.  Both 
structures have a hydrophobic surface of approximately 1.7Å2 which is encircled 
by a ring of polar residues which form salt bridges with the displaced head groups 
of the phospho- and sulpholipids and form the most likely passage for substrate 
access to the enzyme active site (143).  Mutagenesis and inhibitor binding studies 
in a wide variety of species have identified the catalytic motif DCTAE that is found 
in all OSCs (145-147).  Experiments with Rattus norvegicus lanosterol synthase 
and SHC showed that the aspartate in this conserved motif to be the catalytic 
residue required for initiation of the cyclisation reaction (146-147). 
 Another feature that is characteristic of all OSCs and squalene cyclases 
(SCs) is the QW motif.  It was first identified by Karl Poralla through comparisons 
of the AaSHC and Candida albicans lanosterol synthase amino acid sequences.  
Upon aligning the sequences he found four to five repetitions of approximately 16 
amino acids which formed the consensus motif: (R/K)-(G/A)-X2-3-(F/Y/W)-(L/I/V)-
X3-Q-X2-5-G-X-W.  The motif, which is found in β-turns, was named QW due to 
the presence of glutamine and tryptophan residues at the end of the motif (148).  
The AaSHC crystal structure showed that these two residues stabilise the protein 
structure by stacking together and forming hydrogen bonds with the amino end of 
the adjacent outer barrel helix and the carbonyl end of the preceding outer barrel 
helix.  This connects the outer helices of the alpha helical barrel which stabilises 
the protein structure (143).  AaSHC has eight QW motifs whereas the OSC 
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enzymes have fewer motifs with only five but are presumed to have the same 
function as seen in the SCs (144).   
 In addition to the DCTAE catalytic motif and the QW motifs, SCs and both 
sterol and triterpene OSCs have a number of residues that are both common and 
exclusive to each class of cyclase.  These residues play a large role in the 
enzymatic cyclisation mechanism and are responsible for product determination in 
each of the enzymes. 
 
1.5.2 Solving the structures of triterpenoid cyclases 
 The question of why sterol and triterpene synthases, which have 
considerable sequence homology and conserved features, produce such diverse 
products has been at the forefront of secondary metabolite research for many 
years.  Large advances have already been achieved through the cloning of 
enzymes involved in sterol and triterpene synthesis in a wide variety of plant 
species.  Mutagenesis experiments too, have allowed the elucidation of many of 
the important residues required for cyclisation.  Whilst this data is invaluable to 
deciphering the inner workings of one of the most complex reactions in nature, 
they cannot provide the whole story.  The ability of these enzymes to synthesise 
different products is most likely to be due to subtle differences in amino acid 
residues and active site orientations.  This information can easily be obtained 
from crystal structures and the ability to crystallise enzymes with substrates, 
intermediate analogues and products bound would give vital clues into the 
enzymatic mechanism. 
 Membrane proteins represent about one third of the genome but have 
traditionally been difficult to crystallise, with less that 1% having known crystal 
structures.  Expressing eukaryotic membrane proteins in prokaryotes is 
problematic due to the different membrane constituencies of the organisms and 
the inability of bacterial hosts to post-translationally modify eukaryotic proteins.  
Protein purification is also difficult due to the hydrophobic nature of the 
membrane spanning regions of these proteins, and usually requires a delicate 
balance of detergents to solubilise the proteins.  The final challenge lies in 
forming viable crystals, as detergents have complex phase behaviour that hinders 
the formation of well-ordered crystals (149).  As a result, only two structures 
exist for triterpene cyclases, the bacterial SC (AaSHC) and the human OSC 
(hOSC).  No structures currently exist for any of the plant OSCs. 
 The Alicyclobacillus acidocaldarius squalene cyclase (AaSHC) was the first 
of its kind to be cloned from bacteria.  It was expressed in Escherichia coli, 
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Figure 1.13: Crystal structure of Alicyclobacillus acidocaldarius squalene cyclase (AaSHC) 
A.  Stereoview of AaSHC with labelled amino (N) and carboxy (C) termini.  Structure consists of two 
α-helical domains: Domain 1, external helices – royal blue; internal helices – light blue. Domain 2, 
external helices – dark pink; internal helices – light pink; β-sheet structure – green; QW motif – 
orange; non-polar plateau – yellow.  B.  Top view of domain 1 - α-helical barrel forms two concentric 
rings that are stabilised by QW motifs (orange). 
 
purified by anion-exchange chromatography and gel filtration, and produced 
protein crystals that diffracted at 2.9Å resolution (150).  Analysis of the crystal 
structure revealed two domains, domain 1 - an α6-α6 barrel consisting of two 
concentric rings of helices, and domain 2 - an α- α barrel, with the loops of both 
domains forming a β-structure which encloses a 1200Å3 cavity.  The QW motifs 
are found in almost identical conformations, and the stacked glutamine and 
tryptophan side chains connecting several of the outer helices via hydrogen bonds 
which stabilise the structure (Figure 1.13).  There is a non-polar gated channel 
leading from the membrane to the central cavity and this provides the path for 
substrate access to the active site (143). 
 The Homo sapiens lanosterol synthase (hOSC) was cloned in 1995 (97), 
and in 2004 was expressed in Pichia pastoris.  It was purified using metal-chelate 
chromatography and gel filtration and crystals produced by the vapour diffraction 
method diffracted to 2.0Å resolution (151).  Analysis of the crystal structure 
revealed a similar structure to the bacterial enzyme: two α-α barrel domains 
connected by loops which formed three β-structures.  The QW motifs were found 
in the same conformation as AaSHC and an additional domain was found at the 
amino-terminus in between the two domains and may play a role in stabilising 
their orientations (Figure 1.14).  The active site cavity is located between the two  
Domain 1
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Figure 1.14: Crystal structure of Homo sapiens lanosterol synthase (hOSC) 
A.  Stereoview of hOSC.  Structure consists of two α-helical domains: Domain 1, external helices – 
royal blue; internal helices – light blue. Domain 2, external helices – dark pink; internal helices – light 
pink; amino-terminal domain – red; β-sheet structure – green; QW motif – orange; non-polar plateau 
– yellow; detergent molecules – yellow sticks.  B.  Top view of domain 1 - α-helical barrel of domain 1 
forms two concentric rings that are stabilised by QW motifs (orange). 
 
barrel domains and like AaSHC, a non-polar gated channel leads from the active 
site to the membrane.  Presence of bound detergent molecules indicate where the 
membrane-binding helix of the protein is and show that it is amphipathic, so 
inserts into the membrane but does not span it (144). 
 
1.5.3 Insights into enzyme mechanism 
 The extraordinary way in which essentially linear squalene and 2,3-
oxidosqualene are transformed into complex cyclic triterpenoids has been of huge 
interest to the field of science.  In recent years there has been much speculation 
about the exact nature of these reactions which have been investigated through 
studies with artificial substrates, inhibitors and site-directed mutagenesis.  
Elucidation of the structures of two cyclases has confirmed many of these 
theories and shed further light on both the conserved residues and cyclase 
specific residues found in these enzymes.  Due to the inability to isolate reaction 
intermediates triterpenoid synthesis was originally thought to be a concerted 
process in which cyclisation occurred in a single step (152).  However, work in 
the early eighties showed that cyclisation occurred through a number of rigid 
carbocation intermediates and was supported by the isolation of partially cyclised 
triterpenoid intermediates from the Mediterranean shrub Pistacia lentiscus (153-
154). 
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 Structure determination of AaSHC combined with data from mutagenesis 
and organic experiments allowed elucidation of the first mechanism for enzymatic 
triterpene cyclisation (143, 152, 155-164).  In the absence of an OSC crystal 
structure, the similarity of the bacterial and human cyclase, although having only 
26% identity, allowed a model of hOSC to be determined.  This gave further 
insight into the cyclisation differences between eukaryotes and prokaryotes at the 
atomic level (165).  Subsequently the structure of hOSC was solved and 
supported the conclusions drawn by the model (144). 
 The mechanisms for triterpenoid cyclisations between the two enzymes 
are very similar, with very few differences that promote the formation of the 
different products.  They consist of the same basic steps: binding of the substrate 
in a folded conformation, reaction initiation by protonation, ring formation, 
skeletal rearrangement and reaction termination by deprotonation (Figure 1.15).  
Before the reaction begins the substrates are pre-folded to promote cyclisation.  
Each ring is pre-folded into a chair conformation with the exception of the B-ring 
of 2,3-oxidosqualene which is folded into the energetically unfavourable boat 
conformation.  The B-ring is forced into this conformation by Lys331 and Tyr98 
which push the C10 methyl group below the molecular plane.  If cyclisation were 
to proceed via the favourable chair-like conformation, steric hindrance with the 
Tyr98 would cause deprotonation and premature termination of cyclisation, hence 
why the unfavourable boat conformation is formed (144).  
 Initiation of AaSHC and hOSC catalysis occurs via a conserved aspartate 
residue, Asp376 and Asp455 respectively.  In AaSHC, by bonding to His541, 
Asp376 has increased acidity and therefore increased protonating ability.  hOSC 
lacks an equivalent activating residue, but as epoxides such as 2,3-oxidosqualene 
are more readily protonated than alkenes such as squalene, this is expected.  
Instead in hOSC Asp455 is hydrogen bonded to two cysteines (Cys456 and 
Cys533) in order to become activated.  The activated aspartate protonates the 
first carbon-carbon double bond of squalene in AaSHC, and the epoxide group of 
2,3-oxidosqualene in hOSC to commence the cyclisation reaction (143-144, 156).  
 After initiation, ring formation occurs first with formation of the A-, B- and 
C-rings which occurs by a similar process in both enzymes.  Conserved aromatic 
residues promote stabilisation of the C6, C10 and C15 tertiary cations respectively 
via cation-π interactions.  Formation of the D-ring signals the branchpoint 
between AaSHC and hOSC mechanisms.  In AaSHC, the D-ring is formed first as 
a 5-membered carbon ring which upon stabilisation by surrounding aromatic 
residues is expanded to form a six-membered carbon ring.  In hOSC, a five- 
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Figure 1.15: Cyclisation mechanism for hOSC and AaSHC 
Scheme to show each of the cyclisation steps that convert squalene (AaSHC) and 2,3-oxidosqualene 
(hOSC) into the cyclic products hopene and lanosterol respectively.  The reaction is initiated by 
protonation of the substrate.  Cyclisation then takes place via the chair-chair-chair (AaSHC) or chair-
boat-chair (hOSC) conformations.  After ring formation is complete, skeletal rearrangements 
transform the cyclisation product to the final product cation which is then deprotonated to form either 
hopene (AaSHC) or lanosterol (hOSC).  Figure adapted from Schulz-Gasch and Stahl (2003) (165). 
above molecular plane
below molecular plane
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membered carbon D-ring is also formed but it is unable to be stabilised so the 
cyclisation cascade ends and the tertiary protosteryl cation is formed at C20.   
Cyclisation in AaSHC continues to generate a 5-membered carbon E-ring after 
which its cyclisation cascade ends.  This difference in ring number is due to a 
variation in amino acid identity between the two enzymes.  SHC contains two 
phenylalanine residues, Phe601 and Phe605 which stabilise the D-ring thereby 
facilitating the expansion of the D-ring and formation of the E-ring.  hOSC only 
contains one of these phenylalanine residues (corresponding to Phe601 in AaSHC) 
and therefore cannot stabilise the cation formed upon D-ring formation so the 
cyclisation cascade is terminated (144, 164). 
 Skeletal rearrangements then occur to convert the respective cations into 
their final products.  These rearrangements happen by 1,2-shifts of hydride and 
methyl groups which form the hopenyl cation in AaSHC and the lanosterol cation 
in hOSC.  Finally the reactions are terminated by deprotonation of the final 
cations to yield hopene or lanosterol respectively.  In AaSHC, this postulated to 
occur via a polarised water molecule that is found in a network of water 
molecules surrounding Glu45 (164).  In hOSC, the proton is abstracted from the 
lanosterol cation by Tyr503 which is hydrogen bonded to His232 (144). 
 It is clear that solving the structures of both SCs and OSCs has given huge 
insights into the mechanisms by which these remarkable enzymes turn a single 
substrate into a vast variety of products.  It is clear that to further understand 
the nature of these fascinating reactions, more crystal structures need to be 
solved which will provide vital clues as to how the product specificity of each 
enzyme is achieved. 
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Chapter 2 - Homology modelling of AsbAS1 
2.1 Introduction 
 When studying a particular protein, the best tool that can be used to gain 
insights into its structure is X-ray crystallography and generation of a crystal 
structure.  However, there are many obstacles that must be overcome on the way 
to generating a high resolution structure.  First a pure protein sample in milligram 
quantities is needed, followed by the right solution conditions in order to generate 
crystals.  Finally the crystals need to be of an appropriate quality to diffract and 
generate a high resolution image and hours of refinement are needed to generate 
the final structure.  None of these steps are trivial and sometimes can take years 
and be almost impossible to achieve, therefore researchers have had to employ 
other quicker methods, for example homology modelling, to study the structures 
of their proteins. 
 
2.1.1 Homology modelling of oxidosqualene cyclases 
 The Homo sapiens lanosterol synthase (hOSC) is one example where 
homology modelling was used in the absence of a crystal structure.  OSCs were 
rapidly becoming targets for antifungal, hypocholesterolemic and phytotoxic 
drugs due to their involvement at the early stages of both sterol and triterpene 
metabolism. However, due to problems expressing and purifying the enzymes 
because of their membrane-bound nature, no X-ray crystal structures had been 
solved.  The only related structure that was available was the Alicyclobacillus 
acidocaldarius squalene cyclase (AaSHC) which is involved in bacterial hopanoid 
synthesis, a homolog of eukaryotic sterols (143, 150).  Both OSCs and SCs have 
closely related sequences and mechanisms so were predicted to have a similar 
overall fold.  Although the hOSC and AaSHC sequences have only 26% identity 
over the whole sequence; in the active site cavity, identity rises to 50% indicating 
that an accurate model could be generated.  The hOSC model was generated 
using the AaSHC crystal structure as a template and the model produced was 
verified by testing a number of geometric parameters.  The model was then used 
to investigate OSC mechanism at a molecular level and the results supported data 
that had been gathered from mutagenesis and inhibitor studies (165).  
Knowledge about active site size and shape and substrate binding properties 
facilitated the design of novel drugs that had a more potent activity (166).  
Subsequently, when hOSC was crystallised in 2004 (144), the crystal structure 
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confirmed the mechanism hypotheses made from the homology model.  This 
study shows that homology modelling can provide a detailed and accurate picture 
of enzyme structure and function in the absence of a crystal structure. 
  
2.1.2 Site directed mutagenesis of oxidosqualene cyclases 
 In addition to structural investigations through homology modelling, site 
directed mutagenesis has also been used to identify specific amino acid residues 
involved in the enzyme mechanism of OSCs.  The majority of these experiments 
have been done using Saccharomyces cerevisiae lanosterol synthase (ScOSC), 
one of the first sterol OSCs to be cloned (94).  Site-directed mutagenesis 
experiments identified His234 (167), Phe445 (168), Trp232 (169), Tyr707 (170),  
Phe699 (171), Tyr510 (172) and Trp443 (173) as catalytically important residues 
as mutagenesis led to the accumulation of truncated cyclisation products.  As well 
as identifying catalytically important residues, mutagenesis experiments have 
also identified residues that define one type of OSC from another.  Studies in 
Arabidopsis thaliana cycloartenol synthase identified a single mutation, 
Tyr410Thr, that was sufficient to alter the product identity of the enzyme from 
cycloartenol to a mixture of lanosterol, parkeol and 9β-lanosta-7,24-dien-3β-ol 
(174).  Subsequent experiments identified five specific mutations which enabled a 
cycloartenol synthase to produce lanosterol as its sole product, Tyr410Cys, 
Ala469Val, His477Tyr, Ile481Thr and Tyr532His (175).  The only mutagenesis 
studies to be done in triterpene OSCs were carried out on Panax ginseng β-
amyrin synthase (PNY) and Olea europaea lupeol synthase (OEW).   The studies 
identified two residues, Tyr261 (PNY) and Trp259 (PNY)/Leu256 (OEW), which 
are responsible for producing pentacyclic products and altering the product 
identity of the enzyme from β-amyrin to lupeol respectively (176).  Both of these 
residues play vital roles in pentacyclic triterpene formation, but in the absence of 
a crystal structure or homology model for a triterpene synthase the exact role 
that they play in the OSC mechanism is unclear. 
  
2.1.3 Molecular dynamics simulations 
 Whether you determine enzyme structure from an X-ray crystal structure 
of a homology model the final structure will be a snapshot view of the enzyme in 
a single conformation.  If the structure has been crystallised with the substrate, 
intermediate or product bound then this can provide additional insights into either 
the binding, active site residues or one step in the enzyme mechanism.  However 
to see how enzyme structure changes throughout the mechanism from the native 
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protein to substrate binding, catalysis and finally to product release, another level 
of analysis is required.  Molecular dynamics (MD) simulates the movements of 
atoms and molecules over a fixed period of time using the known laws of physics 
and energetics.  It can be used to refine structures, simulate the positions of 
atoms and molecules in the structure and simulate the movement of the enzyme 
over the course of the whole reaction.  MD simulations have been used to develop 
atom interpretations of experimental results and to test hypotheses for enzyme 
mechanism (177).  MD has been used in the characterisation of a number of 
enzymes, for example, aquaporin 1 and the glycerol uptake facilitator which are 
involved in water and glycerol transport respectively (178).  MD has also been 
used by the pharmaceutical industry to test drug targets such as protein kinases 
(179) and to study early events in rhodopsin activation (180). 
 
2.1.4 Aims 
 Currently no crystal structures or homology models are available for any 
triterpene OSC, therefore in order to begin characterisation of Avena strigosa β-
amyrin synthase (AsbAS1) a homology model needs to be generated.  Reaction 
intermediates of 2,3-oxidosqualene cyclisation by AsbAS1 will be modelled into 
the active site using MD simulations which will allow detailed enzymatic 
mechanism of AsbAS1 to be explored.  The structure of AsbAS1 and its 
mechanism will then be compared to hOSC as well as amino acid sequence 
comparisons with plant OSCs sequences from a variety of species.  This 
information will be used to investigate the mechanistic differences between sterol 
and triterpene OSCs at a molecular level and lead to further understanding of how 
vastly different products are produced by highly homologous enzymes which all 
use the same substrate.  Key amino acid residues will also be identified, which 
can be used as targets for future site-directed mutagenesis experiments. 
 
2.2 Materials and methods 
2.2.1 Modelling the structure of AsbAS1 
2.2.1.1 Identification of homologous structures 
An NCBI-BLAST2 search (181) was carried out using as query the AsbAS1 
sequence against the set of proteins that had entries in the RCSB Protein Data 
Bank (PDB) (182).  Homologs were selected as candidates for homology 
modelling according to the quality of the structural data.  The validity of each 
candidate structure was analysed using the information available in the PDB.  
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Parameters that were taken into account were: sequence identity, resolution of 
the crystal structure, R-values, bond lengths and angles, number of outliers in the 
Ramachandran plot and the level of homology with the AsbAS1 sequence.  
Further analysis of the real space R-values were carried out for each residue of 
the candidate structures that had an anomalous R-value using the Uppsala 
Electron Density Server (EDS) (183).  The steric geometry of the candidate 
structures was analysed using MolProbity (184).  Finally, the oligomeric state of 
the structures was analysed using the Protein Quaternary Structure file server 
(PQS) (185).  Only monomeric structures were carried forward to the next stage 
of the modelling process. 
Based on this data analysis, the structures having the best homology, 
good steric and geometric values, the fewest number of outliers in the 
Ramachandran plot,  good quality electron density data (i.e. lowest number of 
residues with real space R-values above 0.3) and were monomeric were carried 
forward to the next stage of the modelling process. 
 
2.2.1.2 Sequence alignment and model generation 
 A structure-based sequence alignment of the AsbAS1 sequence with the 
selected template sequence was generated using FUGUE (186) and the resulting 
alignment was viewed using the CORE evaluation on the TCoffee server (187).  
Proposed insertion and deletions to the template sequence were visualised in 
PyMOL (188) to ascertain whether they could be accommodated into the 
candidate structures. 
 The structure-based sequence alignment was converted into a PIR-format 
alignment file and any minor adjustments to the alignment were made manually.  
The AsbAS1 model was then built using the automated comparative protein 
modelling program MODELLER v9.4 (189). 
 
2.2.1.3 Validation of ASbAS1 model 
Before the structural features of the model could be analysed, the validity 
of the structure was checked to determine if a reliable model had been produced.  
The overall energy of the structure was calculated using the Prosa II web server 
(190) and atomic volumes and dihedral angles for each residue in the structure 
were calculated using PROVE and PROCHECK respectively (191-192).  The 
coordinates of the AsbAS1 model and the template structure were submitted to 
each of the structure validation servers and the results were compared to 
determine how closely the AsbAS1 structure matched the template. 
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2.2.2 Sequence and phylogenetic analysis 
2.2.2.1 Multiple sequence alignment 
  An NCBI-BLAST2 search (181) was carried out using as query the AsbAS1 
protein sequence against a database containing non-redundant protein sequences 
of all known plant proteins.  The output was analysed and only full-length OSC 
sequences were selected for use in the final sequence alignment.  A multiple 
sequence alignment was generated using MUSCLE (MUltiple Sequence 
Comparison by Log-Expectation) (193) and sequence features were viewed and 
annotated using Jalview (194).  
 
2.2.2.2 Phylogenetic analysis 
 The MUSCLE sequence alignment of the plant OSCs was used for 
phylogenetic analysis.  MEGA 4.0 software (195) was used to construct a 
neighbour-joining phylogeny for assessment of sequence diversity. 
 
2.2.3 Molecular dynamics simulations 
2.2.3.1 Generating structures of AsbAS1 reaction intermediates  
Starting molecular structures for reaction intermediates were generated 
using high resolution crystal structures from the Cambridge Structural Database 
(CSD) (196).  Structures for the following intermediates were generated: 
dammarenyl cation based on entry DELWAT (197); baccharenyl cation based on 
entry XENQOX (198); lupenyl cation based on entry ACHLUP10 (199); oleanyl 
cation based on XICPAB (200); and the β-amyrin cation and β-amyrin based on 
DABWUZ (201).  Each intermediate was docked manually into the active site of 
the AsbAS1 model (which was superimposed onto hOSC) by alignment to the 
lanosterol molecule found in the crystal structure of hOSC.  Force-field 
parameters for each of the reaction intermediates were generated using the 
PRODRG server (202).   
 
2.2.3.2 Molecular dynamics simulations 
The position of each docked intermediate was refined with molecular 
dynamics (MD) simulations using GROMACS 3.1 (203) using the force-field 
parameters determined for each intermediate.  The procedure followed for the 
complex of the enzyme with each intermediate was essentially identical.  The 
AsbAS1 model in complex with an intermediate was solvated in a box of water 
molecules, counter ions were added and then underwent 2000 cycles of conjugate 
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gradient energy minimisation to relieve strain.  Position-restrained MD 
(restraining force constant 100 kcal mol-1Å-2) was conducted over 20ps of 
simulation using a time-step of 1.5 fsec, followed by position-unrestrained MD 
conducted over 100ps of simulation with the same time-step.  The final model 
structures were generated by energy minimising (2000 cycles, unrestrained) the 
structure coordinates obtained by averaging over the final 20ps of the position 
unrestrained simulation.  The structures were the viewed in PyMOL for analysis. 
 
2.3 Results and Discussion 
2.3.1 Modelling the structure of AsbAS1 
2.3.1.1 Sequence analysis 
Currently, no crystal structure is available for AsbAS1, so the model was 
created using crystal structure data from a homologous protein.  To serve as a 
template structure in homology modelling, any candidate protein required 
significant sequence homology to the target sequence and a crystal structure in 
the PDB.  The AsbAS1 cDNA sequence was translated into a protein sequence and 
the reading frame which contained the longest coding sequence was selected.  A 
preliminary BLAST analysis of this sequence showed that the AsbAS1 sequence 
showed 98% homology with β-amyrin synthases from other oat species and 
between 71-80% homology with cycloartenol synthases from other plant species 
(Appendix 1).  However, none of these protein sequences had crystal structures, 
so the BLAST search was repeated and restricted to sequences which had crystal 
structures in the PDB (Appendix 2).  The AsbAS1 sequence showed good 
homology with two protein structures in the PDB, the human lanosterol synthase 
(PDB ID: 1W6K) (144) and the bacterial squalene-hopene cyclase (PDB ID: 
2SQC) (143). 
 
2.3.1.2 Structural analysis and validation of template structures 
 The two candidate structures were analysed to determine their suitability 
to act as a template for the AsbAS1 model.  A number of parameters, described 
in Table 2.1 were tested using data obtained from crystal structure data 
(182) and MolProbity analysis.  Sequence identity denotes the percentage of 
amino acid residues that are identical between the template and target sequence.  
1W6K showed much higher sequence identity to AsbAS1 than 2SQC, and also had 
a higher sequence homology – 56% compared with 40% for 2SQC.  The 2SQC 
structure was solved at a slightly higher resolution than 1W6K, and also displayed  
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Table 2.1: Structural analysis of AsbAS1 sequence matches 
Table shows a summary of the structural parameters analysed for each of the crystal structures with 
sequence matches to AsbAS1.  Bond lengths and angle values denote the average standard deviations 
of all bonds in the structure from their mean value.  
 
bond length and angle values which had slightly fewer standard deviations away 
from the mean values.  However, Ramachandran plot analysis favoured 1W6K as 
all residues were found in allowed regions with 98% in favoured regions.  
Although 2SQC also had 98% of its residues in favoured regions, 4 residues were 
found in disallowed regions of the plot indicating steric hindrance between side-
chain and main-chain atoms. 
The R-value is a numerical value (expressed as a percentage) which 
denotes how well the refined structure fits the observed crystallographic data in 
terms of the observed structure factor amplitudes.  A typical value for fully 
refined structures is ten times its resolution (i.e. 20% for a 2.0Å resolution 
structure).  Many refinement programs now calculate the free R-value which is 
used as a form of validation and prevents over-refinement of the structure.  The 
free R-value is calculated in the same way as the R-value but uses 5-10% of the 
structure that is set aside and not used in the refinement of the model.  This 
value is usually 5-10% higher than the R-value.  Both candidate structures show 
free R-factors for the overall structure well within the expected values for 
structures at 2.0Å resolution.  Further analysis of the R-values focused on 
individual residues with anomalous real space R-values (those above 0.3 – three 
standard deviations from the mean).  The real space R-value is a measure of the 
similarity between the electron density map calculated from the experimental X-
ray diffraction data and the refined model.  It allows evaluation of the goodness 
of fit of individual residues in the refined model and can identify specific areas of 
the protein that need further refinement.  For residues with anomalous real space 
R-values, the electron density data was consulted to identify a possible reason for 
these anomalous values.  2SQC contained three deviant values which were all 
located on the protein surface in loops or turns.  These regions are often flexible 
so can result in poor electron density.  For example, the electron density map for 
2SQC: tryptophan 216 (Figure 2.1) shows that the protein structure is not 
consistent with the electron density map and therefore results in the high real 
984<0.5<0.50.1872.00232SQC
980<0.51.00.1882.10401W6K
Residues in 
favoured 
regions 
(%)
Number of 
outliers
Ramachandran plot
Bond angles 
(av. st. dev)
Bond lengths 
(av. st. dev)
R-Value 
(free)
Resolution 
of structure 
(Å)
Identity 
(%)
PDB ID
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space R-value that was observed for this residue.  Unfortunately, no electron 
density data was available for 1W6K, but due to the similarity of its R-value with 
2SQC it was assumed that any anomalous residues would be found in similar 
surface loop regions. 
Figure 2.1: Electron density of 2SQC – Trp 216 
The yellow net shows the electron density map obtained from X-ray crystallography (contoured at 1σ) 
and the local protein structure is shown in sticks format.  The regions not surrounded by a yellow 
electron density map indicate a poor fit between the protein structure and the electron density data.  
 
Finally the likely oligomeric state of the candidate structures was analysed 
using the PQS server.  Data available from the PDB indicated that 1W6K was 
present as a monomer in the asymmetric unit whereas 2SQC was present as a 
dimer.  The PQS server uses CCP4 (204) and WHATIF (205) programs to 
determine the association of the proteins in solution by calculating inter-chain 
atomic contacts.  The results predicted 1W6K to be a monomer and 2SQC to be a 
dimer with non-specific intersubunit contacts which supported the crystallographic 
data. 
This validation analysis showed the two candidate structures to be 
sufficiently reliable to serve as templates for homology modelling.  However 
1W6K displayed significantly higher overall sequence identity and was 
phylogenetically closer to AsbAS1, therefore it was chosen as the most 
appropriate crystal structure to model AsbAS1.  
 
Trp 216
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2.3.1.3 Structure based sequence alignment 
The first step in the modelling process was to align the AsbAS1 sequence 
to the chosen template sequence using the structure based sequence alignment 
program, FUGUE (186).  FUGUE aligns sequences based on the environment of 
each individual amino acid and structure-dependent gap penalty selection 
algorithms.  Each residue requires a particular environment which restricts amino 
acid substitutions, so by using environment-specific substitution tables, 
alignments are more precise.  Gap penalty algorithms take into account the 
position of residues in relation to secondary structure elements (SSEs).  Residues 
in SSEs or solvent inaccessible regions are generally more conserved than those 
in folded or solvent accessible regions, therefore insertions and deletions are less 
likely to occur in these conserved areas (186).  Unlike CLUSTALW (206), MUSCLE 
(193) or TCoffee (187), the FUGUE alignment creates a sequence alignment 
based on SSEs which promises to be more reliable. 
The FUGUE alignment was viewed using CORE evaluation on the TCoffee 
server (Figure 2.2).  This evaluates the consistency between each pair of aligned 
residues and places them on a coloured core index scale between 0-9 (blue-red).  
Residues with a core index ≥5 have a 90% chance of being correctly aligned 
(187).  Areas of red indicate strong sequence homology whilst yellow and blue 
areas indicate average and poor homology respectively.  Areas with extremely 
poor or no homology, such as insertions and deletions, have no colour.   
 Figure 2.2 shows that the majority of the residues are accurately aligned 
and have good sequence homology.  Comparison of the TCoffee alignment with a 
DSSP representation of secondary structure (207) revealed that areas of the 
alignment with poor homology corresponded to loop regions of the protein and 
were not present in alpha-helix or beta-sheet regions.  As loop regions have more 
variability, in terms of the residues that they contain, regions of low sequence 
homology are expected.  A large region containing no homology or alignment to 
1W6K was observed at the N-terminus of AsbAS1. This was a 33 amino acid 
insertion (residues 61-93) which was presumed to form a loop region immediately 
following the amino terminal domain.  Due to the large number of residues in this 
insertion it was postulated that it may have formed an additional secondary  
structure domain, but secondary structure predictions failed to assign any 
structure to this region.  A sequence alignment of the AsbAS1 sequence with a 
selection of plant OSCs from a variety of plant species revealed that these 
enzymes also contained the same inserted region which was restricted to plants 
and not present in bacteria or other eukaryotes.  This region had high sequence 
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Figure 2.2: FUGUE alignment for AsbAS1 against 1W6K 
FUGUE structure-based sequence alignment of AsbAS1 against the template sequence, 1W6K.  The 
scale at the bottom denotes the strength of the alignment, with red indicating a strong alignment, 
orange/yellow indicating an average alignment and green/blue indicating a weak alignment.  Proposed 
insertions to the 1W6K sequences are shown as dashed lines.  The DSSP representation of secondary 
structure is shown below the alignment with alpha and 3-10 helices shown as grey and white cylinders 
respectively; beta sheets shown as arrows and hydrogen bonded turns shown as an arc.  Two 
important conserved motifs, the catalytic DCTAE motif and QW motifs are shown above the sequence 
alignment in black and blue respectively. 
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identity in all plant species indicating that it may have a specific function in 
plants, possibly in additional enzyme stability or protein-protein interactions, but 
it is not clear. 
 The sequence was examined in detail to determine whether the insertions 
and deletions proposed by the FUGUE alignment could be accommodated into the 
1W6K structure and each position was viewed using PyMOL.  There were six 
insertions and three deletions proposed which, due to the ability of FUGUE to 
recognise SSEs all occurred in loop regions so could be accommodated into the 
1W6K structure without disrupting secondary structure elements. 
 
2.3.1.4 Generating a structural model for AsbAS1  
 An AsbAS1 homology model was generated by MODELLER.  MODELLER 
uses comparative protein structure modelling to generate a model from an 
alignment of the target sequence to the template sequence.  The model is 
assigned a number of restraints, which assume that distances between template 
residues will be the same as for the aligned residues in the target sequence.  The 
molecular mechanics force-field adds additional restraints on bond lengths, bond 
angles, dihedral angles and non-bonded atom-atom contacts.  The model then 
undergoes optimization which minimises the energy conflicts.  The final model 
coordinates are exported as a pdb format file (189). 
Figure 2.3: Comparison of the AsbAS1 model to the 1W6K structure 
The 1W6K template structure is shown on the left and the AsbAS1 model is shown on the right.  
Domain 1 is a double α-helical barrel with the inner helices shown in light blue and the outer helices 
shown in dark blue.  Domain 2 consists of 12 α-helices with the outer helices shown in dark pink and 
the inner helices shown in light pink.  β-sheets are found between the two domains and are shown in 
green.  The amino terminal domain is shown in red and the membrane attachment helix is shown in 
yellow.  
1W6K AsbAS1
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 The AsbAS1 model structure was viewed PyMOL and superimposed onto 
the 1W6K template structure.  As expected from the secondary structure 
predictions, no secondary structure was assigned to the 33 amino acid inserted 
region at the N-terminus.  This region was modelled as an unordered loop which 
extended away from the surface of the protein, therefore as it contained no 
secondary structure information it was removed from the final model (Appendix 
3).  Structural comparison of the final model against the template structure 
(Figure 2.3) shows that many of the secondary structure elements and motifs are 
conserved in the AsbAS1 model, with the overall domain structure almost 
identical between the two structures.  This preliminary analysis indicates that 
1W6K appears to be a good template for AsbAS1.  
 
2.3.1.5 Validation of the AsbAS1 model 
 The AsbAS1 model was subjected to validation to determine whether a 
reliable model had been produced.  The validation process examined the overall 
energy of the structure, dihedral angles and atomic volumes.  This would give an 
indication of the stability of the model and determine whether it had the features 
characteristic of other protein structures solved by X-ray crystallography and 
refined at high resolution. 
 Overall protein structure was analysed using Prosa II, which calculates the 
energy of the whole structure using a distance-based pair potential which 
incorporates all forces acting between groups of atoms and the surrounding 
medium. This energy value is normalised to give a Z-score which is displayed in a 
plot containing the Z-score of all proteins currently in the PDB (208).  Z-scores 
differ based on the length of the protein, with small proteins having high Z-scores 
whereas larger proteins have much lower Z-scores.  1W6K and AsbAS1 were 
calculated to have Z-scores of -11.31 and -10.56 respectively which places them 
well within the range of Z-scores observed for proteins of similar size (Figure 
2.4).  Due to their similar size and high sequence homology, the Z-scores of both 
structures were expected to have similar values and this was observed.  This 
confirms that the overall structure of the model produced is reliable and unlikely 
to contain major structural errors.  
 The AsbAS1 model was analysed in more detail using PROCHECK, which 
calculates the phi (φ) and psi (ψ) angles for all residues and displays them on a 
Ramachandran plot.  All residues fall into distinct areas of the Ramachandran plot 
depending on the secondary structure element they are located in (alpha-helix, 
beta-sheet, left-handed helix, beta-turns and extended chains).  The majority of 
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Figure 2.4: Prosa II analysis of AsbAS1 model 
The overall energy (Z-score) of the AsbAS1 model (right) was calculated using Prosa II and compared 
to the 1W6K template structure (left).  The light and dark blue dots show the Z-score of all known 
structures in the PDB relative to their size.  The black dot shows where the analysed structure is 
placed.  Both AsbAS1 and 1W6K have comparable Z-scores to other proteins of their size.  
 
these residues should fall into these distinct areas, and structures solved to 2Å 
resolution are expected to have over 90% of residues in allowed regions.  
Structures that contain a significant number of residues in disallowed areas are 
likely to have steric irregularities therefore indicating that the model quality is 
low. 
 PROCHECK analysis of the AsbAS1 model showed that 99.3% of residues 
were in allowed regions (90.3% in most favoured regions, 7.8% in additionally 
allowed regions and 1.4% in generously allowed regions) (Figure 2.5).  1W6K 
also showed similar results with 99.7% of residues in allowed regions (93.3% in 
most favoured regions, 5.9% in additionally allowed regions and 0.5% in 
generously allowed regions).  The AsbAS1 model had only three residues in 
disallowed regions, Glu459, Ser434 and Val692, all of which were present in loop 
regions on the protein surface.  Surface loop regions are flexible and mobile, so 
unusual dihedral angles are commonly found.  These data show that the majority 
of the dihedral angles in the AsbAS1 model are in allowed regions of the 
Ramachandran plot which further verifies that the model is reliable.   
 The final validation of the AsbAS1 was carried out using PROVE which 
analyses the atomic volumes for each of the residues in the structure.  These 
values are compared to normal ranges for atomic and residue volumes that have 
been calculated from 64 highly resolved and well refined structures (191).  The 
  
1W6K AsbAS1
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Figure 2.5: Ramachandran plot of AsbAS1 model 
The dihedral angles of the AsbAS1 model were analysed by PROCHECK and the results displayed in a 
Ramachandran plot.  The plot is split into different regions: red – most favoured, yellow – additionally 
allowed, beige – generously allowed and white – disallowed.  The majority of the residues fall within 
the red and yellow areas indicating that the model is reliable.  
 
results showed that atomic volumes throughout the AsbAS1 structure were 
similar to 1W6K and both scores were within the range seen for other proteins 
solved at the same resolution. 
 Together, the validation methods show that structural parameters for 
AsbAS1 are very similar to the template structure 1W6K and other proteins of 
similar size.  It was therefore concluded that the model produced was reliable and 
could now be used for a detailed analysis of β-amyrin synthase structure and 
mechanism. 
 
2.3.1.6 Overall AsbAS1 structure 
 The AsbAS1 model structure was superimposed onto that of hOSC using 
PyMOL (Figure 2.6).  As observed in Figure 2.3, many of the secondary structure 
elements and motifs are conserved in the AsbAS1 model, with the overall domain 
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Figure 2.6: Comparison of structural features of AsbAS1 and hOSC 
Superimposed image of hOSC crystal structure (green) and the AsbAS1 model (lilac).  The features 
shown in spheres were solved from the hOSC crystal structure. The product of hOSC catalysis – 
lanosterol (red sticks) is shown bound in the active site.  Detergent molecules (purple spheres) used 
for solubilisation  and crystallisation of hOSC show the orientation of the enzyme at the membrane.  A 
detergent molecule is also bound in the substrate access channel.  
 
structure almost identical between the two structures.  The superimposed image 
also shows that alpha helices and beta sheets are of similar length and although 
some loop regions are longer in AsbAS1, they are well aligned to 1W6K. 
 AsbAS1, like 1W6K, has two α-α barrel domains connected by loop regions 
which form three β-structures.  The active site is found between the two domains 
where the product of hOSC catalysis, lanosterol, can be seen represented by red 
sticks.  The hOSC protein was crystallized with detergent present as it is a 
membrane-associated protein, and these can be seen in the crystal structure 
represented by purple spheres (151).  The location of these detergents shows 
how the protein is orientated in the membrane and also show position of the 
substrate access channel which leads from the membrane to the active site.   
 
2.3.2 Analysis of the initial stages of AsbAS1 mechanism 
 The AsbAS1 structure and mechanism were analysed in detail to 
investigate the similarities and differences between sterol and triterpene OSCs.  
This would allow the mechanistic differences between the two enzyme classes to 
be investigated at a structural level.  As human lanosterol synthase (hOSC) is the 
only sterol OSC to have its crystal structure solved, this structure was used as a 
1W6K (hOSC)
AsbAS1 (βAS)
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representative structure for sterol OSCs (144).  In addition to looking at 
structural information, sequence and phylogenetic analysis was also used to 
investigate OSC mechanism.  A large number of OSCs (both sterol and triterpene 
OSCs) from a variety of different plant species have been cloned and functionally 
characterised and their sequence information together with the structural 
information from the hOSC crystal structure and the AsbAS1 model provided 
additional insights into OSC mechanism.  Note that in this section, in the 
main text and figure legends, hOSC residues are numbered in normal text 
and AsbAS1 residues are numbered in italics.  In figures both enzyme 
residues are numbered in normal text and colour coded as described. 
 
2.3.2.1 Phylogenetic analysis of plant oxidosqualene cyclases 
 To investigate the phylogeny between sterol and triterpene OSCs, a 
multiple sequence alignment was generated in MUSCLE (193).  This included 81 
amino acid sequences from all cloned and/or functionally characterised plant 
OSCs, together with 20 sequences for predicted OSCs from a variety of plant 
species.  The multiple sequence alignment was then used to generate a 
neighbour-joining phylogenetic tree (195) (Figure 2.7). 
 Preliminary analysis supports previous conclusions made by Qi et al. (63) 
that AsbAS1 is more closely related to plant cycloartenol synthases than the dicot 
β-amyrin synthases.  With the increasing availability of sequence data from other 
monocot species, it is clear to see that all predicted monocot triterpene synthases 
are found in the same clade as AsbAS1 indicating that the monocot and dicot 
triterpene synthases have evolved separately.  The tree also shows that enzymes 
involved in sterol synthesis have remained constant throughout evolution, with 
cycloartenol synthase being the sole enzyme required for sterol synthesis in all 
plants.  Enzymes involved in triterpene synthesis however, have undergone much 
more diversification in all plant species, resulting in evolution of both specific and 
multifunctional enzymes that produce a wide range of secondary metabolites.  
Some of these enzyme classes are found in clearly defined clades, for example, 
the dicot β-amyrin synthases and the dicot lupeol synthases.  The remainder of 
the clades contain many enzyme classes that produce a vast range of products.  
With the recent advances in whole genome sequencing, as more sequences 
become available these clades will become more clearly defined and evolutionary 
relationships between triterpene synthases will become more clearly understood. 
 The information gathered from this comprehensive sequence alignment 
and phylogenetic tree was then used together with the AsbAS1 model to  
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Figure 2.7: Phylogenetic analysis of plant oxidosqualene cyclases. 
A neighbour-joining phylogenetic analysis of aligned protein sequences from plant OSCs is shown.  Bootstrap values (percentage values from 1000 replicates) are shown for 
key branches.  The scale bar indicates 0.05 substitutions per site.  The clades are highlighted based on enzyme classification.  Filled circles () indicate enzymes that have 
been functionally characterised in yeast, empty circles () indicate enzymes that have been cloned and the remainder that are blank are predicted sequences deduced from 
whole genome sequencing.  Protein sequence accession numbers and the multiple sequence alignment can be found in Appendices 4 and 5 respectively   
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investigate AsbAS1 mechanism and the mechanistic differences between the 
sterol and triterpene OSC classes. 
  
2.3.2.2 Substrate entry to the active site 
The hOSC structure contains a detergent molecule bound in a channel leading 
from the membrane to the active site, which allows the passage of the substrate, 
2,3-oxidosqualene.  This channel is also observed in the AsbAS1 model.  In hOSC, 
this channel is blocked by three residues, Tyr237, Cys233 and Ile524 (hOSC 
numbering), which are presumed to undergo a conformational change to allow 
the substrate to enter the active site (144).  Examination of the same region in 
the AsbAS1 model revealed that two of the residues, Tyr237 and Ile524, were 
conserved, and the third residue, Cys233, was substituted with threonine which 
of a similar size (Figure 2.8).  These three residues were found in the same 
orientation in both hOSC and AsbAS1 indicating that substrate entry into the 
active site occurs by the same mechanism for both sterol and triterpene enzymes.  
The multiple sequence alignment of all plant OSCs showed that these three 
residues are very highly conserved (Appendix 5), with any substitutions being for 
residues of similar size and charge, which provides further evidence for a single 
substrate entry mechanism in all OSCs. 
Figure 2.8: Comparison of residues blocking substrate access in AsbAS1 and hOSC 
A. Image to show path of substrate entry to active site in hOSC.  AS – Active site; SAC – Substrate 
access channel; M -  Membrane attachment surface.  The product, shown in red sticks, is bound in the 
active site.  The substrate access channel leads from the membrane to the active site has a detergent 
molecule (purple sticks) bound.  The channel is blocked by 3 residues, labelled in orange sticks, that 
separate the channel from the active site.  They are predicted to undergo a conformational change to 
allow the substrate to enter the active site.  B.  Superimposition of residues blocking substrate access 
in hOSC (green, black labels) and AsbAS1 (purple, purple labels).  Residues labelled in bold are 
conserved between the two enzymes.  
 
Y237/Y264
I524/I554
C533/T260
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2.3.2.3 Pre-folding of the substrate in the active site 
After the 2,3-oxidosqualene substrate has entered the active site, the first 
three rings are pre-folded into an energetically favourable conformation for 
cyclisation.  Each ring is capable of forming two different conformations, chair or 
boat, and the combination of these conformations differs between sterol and 
triterpene enzymes and represents one of the major differences between their 
mechanisms.  Sterol OSCs are pre-folded into the chair-boat-chair conformation, 
whilst in triterpene OSCs the chair-chair-chair conformation is formed (Figure 
2.9).   
Figure 2.9: Pre-folded conformations of 2,3-oxidosqualene for sterol and triterpene cyclisation. 
Diagram to show how 2,3-oxidosqualene is pre-folded in the active site of sterol and triterpene OSCs.  
Each ring of the substrate can be folded in two different conformations – chair and boat.  In sterol 
OSCs, the first 3 rings of 2,3-oxidosqualene form the chair-boat-chair conformation whilst triterpene 
OSCs form the chair-chair-chair conformation.  This difference in B-ring conformation represents one 
of the major differences between sterol and triterpene OSCs.  
 
 In hOSC the B-ring forms a boat conformation due to the presence of 
Tyr98, which pushes the C10 carbon of 2,3-oxidosqualene below the molecular 
plane.  The boat conformation is energetically unfavourable, due to the flagpole 
interaction between the two axial 1,4-hydrogen atoms of the carbon ring, but is 
enforced due to the steric pressure of the tyrosine (144, 209).  Therefore in 
triterpene OSCs, a lack of steric pressure was expected at the equivalent Tyr98 
position to allow the energetically favourable chair conformation to be formed.  
The multiple sequence alignment showed that dicot triterpene OSCs had a smaller 
residue at the equivalent position which would remove the steric pressure on the 
B-ring, but a tyrosine was still present in the monocot triterpene OSCs.  
Therefore, this region was studied in the superimposed structures of AsbAS1 and 
hOSC to understand how the different B-ring conformations are achieved (Figure 
2.10). 
 
KEY Boat Chair
Sterol OSCs
chair-boat-chair
Triterpene OSCs
chair-chair-chair
2,3-oxidosqualene
A B
C
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Figure 2.10: Residues enforcing B-ring conformation 
Diagram to illustrate how B-ring conformation is determined in hOSC (green, black labels) and AsbAS1 
(purple, purple labels).  Tyr98 in hOSC enforces the boat conformation by forcing the C10 of 2,3-
oxidosqualene below the molecular plain.  Tyr98 is held in place by a large residue above and a small 
residue below.  In AsbAS1 these positioning residues are reversed which elevates the tyrosine relative 
to its hOSC counterpart.  This removes the steric pressure on C10 and allows the B-ring to adopt the 
energetically favourable chair conformation.  
 
 In hOSC, Tyr98 is held in position by a bulky residue above, Phe444, and a 
small residue below, Ile702, which creates the steric pressure to enforce the boat 
conformation.  In AsbAS1, these positioning residues are reversed, so the 
tyrosine (Tyr119) is held in place by a small residue above, Leu473, and a bulky 
residue below, Phe731, which elevates its position in relation to the hOSC 
tyrosine.  This elevation presumably removes the steric pressure on the substrate 
C10 to allow it to adopt the chair conformation.  The sequence and phylogenetic 
analysis of all plant OSCs shows that this residue reversal is restricted to the 
monocot triterpene OSC clade.  Dicot triterpene OSCs have the same positioning 
residues as hOSC but have a much smaller residue, typically asparagine, cysteine 
or isoleucine, at the equivalent Tyr98 position so the B-ring is free to adopt the 
favourable chair conformation.  This clear difference between monocot and dicot 
OSCs may be a result of the divergent evolutionary origins of the two groups.  
Phylogenetic analysis has shown that monocot triterpene OSCs are more closely 
related to cycloartenol synthases, responsible for plant sterol biosynthesis, than 
other dicot plant triterpene OSCs, indicating the two triterpene OSC groups 
evolved separately (63).  The more cycloartenol synthase-like character of the 
monocot triterpene OSCs might explain why some of the features of sterol OSCs 
I702/F731
Y98/Y119
F444/L473
hOSC C10
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have been maintained and modified to allow the enzyme to function as a 
triterpene OSC.  
 
2.3.2.4 Reaction initiation 
 Once the substrate is pre-folded in the active site, cyclisation can occur.  
The reaction is initiated by protonation of the epoxide group of 2,3-oxidosqualene 
by a highly conserved aspartate residue which induces the cyclisation reaction.  
The conserved aspartate is part of a highly conserved DCTAE catalytic sequence 
motif and is present in all OSCs, suggesting that the reaction initiation 
mechanism is conserved amongst all OSCs (52, 124, 210-211).  In hOSC, Asp455 
is the proton donor for reaction initiation and is hydrogen bonded to two cysteine 
residues, Cys456 and Cys533, which increase its acidity to allow protonation of 
the 2,3-oxidosqualene epoxide group.  This aspartate (Asp484) is conserved in 
AsbAS1 and is hydrogen bonded to two cysteine residues, Cys485 and Cys563.  
All three residues were found in an identical orientation to hOSC which implies 
that initiation occurs by a common mechanism (Figure 2.11) (144, 212). 
Figure 2.11: Reaction initiation 
Superimposition of the residues involved in cyclisation initiation in hOSC (green, black labels) and 
AsbAS1 (purple, purple labels).  Initiation occurs via a catalytic aspartate hydrogen bonded to two 
cysteine residues which increase its acidity and allow it to protonate the epoxide group of 2,3-
oxidosqualene substrate.  Hydrogen bonds are shown by dashed lines.  
 
2.3.3 Analysis of the cyclisation steps in AsbAS1 mechanism 
 After reaction initiation, cyclisation of the substrate can proceed.  
Cyclisation was originally thought to be a concerted process (152), but 
experiments conducted by Van Tamelen et al. found evidence that cyclisation 
proceeded via a series of discrete, conformationally rigid carbocationic 
3.5Å
3.9Å
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intermediates (153).  Rings are numbered A through to E and are formed 
sequentially, with each ring requiring stabilisation before the next one can be 
formed.  Stabilisation occurs via aromatic residues in the active site cavity which 
stabilise the positive charge formed on the newly cyclised ring via cation-π 
interactions.  The aromatic ring stacks against the new ring and the delocalised 
electrons stabilise the positive charge (164). 
 Ring formation represents another major difference between sterol and 
triterpene OSC mechanisms as sterol OSCs form tetracyclic products whereas 
triterpene OSCs predominantly form pentacyclic products.  Mutagenesis studies 
have shown that ring stabilisation by active site aromatic residues plays a vital 
role in product determination (167-171, 174, 176).  Mutagenesis of only one 
critical active site residue can result in cyclisation termination due to lack of 
stabilisation of the developing positive charge. (139, 213).  Stabilisation is only 
achieved by aromatic residues, therefore a single substitution of a stabilising 
residue can change the active site environment and result in a different product 
being formed.  Due to the high sequence similarity between sterol and triterpene 
OSCs, identification of subtle differences in active site residues could allow further 
understanding of the mechanistic differences between the these two enzyme 
groups. 
 To further analyse AsbAS1 mechanism, each step of the cyclisation 
process was studied in detail to identify residues that are likely to be catalytically 
important and explore differences to the sterol OSC mechanism.  Reaction 
intermediates, generated from structures in the Cambridge structural database, 
were docked into the active site of the AsbAS1 model (Figure 2.12).  Molecular 
dynamics (MD) simulations were then performed on all docked intermediates to 
create a realistic representation of their position in the active site.  
 MD simulates the movement of atoms and molecules in protein structures.  
In vivo, all atoms and molecules are constantly moving, so MD simulates the 
atom movements in an aqueous environment to find an optimal, energetically 
favourable position for the intermediate in the active site.  Despite being 
membrane associated, the model was simulated in an aqueous environment.  
Superimposition of AsbAS1 onto hOSC implies that like hOSC, AsbAS1 is 
membrane associated via a single helix therefore the majority of the protein is 
exposed to the aqueous environment of the cytoplasm.  So, whilst membrane 
attachment may affect the low frequency movements associated with substrate 
entry, it is unlikely to affect the high frequency movements of the active site 
during catalysis.  Therefore the simulation of reaction intermediates can be 
accurately modelled using an aqueous environment.  
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Figure 2.12: Carbocation intermediates of β-amyrin synthesis 
Pathway to show intermediates formed on cyclisation of 2,3-oxidosqualene to β-amyrin.  Cyclisation is 
concerted up to formation of the 5-membered D-ring (dammarenyl cation).  Three more intermediates 
are formed upon D-ring expansion, E-ring formation and E-ring expansion leading to the oleanyl 
cation which undergoes skeletal rearrangement followed by deprotonation to form the final β-amyrin 
product. Red stars denote the structures docked into the AsbAS1 active site using molecular 
dynamics. 
  
 The final AsbAS1 model structures were analysed to identify residues 
involved in ring stabilisation.  Stabilising residues from AsbAS1 and hOSC were 
compared along with information from the multiple sequence alignment to find 
residues responsible for product differences between sterol and triterpene OSCs. 
 
2.3.3.1 A-ring formation 
 The A-ring is the first to be cyclised and ring closure forms a positive 
charge at C6 (2,3-oxidosqualene numbering – Figure 2.12).  This charge must be 
stabilised in order for cyclisation to continue, and in hOSC this is achieved by 
Trp581.  Trp581 is located below C6 in the active site, and forms cation-π 
interactions to stabilised the positive charge (144).  Further stabilisation comes 
from the hydroxyl groups of three nearby tyrosine residues, Tyr503, Tyr704 and 
Tyr707, which are directed towards the active site to provide additional negative 
electrostatic potential (165). 
 Analysis of A-ring stabilisation in the AsbAS1 model was carried out with 
the tetracyclic dammarenyl cation docked into the active site, as the CSD did not 
contain a suitable template to generate a monocyclic triterpene structure.  
Residues for A-ring stabilisation are completely conserved between the two 
enzymes, with the C6 cation stabilised from below by Trp611, and tyrosine 
residues Tyr533, Tyr733 and Tyr736 (AsbAS1 numbering) providing additional 
negative charge.  The plant OSC multiple alignment shows that with the 
exception of Tyr533 which is replaced by a tryptophan in dicot triterpene 
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synthases, these residues are highly conserved in all sterol and triterpene OSCs, 
suggesting that A-ring formation occurs by the same mechanism. 
 
2.3.3.2 B-ring formation 
 Formation of the B-ring results in a shift of the positive charge from C6 to 
C10 (2,3-oxidosqualene numbering – Figure 2.12).  In hOSC, this charge is 
stabilised via cation-π interactions from above and below by Phe444 and Trp581 
respectively.  As for A-ring formation, the hydroxyl groups of surrounding 
tyrosine residues provide additional negative charge to stabilise the developing 
positive charge (144). 
 Analysis of B-ring stabilisation in the AsbAS1 model was carried out with 
the tetracyclic dammarenyl cation docked into the active site, as the CSD did not 
contain a suitable template to generate a bicyclical triterpene structure.  For B-
ring stabilisation, the conserved Trp611 is present below C10 to stabilise the 
positive charge and tyrosine residues Tyr533, Tyr733 and Tyr736 are also 
conserved.  However, Phe444 is not conserved in AsbAS1 and other monocot 
triterpene OSCs and is substituted for a leucine residue (Leu473), which appears 
to play a role in Tyr119 positioning to allow the B-ring to form a chair 
conformation (see section 2.3.2.3).  As stated in section 2.3.2.3, Tyr119 is 
positioned by a pair of residues, Phe731 (below) and Leu473 (above), both of 
which are conserved in monocot triterpene OSCs.  Together they raise the  
Figure 2.13: B-ring stabilisation in hOSC and AsbAS1 
Diagram shows differences in B-ring stabilisation between hOSC (left) and AsbAS1 (right).  The 
reaction intermediate is shown in grey and the C10 cation is shown as a white sphere.  In hOSC (and 
all dicot OSCs), C10 stabilisation occurs via Trp581 and Phe444.  In AsbAS1 C10 stabilisation occurs via 
Trp611 (conserved amongst all OSCs) and Phe731 (unique to monocot triterpene OSCs). Residues 
involved in stabilisation and conformation of the B-ring are shown in green (hOSC) and purple 
(AsbAS1), and conserved residues are shown in red.  Tyrosine residues providing additional negative 
potential to the active site are shown as light grey sticks. 
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position of Tyr119 in relation to the positive charge at C10, so that it no longer 
causes steric hindrance the B-ring.  In hOSC and all sterol OSCs, these 
positioning residues (Phe444 and Ile702) are reversed which lowers the position 
of Tyr98 in relation to the positive charge at C10, which creates the steric 
hindrance to enforce the boat conformation of the B-ring.  Phe731 is therefore 
indirectly conserved, and although it is found in a different location to Phe444, it 
is appropriately positioned to stabilise the C10 cation (Figure 2.13).  Monocot 
triterpene OSCs are the only triterpene OSCs that contain an equivalent Tyr98 
residue, usually only observed in sterol OSCs.  This difference in B-ring 
stabilisation may have arisen as a result of the separate evolution of monocot and 
dicot triterpene OSCs (63).  
 
2.3.3.3 C-ring formation 
 Formation of the C-ring results in a shift of the positive charge from C10 to 
C14 (2,3-oxidosqualene numbering – Figure 2.12).  In hOSC this charge is 
stabilised via cation-π interactions from above and below by Phe444 and Phe696 
respectively.  His232 also interacts with the C14 cation to stabilise the charge 
(144).  Mutagenesis studies of Saccharomyces cerevisiae lanosterol synthase 
have shown that deletion of His232 or Phe444 leads to formation of tricyclic 
products, indicating that these residues are vital for C-ring formation (167-168).   
 Analysis of C-ring stabilisation in the AsbAS1 model was carried out with 
the tetracyclic dammarenyl cation docked into the active site, as the CSD did not  
Figure 2.14: C-ring stabilisation in hOSC and AsbAS1 
Diagram shows differences in C-ring stabilisation between hOSC (left) and AsbAS1 (right).  The 
reaction intermediate is shown in grey and the C14 cation is shown as a white sphere.  In hOSC (and 
all dicot OSCs), C14 stabilisation is mediated by His232, Phe444 and Phe696.  In AsbAS1, Phe696 is 
conserved (Phe725)  and Phe444 is indirectly conserved (Phe731), but His232, a residue conserved in 
all sterol OSCs, is replaced by Phe259, a residue conserved in all triterpene OSCs.  Residues involved 
in stabilisation of the C-ring are shown in green (hOSC) and purple (AsbAS1), and conserved residues 
are shown in red.  
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contain a suitable template to generate a tricyclic triterpene structure.  For C-ring 
stabilisation, the phenylalanine below C14 (Phe725) is conserved, but Phe444 and 
His232 are not conserved (Figure 2.14).  However, as Phe444 is indirectly 
conserved (Phe731), it may assume the same role that Phe444 has in B and C-
ring stabilisation.  The absence of His232 represents one of the major differences 
between sterol and triterpene OSCs.  The plant OSC multiple sequence alignment 
(Appendix 5) shows that His232 is conserved throughout all sterol OSCs whereas 
all triterpene OSCs have an aromatic phenylalanine (Phe259) or tyrosine.  Phe259 
plays a vital role in later cyclisations but for C-ring stabilisation it assumes the 
same role as His232. 
 
2.3.3.4 D-ring formation 
 Formation of the 5-membered D-ring results in a shift of positive charge 
from C14 (2,3-oxidosqualene numbering – Figure 2.12) to C20 (lanosterol 
numbering), forming the protosteryl cation in hOSC and the dammarenyl cation in 
AsbAS1.  It is here that the sterol and triterpene OSC mechanisms diverge, with 
D-ring formation signalling the end of sterol OSC cyclisation, whereas triterpene 
OSC cyclisation continues.  In hOSC, the positive charge at C20 is coordinated 
from above and below by His232 and Phe696 respectively.  However, the 
negative potential of these residues is not sufficient to stabilise the charge at C20, 
which would allow expansion of the D-ring and formation of the 5-membered E-
ring.  Lack of stabilisation results in cyclisation termination and deprotonation 
takes place to yield the lanosterol product (144, 165). 
 Analysis of D-ring stabilisation in the AsbAS1 model was carried out with 
the tetracyclic dammarenyl cation and baccharenyl cations docked into the active 
site.  In AsbAS1 the phenylalanine below C20 (Phe725) is conserved, but His232 is 
not conserved and is replaced by a phenylalanine (Phe259).  This phenylalanine 
appears to provide the additional negative potential required to stabilise the 
positive charge on the dammarenyl cation and allow expansion of the 5-
membered D-ring to form the baccharenyl cation (Figure 2.15).  The expansion of 
the D-ring transfers the positive charge to C18 (β-amyrin numbering – Figure 
2.12), which is also stabilised by Phe259 and Phe725.  As mentioned previously, 
the plant OSC multiple sequence alignment shows that all sterol OSCs have a 
histidine residue at the His232 position whereas all triterpene OSCs have either a 
phenylalanine (monocots) or a tyrosine (dicots).  This provides a clear residue 
difference between sterol and triterpene enzymes at the exact cyclisation stage 
that forms their differing products – which indicates that Phe259 may be the key 
residue required for producing pentacyclic products.  Mutagenesis studies on β-
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amyrin synthase from Panax ginseng have provided further support for this 
theory, as mutation of this residue to a histidine, as seen in sterol OSCs, resulted 
in the formation of tetracyclic dammarene-like products (176). 
Figure 2.15: D-ring stabilisation in hOSC and AsbAS1 
Diagram shows differences in D-ring stabilisation between hOSC (left) and AsbAS1 (right).  The 
reaction intermediate is shown in grey and the C20 cation is shown as a white sphere.  In hOSC (and 
all sterol OSCs), Phe696 and His232 are not enough to stabilise the charge at C20 resulting in 
cyclisation termination and deprotonation.  In AsbAS1 (and other triterpene OSCs), His232 is replaced 
by an aromatic residue (Phe259), which together with Phe725 is able to stabilise the C20 charge and 
allow cyclisation to continue by expansion of the D-ring to form the baccharenyl cation.  Residues 
involved in stabilisation of the D-ring are shown in green (hOSC) and purple (AsbAS1), and conserved 
residues are shown in red. 
 
 
2.3.3.5 E-ring formation 
 E-ring formation only occurs in triterpene OSCs, as sterol OSCs cease 
cyclisation at the D-ring due to lack of cation stabilisation.  Formation of the 5-
membered E-ring results in a shift of positive charge from C20 (lanosterol 
numbering) to C20 (β-amyrin numbering – Figure 2.12), forming the lupenyl 
cation.  Stabilisation of the positive charge allows E-ring expansion to form the 
oleanyl cation.  Mutagenesis and chimeric studies between lupeol synthase from 
Olea europaea (OEW) and β-amyrin synthase from Panax ginseng (PNY) identified 
a single residue, Trp257, that appeared to be responsible for stabilising the 
expanded E-ring in triterpene OSCs (176).  If the E-ring expansion is not 
stabilised then cyclisation is halted at the lupenyl cation which is deprotonated to 
form lupeol.  OEW has a leucine residue at the equivalent Trp257 position, and 
mutation of this residue to tryptophan resulted in production of β-amyrin. 
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Figure 2.16: E-ring stabilisation in AsbAS1 
Diagram shows how E-ring is stabilised in AsbAS1.  The lupenyl cation intermediate is shown in grey 
and the C20 cation is shown as a white sphere.  The positive charge is stabilised by Trp257 and Phe259 
which enables expansion of the E-ring to form the oleanyl cation.  Residues involved in stabilisation 
are shown in purple. 
 
Likewise, mutation of tryptophan in PNY to leucine resulted in production of lupeol 
(176, 214).  Although mutagenesis studies of triterpene OSCs have been carried 
out (176, 214), AsbAS1 is the first triterpene OSC to be structurally modelled.  
This provides a unique tool to study the residues responsible for E-ring 
stabilisation in the active site. 
 Analysis of E-ring stabilisation in the AsbAS1 model was carried out with 
the pentacyclic lupenyl and oleanyl cations docked into the active site.  The model 
suggested that the positive charge at C20 could be stabilised through cation-π 
interactions with Phe259 and Trp257, which would allow expansion of the 5-
membered E-ring forming the oleanyl cation (Figure 2.16).  The results observed 
for the mutagenesis of Trp257 in PNY can be clearly explained by the AsbAS1 
model.  Mutation of the tryptophan to leucine results in the C20 cation being 
stabilised solely by Phe259 which does not provide sufficient stabilisation to allow 
E-ring expansion, therefore lupeol is formed.  Consequently mutation of the 
equivalent leucine in OEW to tryptophan provides additional stabilisation to the 
C20 cation allowing E-ring expansion and hence β-amyrin formation.  The plant 
OSC multiple sequence alignment shows that all lupeol synthases have a leucine 
residue at the Trp257 position whereas the β-amyrin synthases have a 
Lupenyl 
cation
Oleanyl 
cation
F259
W257
AsbAS1
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tryptophan residue.  Together these results provide strong evidence that Trp257 
is required for E-ring expansion in triterpene OSCs. 
 
2.3.3.6 Skeletal rearrangement and deprotonation 
 After cyclisation is complete, the intermediate undergoes skeletal 
rearrangement to form the product cation, which is deprotonated to yield the final 
product.  Skeletal rearrangement causes a shift of the positive charge from a 
region of low electron density to an area of high electron density by 1,2 shifts of 
methyl and hydride groups.  Migration is thought to be induced by the steric 
difficulty associated with the chair-boat/chair-chair folds (165, 213).  After 2,3-
oxidosqualene cyclisation by hOSC, the positive charge resides on C20 (lanosterol 
numbering) creating the protosteryl cation.  Skeletal rearrangement shifts the 
positive charge from C20 to C8/9 (lanosterol numbering) which forms the lanosterol 
cation (144).  Deprotonation of the lanosterol cation completes the cyclisation 
reaction.  In hOSC, His232 is the only catalytic base present in the vicinity of the 
lanosterol cation and forms a hydrogen bond to Tyr503.  It is presumed that this 
activated tyrosine accepts the proton from C8/9 (lanosterol numbering) to form 
the lanosterol product (144, 164-165). 
 Analysis of skeletal rearrangement in the AsbAS1 model was carried out 
with the pentacyclic β-amyrin cation docked into the active site.  In AsbAS1 the 
Figure 2.17: Deprotonation in hOSC and AsbAS1 
Diagram shows how deprotonation occurs in hOSC (left) and a possible candidate for deprotonation in 
AsbAS1 (right).  The product cation is shown in grey, the location of the final cation is shown by a 
white sphere (N.B. lanosterol cation can reside on C8 or C9) and the location of the proton that is 
removed is shown as a dark grey dot.  In hOSC, His232 hydrogen bonds to Tyr503 which acts at the 
final proton acceptor.  AsbAS1 lacks a suitable catalytic base, but may use a water molecule activated 
by Tyr533 as a final proton acceptor.  Residues involved in deprotonation are shown in green (hOSC) 
and conserved residues are shown in red.  Hydrogen bonds are represented by a dotted blue line, and 
distances are shown as a dotted red line. 
 
Y503
H232
Y533
F259
4.5Å
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positive charge shifts from C19 to C13 (β-amyrin numbering) to form the β-amyrin 
cation (163).  Deprotonation occurs at C12 (β-amyrin numbering), but the 
catalytic base is harder to determine as there is no equivalent to the His232 
residue, as in hOSC, to activate the equivalent tyrosine residue, Tyr533.  In the 
search for a candidate base, the location of each basic residue in the active site 
vicinity was determined to identify a residue close enough to C12 (β-amyrin 
numbering) to act as a catalytic base.  However the only residue in close contact 
with C12 (β-amyrin numbering) is the conserved Tyr533 at a distance of 4.5Å 
(Figure 2.17).  With no other candidate present, it is postulated that in AsbAS1, 
the hydroxyl group of Tyr533 may form a hydrogen bond with a water molecule 
to facilitate deprotonation at C12 (β-amyrin numbering).  The plant OSC multiple 
sequence alignment shows that although Tyr533 is conserved in monocot 
triterpene OSCs and in all sterol OSCS, dicot triterpene OSCs have a tryptophan 
residue at the corresponding position, which leaves the mechanism for 
deprotonation in dicot OSCs unclear. 
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Chapter 3 - Genetic characterisation of sad1 mutants 
3.1 Introduction 
 The sad mutant collection has been an invaluable tool in the elucidation of 
the genes involved in the avenacin pathway.  Using the mutagen sodium azide, 
92 mutants have been identified in total using a reduced root fluorescence screen 
that exploited the fluorescent property of the major end product of the pathway, 
avenacin A-1.  This comprehensive set of metabolic pathway mutants is the first 
to be isolated through a forward screen for loss of function.  These mutants have 
defined at least seven loci involved in avenacin synthesis and characterisation of 
these mutants has provided insights into each individual step of the pathway. 
 
3.1.1 Characterisation of the original sad1 mutants 
 Of the ten sad mutants identified in the first reduced root fluorescence 
screen, two, #109 and #610, had single point mutations at a locus defined as 
Sad1 which was later identified as the β-amyrin synthase gene.  Both of these 
mutants lacked β-amyrin and had no detectable β-amyrin synthase activity.  
Sequencing of the Sad1 gene in each of these mutants revealed single point 
mutations that resulted in predicted premature termination of translation codons.  
Further characterisation revealed that Sad1 transcript levels were substantially 
reduced in both mutants, possibly as a result of nonsense-mediated mRNA decay.   
 
3.1.2 Identification of additional sad1 mutants from the oat mutant collection 
 Characterisation of mutants in the extended mutant collection has 
identified six additional sad2 mutants and one additional sad7 mutant.  To 
identify additional sad1 mutants in the extended mutant collection, methanolic 
root extracts of 6-day old oat seedlings were analysed by TLC to identify mutants 
that accumulated 2,3-oxidosqualene, as seen for the two original sad1 mutants.  
The methanolic extracts were dissolved in 100μl chloroform:methanol (7:3 v/v) 
and analysed by TLC (hexane:acetone 80:20 v/v) which identified 15 candidate 
sad1 mutants that lacked avenacin and accumulated 2,3-oxidosqualene.  Root 
extracts were also dissolved into hexane for GC-MS analysis which confirmed the 
accumulation of 2,3-oxidosqualene in the original two Sad1 mutants and the 15 
candidate sad1 mutants thereby confirming these mutants as new sad1 mutants 
(215). 
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3.1.3 Aims 
 Two sad1 mutants and 15 candidate sad1 mutants have been identified 
from the extended oat mutant collection and partially characterised.   The aim of 
this part of the project was to characterise the sad1 mutant collection at a gene, 
transcript and protein level.  The gene and transcript analysis of the sad1 gene in 
each of the 17 mutants is discussed in this chapter and the protein analysis will 
be discussed in Chapter 4. 
 Characterisation of the sad1 mutants at a genetic level will involve 
sequencing of the Sad1 gene in each of the new sad1 mutants to determine the 
nature of the mutations.  The sad1 mutants will then be characterised at the 
transcript level by reverse-transcription PCR and Northern blotting. 
 
3.2 Materials and Methods 
3.2.1 Isolation of genomic DNA from sad1 mutants 
 Seeds of Avena strigosa S75 (wild-type) and sad1 mutants were surface 
sterilised in 0.05% (v/v) sodium hypochlorite solution for 10 minutes and 
incubated on Whatman No.1 9 cm filter circles (Sartorius Stedim UK Ltd) at 4°C 
in the dark for 48 hours.  For germination, seeds were transferred to 1% (w/v) 
agar plates and incubated for 6 days at 22°C with 16 hours light and 8 hours 
dark.  Genomic DNA (gDNA) was extracted from 4 cm of leaf material using the 
DNeasy Plant Mini Kit (Qiagen) and analysed by 1% (w/v) TAE agarose gel 
electrophoresis to confirm recovery of gDNA. 
 
3.2.2 PCR amplification of Sad1 genomic DNA   
 The Sad1 gene was amplified using the gDNA of each of the sad1 mutants 
as a template.  The gene was amplified in four segments and the following 
primers were used: Segment 1, AmyStaF1 = ACGAGTGCTTGTTTTCCTCGTA and 
Amy610R = CATACCGACAACCATATTTTTCCCCA; Segment 2, Amy610F = GTCGCT 
ACATTTACAATCAACAGGCAT and Amy109R = TCTATACCAACCTGTGCCTTCATTCC; 
Segment 3, Amy109F = TATCCATTATGACGACGAATCAACC and Amy23R = TCGGA 
ACATTGTCGTGGACTA; Segment 4, Amy12F = CTCAACCCTTCTGAGAGTTTT and 
AmyEndR1 = TGATGACATCGGTAGGAA.  Gradient PCR was carried out using 
Phusion™ High Fidelity DNA polymerase (Finnzymes) for 35 cycles (program: 
98°C for 10 seconds, 40-65°C for 1 min, 70°C for 1.5 mins (segments 2 and 3) or 
2 mins (segments 1 and 4), and final extension at 72°C for 10 min).  Fractions 
which contained a single band at the correct size were confirmed by 1% TAE 
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agarose gel electrophoresis with ethidium bromide staining.  These fractions were 
pooled and purified using a Wizard PCR Preps Kit (Promega).  
 
3.2.3 Sequencing of sad1 genomic DNA segments  
 Sequencing reactions were carried out using BigDye® Terminator v3.1 
Ready Reaction Mix (Applera) using the program: 92°C for 40 seconds, 52°C for 
15 seconds, 60°C for 4 minutes followed by 25 cycles of 95°C for 10 seconds, 
52°C for 15 seconds and 60°C for 4 minutes.  Purified DNA segments from each 
of the sad1 mutants were sequenced using a variety of primers along the length 
of the Sad1 gDNA (Table 3.1).  Sequencing reaction analysis was carried out by 
the Genome Laboratory at the John Innes Centre, Norwich.  Sequencing data was 
viewed using Chromas (Technelysium Pty Ltd) and the resulting sequence was 
aligned to the gDNA sequence from wild-type Sad1 using BioEdit (IBS 
Therapeutics) (216).  Each mutant was sequenced to at least 2-fold coverage 
using the primers listed in Table 3.1. 
 
Table 3.1: Primers used for sad1 mutant sequencing 
Name and sequence of primers used to sequence each segment of the Sad1 gene are shown.  Primers 
suffixed with F or F1 are the primers for the sense DNA strand and primers suffixed with R or R1 are 
the primers for the antisense strand.  Capital letters denote exon sequence whereas small letters 
denote intron sequence.  The exact location of each primer on the gDNA is shown in Appendix 6. 
3.2.4 Diversity Array Technology (DArT) analysis of sad1 mutants 
 Genomic DNA was extracted from a single leaf of a 6 day old oat seedling 
as described in section 3.2.1, and analysed by 1% (w/v) TAE agarose gel 
electrophoresis to confirm recovery of gDNA.  Two independent genomic DNA 
samples from each mutant were sent for Diversity Array Technology (DArT) 
analysis (Diversity Arrays Technology Pty Ltd). 
tctataccaacCTGTGCCTTCATTCC
GTCCCAATTAATGTTGCAGTAAG 
CTGCGACAAGACCTCTATA
GTCGCTACATTTACAATCAACAGgcat
catacCGACAACCATATTTTTCCCC
agttcaaccaagattttagacaac
ATCGTCTGCTTGTAGAGAGGA
gtggctcatcacattgatcaca
CAGTGGGATTCTCTTCATTATGC
gtatggatttcgtaccgtaaat
ACGAGTGCTTGTTTTCCTCGTA
Primer sequence
AmyEndR1
Amy22R
Amy19F
Amy08F
Amy12F
Segment 4
Amy23R
Amy17R
Amy06F
Amy05F
Amy109F
Segment 3
Primer name
Amy109R
TCAGCTCTTAATCGCAAGAAGTAmy24R
tggacacggtcatcaaaactgAmy11F
TGGGCAATGTTGGCTTTAATTTAmy610F
GTGGATGGGGTGAAGACTSegment 2
CTCAACCCTTCTGAGAGTTTAmy610R
Amy25R
TAGTCCACGACAATGTTCCGA Amy26R
AGCCTTTTGATCTGTGGCGATAAmy18F
TATCCGCTGACCTTGTTGAmy16F
TGGATGTCATAGCTGGGAAmy10F
TATCCATTATGACGACGAATCAACCAmyStaF1
Segment 1
Primer sequencePrimer name
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3.2.5 Transcript analysis of sad1 mutants 
 Total RNA was extracted from the terminal 0.5 cm roots of 3 day old oat 
seedlings using TRI-REAGENT (Sigma) followed by DNase digestion at 37°C for 
10 minutes by adding 2 µl of DNase I (Roche) to 50 µl RNA.  DNase was removed 
by phenol/chloroform extraction and ethanol precipitation and the RNA 
concentration was determined spectrophotometrically using a NanoDrop ND-1000 
(Thermo Scientific).   
 For RT-PCR, cDNA was synthesised using 1 µg of DNase treated RNA which 
was primed with 0.5 µg Oligo(dT)15 primers and 0.5 mM each of dATP, dCTP, 
dGTP, dTTP (Invitrogen) in a final volume of 13 µl at 65°C for 5 minutes then 
immediately chilled on ice for 1 minute.  First strand cDNA synthesis was carried 
out by adding the following components to the denatured RNA to yield a final 
concentration of 1 x First Strand Buffer (Invitrogen), 5 mM dithiothreitol 
(Invitrogen), 40 U RNaseOUT™ (Invitrogen) and 200 U of Superscript III Reverse 
Transcriptase (Invitrogen).  The reverse transcription was carried out at 50°C for 
1 hour and the enzyme was inactivated by incubation at 70°C for 50 minutes.  
cDNA was stored at -20°C and cDNA was diluted 5-fold for use in RT-PCR 
reactions.  PCR amplification of the Sad1 and GAPDH was carried out using the 
following primers: Sad1-5’ = ATGTGGAGGCTAACAATAGG, Sad1-3’ = TATCTCATG 
ACGATGTTCCG, AsGAPDH-5’ = CGCCATGGGCAAGATTAAGATCGGAATCAACG and 
AsGAPDH-3’ = GTGGCAGTGATGGCATGAACAGTKGTCATCA.  PCR amplification of 
splice site regions in the four splicing mutants was carried out using the following 
primers: 110, Amy08F = GTGGATGGGGTGAAGACT and AmyEndR1 = TGATGACAT 
CGGTAGGAA; 225 and 589, Amy11F = CTGCGACAAGACCTCTATA and Amy17R = 
TATCGCCACAGATCAAAAGGCT; and 1001, Amy05F = TGGATGTCATAGCTGGGA 
and Amy23R = TCGGAACATTGTCGTGGACTA. PCR was carried out using Taq DNA 
polymerase (HT Biotechnology) using the program: 95°C for 2 minutes followed 
by 29 cycles of 95°C for 30 seconds, 55°C for 40 seconds, 72°C for 40 seconds 
and a final extension at 72°C for 3 minutes.  Products were then run on a 1% TAE 
agarose gel and visualised with ethidium bromide staining. 
 For Northern blotting, 10 µg of total RNA was run on a 1.2% agarose/0.25 
M formaldehyde gel at 60 V for 4 hours and RNA was visualised with ethidium 
bromide staining.  The gel was soaked in 10x SSC for 20 minutes and transferred 
to a Hybond-N+ nylon membrane (Amersham) in 10x SSC overnight.  After 
transfer was complete, RNA was immobilised on the membrane by baking at 80°C 
for 3 hours.  cDNA probes for the 5’ and 3’ end of the Sad1 gene were generated 
using the following primers: 5’ probe, Sad1-5’-F = ATGTGGAGGCTAACAATAGG 
and Sad1-5’-R = TATCTCATGACGATGTTCCG; 3’ probe, Sad1-3’-F = CGA 
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ATCCACGATATCGAAGAG and Sad1-3’-R = TCAGCTCTTAATCGCAAGAAG. Each 
probe was purified using the QIAquick PCR purification Kit (Qiagen) and eluted in 
TE buffer pH 8.0.  Probes were labelled with 32P-dCTP using the Rediprime II 
Random Prime Labelling Kit (Amersham).  Hybridisations were carried out 
overnight at 65°C in 10 ml Church Buffer, 0.1 mg/ml salmon sperm DNA (Sigma) 
and 50 µl 32P-dCTP labelled probe.  Membrane was washed at 65°C in 0.1% (w/v) 
SDS with decreasing concentrations of SSC until radioactivity was localised to a 
specific region of the membrane.  The membrane was exposed to a BAS-IIIS 
imaging plate (Fuji) overnight and imaged using a Typhoon 9200 Variable Mode 
Imager (Amersham).  Blots were stripped by incubation with two washes at 85°C 
in 5 mM sodium phosphate buffer pH 7.2 and 0.1% SDS (w/v) for 10 minutes and 
then exposed to a phosphoimaging screen overnight to check the quality of the 
stripping. 
 
3.3 Results and Discussion 
3.3.1 Sequence analysis of sad1 mutants 
 Fifteen potential sad1 mutants (in addition to the two previously 
characterised sad1 mutants, #109 and #610 (49)) were identified from a TLC 
screen of the extended collection of 92 reduced fluorescence oat mutants which 
looked for mutants which accumulated 2,3-oxidosqualene, the β-amyrin synthase 
substrate (215).  These mutants were isolated by screening for reduced root 
fluorescence (avenacin deficiency) and shown to have undergone loss of function 
mutations in the Sad1 gene via complementation tests and/or TLC analysis (18, 
215).  To determine the nature of the mutations in the 15 new sad1 mutants, the 
Sad1 gene in each of the 15 new sad1 mutants, as well as the two previously 
characterised sad1 mutants, was sequenced.  The location of these mutations has 
the potential to provide valuable clues as to amino acid residues and regions of 
the gene that are important for function. 
 
3.3.1.1 Gradient PCR amplification of sad1 mutant gDNA 
 Sad1 is a large gene containing 7340 base pairs, 18 exons and 17 introns, 
therefore in order to amplify it effectively it was split into four overlapping 
segments of between 1.7 and 2.3kb (Figure 3.1).  PCR amplification for each 
segment using the optimal annealing temperatures calculated for each set of 
primer pairs was inconsistent as not all gDNA samples produced a product at the 
desired size.  Therefore the protocol was modified and each segment was 
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amplified using gradient PCR and products were analysed by 1% TAE agarose gel 
electrophoresis to look for those annealing temperatures which produced a single 
band at the correct size.  Products from these temperatures were then pooled, 
purified and used in the sequencing reactions.   
Figure 3.1: Position of segments designed for amplification of Sad1 genomic DNA 
The Sad1 gene contains 18 exons and is 7.34kb in length.  Exons are represented as red boxes and 
introns as lines connecting the boxes.  The positions of the four segments designed for amplification of 
the gene are shown in yellow with the forward and reverse primers labelled at the beginning and the 
end of the segment respectively.  
 
3.3.1.2 Genomic DNA sequence analysis of sad1 mutants 
 The sad mutants were generated previously by mutagenising Avena 
strigosa S75 with sodium azide (18, 217).  Sodium azide has been widely used as 
a mutagen in many plant and microbial species due to its ability to produce single 
base substitutions that result in single point mutations.  Unlike other mutagens, 
e.g. ionizing radiation and ethyl methanesulfonate (EMS), chromosome 
abnormalities are not observed, which is a huge advantage as mutagenesis is 
more specific and efficient (218-221).  Therefore when sequencing the sad1 
mutants, it was expected that single point mutations would be found in the 
coding regions of the genomic DNA.  Each segment was sequenced with 
overlapping sense and antisense primers to give at least 2-fold sequencing 
coverage to each segment.  Primers used for sequencing are shown in Table 3.1. 
 Sequencing chromatogram data were analysed using Chromas and yielded 
very clear peaks for identification of each individual base, which showed that the 
consensus sequence obtained was very reliable.  The FASTA sequence from each 
sequencing run was then exported and aligned to the Sad1 genomic DNA 
sequence in order to find the location of the point mutation.  The use of high 
fidelity Taq DNA polymerase and at least 2-fold coverage of the Sad1 genomic 
DNA sequence identified 5 base changes in introns 1, 8, 15 and 17 in addition to 
the single point mutation found in the exon.  These 5 intron base changes were 
seen in all mutants and the re-sequenced wild-type Sad1 gene, and as sodium 
azide mutagenesis does not usually cause point mutations in non-coding DNA, 
this indicated that the original gDNA sequence was incorrect.  The Sad1 gDNA 
sequence was therefore updated. 
Segment 1
~2.1kb
1.75kb
1.88kb
~2.26kb
Segment 2
Segment 3
Segment 4
AmyStaF1 Amy109FAmy610R Amy23R
Amy610F Amy12FAmy109R AmyEndR1
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 Sequence analysis of all 15 new sad1 mutants showed that in each case all 
15 mutants had single point mutations in the coding sequence of the Sad1 gene.  
The mutations observed fell into three different categories: predicted premature 
termination of translation, splicing errors and amino acid substitutions (Table 
3.2). 
Table 3.2: Sequence analysis of sad1 mutants 
3.3.1.2.1 Premature termination of translation mutants 
 The first group of mutants (#A1, #B1, #109, #610, #1146 and #1293) all 
had single point mutations which substituted a guanine for an adenine and 
changed the coding sequence from TGG to TGA (Figure 3.2A).  These nonsense 
mutations resulted in predicted premature termination of translation codons 
(PTCs) being introduced into the coding sequence.  Nonsense mutations have 
been shown to cause nonsense-mediated mRNA decay (NMD) in order to prevent 
the cell from producing C-terminally truncated proteins that have deleterious 
effects (222-225).  If this was the case for the STOP codon mutants then the 
mRNA transcript would be degraded, AsbAS1 protein would not be formed and 
the avenacin pathway would be prematurely terminated, which would explain why 
these mutants have severely reduced root fluorescence. 
 
3.3.1.2.2 Splicing error mutants 
 The second group of mutants (#110, #225, #589 and #1001) had single 
point mutations at intron-exon boundaries and so were likely to be affected in 
Mutant  Mutation event 
Predicted 
amino acid change 
Predicted 
Mutation type 
    
A1 G1912A Tyr165STOP 
Premature 
termination of 
translation 
B1 G1912A Tyr165STOP 
109 G3417A Tyr380STOP 
610 G1912A Tyr165STOP 
1146 G4169A Tyr471STOP 
1293 G39A Tyr13STOP 
    
110 G6689A - 
Splicing error 
225 G3302A - 
589 G3914A - 
1001 G4365A - 
    
297 G3939A Glu419Lys 
Amino acid 
substitution 
358 G5234A Cys563Tyr 
384 C7249T Ser728Phe 
532 G549A Gly121Glu 
599 G2809A Gly277Glu 
1023 C7249T Ser728Phe 
1217 G2025A Gly203Glu 
 
a
a
a
b
b
a Identical mutations (G1912 → A)
b Identical mutations (G7249 → A)
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pre-mRNA splicing.  Mutants #110 and #225 had mutations at the 5’ splice site of 
introns 16 and 7 respectively (Figure 3.2B).  The consensus sequence at the 5’ 
splice site in plants is AG/GTAAGT, where the / symbol represents the exon-intron 
boundary, and this where the U1 small nuclear ribonucleoprotein particle (snRNP) 
binds and initiates the formation of the major spliceosome.  This consensus 
sequence contains the dinucleotide, GT, found at the start of the intron, which is 
absolutely conserved in all organisms (226-227).  Mutant #110 had a mutation of 
the guanine preceding the conserved dinucleotide and mutant #225 had a 
mutation of the guanine in the conserved dinucleotide.  Both of these mutations 
would most likely be affected in the binding of the U1 snRNP and may prevent 
correct splicing of the mRNA at this location.  Mutants #589 and #1001 had 
mutations at the 3’ splice site of introns 8 and 10 respectively.  The consensus 
sequence at the 3’ splice site in plants is TGCAG/G, where the / symbol 
represents the intron-exon boundary, and also contains the dinucleotide AG at 
the end of the intron which is absolutely conserved in all organisms.  Both of 
these mutants had a mutation of the guanine in the conserved dinucleotide which 
is involved in the binding of the U5 snRNP and are therefore likely to have splicing 
errors at this location (226-227).  Mutations that affect splice sites may cause an 
exon to be deleted, an intron to be included which may introduce a PTC, or cause 
splicing at an aberrant site (228).   
 
3.3.1.2.3 Amino acid substitution mutants 
 The final group of mutants (#297, #358, #384, #532, #599, #1023 and 
#1217) had single point mutations in the coding sequence of the sad1 gene which 
resulted in amino acid substitutions (Figure 3.2C).  Unlike the previous two 
mutant groups which are likely to be affected at the post-transcriptional or 
translational stage, substitution of an amino acid would not be expected to have 
any effect on transcription or translation, therefore this group of mutants was 
most likely to be affected at the protein level.  In each case the resulting 
substitution changes the size as well as the charge or polarity of the amino acid 
at that position.  Amino acid substitutions may affect protein folding or stability 
leading to protein degradation or should fully folded protein be produced, 
substitutions may impede the catalytic mechanism.  If the latter occurs, this may 
provide an insight into amino acid residues or regions of the protein that are 
critical for function.   
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Figure 3.2: Location of single point mutations in sad1 mutants 
Schematic of the intron-exon structure of the Sad1 gene for each of the sad1 mutants showing the 
location of the different point mutations.  Exons are represented by boxes and introns by lines.  The 
wild-type S75 is shown in red and the mutants are shown in grey.  The mutants are organised 
according to the type of mutation they contain ( see Table 3.2) and the location of the mutation within 
the gene is shown by a vertical line. A.  Premature termination of translation mutants. B. Splicing 
error mutants. C. Amino acid substitution mutants. 
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3.3.1.3 DArT analysis of sad1 mutants 
 Sequencing of the 17 sad1 mutants had shown that all had single point 
mutations in the Sad1 gene, however closer inspection of the mutation locations 
revealed that there were two sets of mutants that had identical mutations.  
Mutants #A1, #B1 and #610 all had a mutation in base 1912 (guanine to adenine 
mutation) and mutants #384 and #1023 had a mutation in base 7249 (guanine 
to adenine) (Table 3.2).  The location of each mutation was verified 
independently from two different gDNA samples so sampling error was ruled out a 
cause of the identical mutants.  The mutants were generated by mutagenising oat 
seed with sodium azide and one bag of M2 seed was collected from individual M1 
plants and sequentially numbered to avoid the isolation of siblings.  However 
during seed collection and bagging there may have been cross-contamination 
between mutant populations which would account for the results that were 
obtained.  It was therefore important to ascertain whether the mutants were 
genetically identical or independent. 
 As sodium azide mutagenesis results in single point mutations, it can be 
assumed that in addition to the single point mutation found in the Sad1 gene of 
each mutant, there will be other single point mutations located throughout the 
genome.  If the mutants are genetically independent then these additional 
mutations will be found in different locations, but if the mutants are genetically 
identical then the mutation pattern will be identical.  Diversity Array Technology 
(DArT) is a high-throughput genotyping system that can be used to differentiate 
between the 17 sad1 mutants.  It is a solid-state, open-platform method for 
analysing DNA polymorphisms in a number of different organisms without the 
need for DNA sequence information.  Genomic representations of the DNA sample 
are generated and hybridised to an array containing a library specific to the 
target organism.  DNA polymorphisms are detected by comparing hybridisation 
patterns of genomic representations from different genotypes (229-230).  For 
DArT analysis of the 17 sad1 mutants, two independent gDNA samples were 
extracted from the leaf of a 6 day old oat seedling for each mutant and the wild-
type S75.  The subsequent DArT analysis was carried out at the DArT laboratory 
in Canberra, Australia.   
 The first step involves creating the array containing the library of oat 
specific markers.  Genomic representations from a pool of individuals that cover 
the genetic diversity of the target species are generated using complexity 
reduction which involves restriction enzyme digestion with a rare and frequent 
cutter, adapter ligation and amplification.  The genomic representations are 
 
Chapter 3 – Genetic characterisation of sad1 mutants 
 
 
77 
 
 
Figure 3.3: Schematic representation of DArT analysis of sad1 mutants 
A. Generation of a library of oat specific markers.  Genomic DNA (gDNA) from a variety of oat species 
is pooled and the complexity of the sample is reduced by restriction enzyme digestion, adapter 
ligation and PCR amplification using primers with selective overhangs.  The fragments are cloned into 
E. coli and the inserts are amplified using vector-specific inserts, purified and arrayed onto a solid 
support.  B. DArT analysis of sad1 mutants.  gDNA from each sad1 mutant undergoes complexity 
reduction and cloning as in A and is then labelled with a fluorescent dye.  To allow for quantification of 
the signal, fragments of the cloning vector, which are common to all elements of the array are 
amplified and labelled with a different fluorescent dye (reference DNA).  Both reference DNA and the 
mutant gDNA representation are hybridised to the library array created in A. The ratio of signal 
intensity between the reference and mutant DNA is measured for each position on the array and is 
displayed in a binary format (1 – marker present; 0 – marker absent).  Each mutant gDNA 
representation can be hybridised to the array and polymorphic spots can be identified by comparing 
the binary plots between all the mutants.  Figure adapted from Jaccoud et al. (2001) (229) 
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cloned into E. coli and arrayed onto a solid support which can then be hybridised 
to labelled representations from specific genotypes (Figure 3.3A).  Then, a 
genomic representation of each of the oat mutants is generated and labelled with 
a fluorescent dye. This is hybridised to a library array containing the genomic 
representations (markers) from the target species (which is this case is oat).  The 
arrays are also hybridised with fluorescently labelled reference DNA which binds 
to a fragment of the cloning vector common to all elements of the array.  This 
allows the signal from each marker to be quantified and the relative hybridisation 
intensity is measured for each marker on the array.  Each position is scored 
based on whether the marker is present (1) or absent (0) which gives each 
genotype a unique binary pattern (Figure 3.3B) (229-230).  It was expected that 
the binary pattern would be identical between the two replicates from each oat 
mutant whereas those mutants with differing point mutations would have 
different binary patterns.  Of the two groups of mutants with identical mutations, 
if any of the mutants were genetically identical then their binary patterns would 
be identical.  If the binary patterns are different then the mutants are genetically 
independent but contain the same Sad1 polymorphism. 
 The DArT library array used for analysis of the sad1 mutants contained 
15,000 markers, of which only 35 markers were found to be polymorphic.  This 
showed that there was no significant source of genetic variation between the 
samples which allowed the subtle changes due to mutagenesis to be identified.  
The DArT binary data for all the sad1 mutants is shown in Appendix 7.  The 
binary data for each mutant was analysed using a Humming matrix which gives a 
numerical score of the similarity between each of the mutants.  It is calculated by 
dividing the number of differences (excluding missing data) between a pair of 
samples by the total number of active comparisons.  A dendrogram was 
generated from the Humming matrix using statistiXL (231) which provided a 
visual representation of the similarity between the mutants (Figure 3.4).  The 
furthest neighbour method was chosen for clustering as it calculates the greatest 
dissimilarity between clusters therefore produces tight clusters of similar cases.  
As two independent samples were analysed for each mutant, this provided a 
negative control as both samples are genetically identical so should display a 
distance of zero on the Humming matrix.  Eleven out of the 17 sad1 mutants 
were found to have genetically identical samples pairs and are labelled in green in 
Figure 3.4.  However not all of the mutants had identical sample pairs, five of the 
mutants (110, 297, 384, 532 and 1293) had both samples present in the same 
branch but were not found to be identical and only the remaining mutant (384) as 
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Figure 3.4: Distance dendrogram of Humming matrix data from sad1 mutant DArT analysis 
Furthest neighbour dendrogram based on hybridisation of 17 sad1 mutant genotypes to 35 DArT 
markers.  Two independent samples were analysed for each mutant and are labelled -1 and -2 
respectively.  Mutant numbers highlighted in green represent sample pairs with a genetic distance of 
0.  Mutant numbers highlighted in orange represent sample pairs that are closely related in the same 
branch but did not produce identical results.  Finally mutant numbers highlighted in red represent 
mutant numbers whose paired sample was distantly related and is likely to be as a result of sampling 
error. 
 
well as the wild-type S75 were found to be significantly different.  These 
significant differences are most likely to be due to sampling errors or DNA 
contamination as the sample pairs have such large differences.   
 Nevertheless, in spite of the two anomalous results the data indicated that 
the majority of the mutants were genetically independent.  Most sample pairs 
were shown to have identical (65%) or very similar (30%) genetic profiles so 
should any of the mutants with identical sad1 polymorphisms been genetically 
a
b
a
a
b
a Identical mutations (G1912 → A)
b Identical mutations (G7249 → A)
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identical, it would have been clearly seen.   For the two groups of identical 
mutants in question (A1, B1 and 610; 384 and 1023), #384 and #1023 were 
found in different branches therefore it was concluded that although this group 
contained the same sad1 polymorphism, the mutants were genetically 
independent.  Results for the other group showed #610 was genetically 
independent from #A1 and #B1 as it was found in a separate branch, however, 
#A1 and #B1 although not in the same branch were, genetically, the most 
similar.  Of the DArT markers that were 100% reproducible #A1 and #B1 were 
95% identical, but for DArT markers that were only 97% reproducible they were 
only 47% identical.  These results indicate that #A1 and #B1 are highly similar 
but does not provide conclusive proof that these mutants are identical, so they 
will be treated as independent mutants in the subsequent analysis. 
 
3.3.2 Transcript analysis of sad1 mutants 
 Sequence analysis revealed that all of the 17 sad1 mutants were 
independent (with the possible exception of #A1 and #B1) and had single point 
mutations in the Sad1 gene which fell into three different categories: predicted 
premature termination of translation, splicing errors and amino acid substitutions.  
It was now of interest to study the level of Sad1 transcript in each of the mutants 
in order to gain further information.   
 Previous analysis of the two original sad1 mutants, #109 and #610, had 
revealed PTCs in the coding sequence and further characterisation revealed 
transcript levels were severely reduced in the roots of both mutants (49).  On the 
basis of these results, it was expected that the other four predicted premature 
termination of translation mutants would all show the same transcript phenotype.  
It was also expected that the amino acid substitution mutants would all have 
transcript present as nonsynonymous mutations are not anticipated to affect 
transcript stability.  Mutations at intron-exon boundaries can affect the mRNA 
transcript in different ways.  If intron inclusion occurs in the splicing mutants then 
this may introduce a PTC into the transcript, resulting in NMD and hence severely 
reduced transcript levels.  If exon exclusion occurs, this can also shift the reading 
frame of the transcript, which may also introduce a PTC.  In order to determine 
how the intron-exon structure of the sad1 mutants were affected, transcript levels 
were studied using RT-PCR and Northern blotting. 
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3.3.2.1 Transcript analysis of sad1 mutants by RT-PCR 
 For RT-PCR analysis, RNA was extracted from the terminal 0.5 cm of root 
tips of 3 day old oat seedlings and 1µg was used for cDNA synthesis.  The primers 
used for RT-PCR were designed complementary to the first 20 bases of the Sad1 
gene, starting from the ATG start codon.  In order to standardise the levels of 
cDNA used for each RT-PCR reaction, the Avena strigosa glyceraldehyde 3-
phosphate dehydrogenase (AsGAPDH) gene was used.  The products of the RT-
PCR reactions were run on a 1% TAE agarose gel and visualised using ethidium 
bromide staining. 
 
3.3.2.1.1 Premature termination of translation mutants 
 As expected, when compared to the wild-type S75 all predicted premature 
termination of translation mutants showed a severe reduction in transcript levels 
(Figure 3.5A).  The correlation between the presence of PTCs and decreased 
levels of mRNA abundance is thought to be caused by NMD (232-241).  Studies in 
crop plants have found that mRNA decay occurs post-transcriptionally and may 
cause mRNA instability which leads to decay (236).  The mechanism by which 
PTCs are identified in plants is as yet unknown, but is a different mechanism to 
that seen in mammals and yeast.  It is thought that normal and premature 
codons are distinguished by measuring the spacing between the termination 
codon and elements present within the 3’ untranslated region (3’ UTR) of the 
gene.  Unusually long 3’ UTRs are thought to trigger NMD as well as the presence 
of introns in the 3’ UTR (242-243).  Once transcripts have been targeted for NMD 
they are degraded in a similar manner to general mRNA decay, but the 
mechanism used in plants has yet to be identified (243). 
 It is highly likely that the reduction in transcript levels in the premature 
termination of translation mutants is due to NMD.  Without the Sad1 transcript, 
these mutants cannot synthesise AsAS1, leaving the avenacin pathway halted at 
the first stage. 
 
3.3.2.1.2 Splicing error mutants 
 RT-PCR of the four splicing mutants revealed that all had Sad1 transcript 
present (Figure 3.5B).  Errors at splice sites can cause intron inclusion or exon 
deletion, but as the primers used for RT-PCR were designed at the 5’ end of the 
Sad1 gene and did not span any of the regions affected by splicing errors, the 
results did not give any indication as to whether transcript size had been affected 
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Figure 3.5: RT-PCR to investigate transcript levels in sad1 mutants 
RT-PCR using GAPDH and Sad1 primers to determine transcript levels in wild-type and sad1 mutants.  
GAPDH was used as positive control of expression and to standardise the levels of cDNA.  The levels of 
gene expression for each of the sad1 mutants were compared to the wild-type S75.  A. Premature 
termination of translation mutants. B. Splicing error mutants.  C. Amino acid substitution mutants.    
 
by these mutations.  In order to further investigate transcript size, Northern 
blotting and further RT-PCR reactions spanning the splice site mutation locations 
were carried out and these results are discussed in section 3.3.2.2 and 3.3.2.3 
respectively.   
 
3.3.2.1.3 Amino acid substitution mutants 
 As expected when compared to the wild-type S75, all amino acid 
substitution mutants had transcript present (Figure 3.5C).  As these mutants had 
single point mutations which were predicted to result in a single amino acid 
substitution, it was assumed that transcript size was not affected in these 
mutants, therefore the cause of non-functionality in these mutants must 
presumably have occurred at the protein level. 
 
3.3.2.2 Northern blot analysis of splicing error mutants 
 RT-PCR analysis using primers at the 5’ end of the Sad1 gene had shown 
that all splicing mutants had transcript present but gave no indication as to 
whether transcript size had been altered by the mutations.  All of the splicing 
mutants were analysed by Northern blotting to obtain valuable information about 
overall transcript size, using probes for the 5’ and 3’ ends of the gene. 
A B
C
GAPDH
Sad1
GAPDH
Sad1
GAPDH
Sad1
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 Ten micrograms of root total RNA was used for Northern blot analysis.  All 
four splicing error mutants were analysed, together with the following controls: 
wild-type S75 as a positive control for expression; predicated premature 
termination of translation mutant 109 as a negative control; and amino acid 
substitution mutant 532 as a positive mutant control.  All samples were run on a 
1.2% agarose/0.25 M formaldehyde gel and visualised using ethidium bromide 
staining to check that sample loading levels were equal (Figure 3.6A).  After the 
RNA had been transferred and immobilised on the nylon membrane, it was 
probed with cDNA probes complementary to the 5’ and 3’ end of the Sad1 gene. 
Hybridisation was performed at 65°C overnight with 32P-dCTP labelled probes.  
After the membrane had been thoroughly washed to remove background 
radiation, it was exposed to a phosphoimaging screen overnight. 
 Ethidium bromide staining showed that sample loading was mostly even 
between all samples – wild-type S75 had slightly lower levels than the mutants 
(Figure 3.6A).  Both the 28S and 18S ribosomal RNA bands could be clearly seen 
Figure 3.6: Northern blot analysis of RNA from roots of splicing error mutants 
A. Ethidium bromide stained formaldehyde agarose gel of root tip RNA to ensure even loading. B. 
Membrane hybridised with Sad1 5’ cDNA probe. C.  Membrane hybridised with Sad1 3’ cDNA probe.  
Lane 1, S75 – wild-type positive control; Lane 2-5, splicing mutants 110, 225, 289 and 1001; Lane 6, 
premature termination of translation mutant 109 – negative control; Lane 7, amino acid substitution 
mutant 532 – positive mutant control.  Ten micrograms of RNA was loaded in each lane and RNA 
levels were monitored using ethidium bromide staining. 
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and no lower size bands were detected, which confirmed that the RNA was of 
good quality.  The Sad1 5’ cDNA probe was generated using the same primers as 
for the RT-PCR analysis, therefore hybridisation with this probe was expected to 
produce the same results.  The Northern blot results confirm the results seen 
from RT-PCR analysis, as transcript is seen in the wild-type controls as well as all 
of the splicing mutants and the positive mutant control 532.  As seen in RT-PCR 
analysis, premature termination of translation mutant 109 does not have 
transcript (Figure 3.6B).  The Sad1 3’ cDNA probe was generated from the 
terminal 21 bases of the Sad1 gene and presence or absence of transcript would 
be indicative of whether mRNA decay had taken place which would provide clues 
as to the type of splicing error that had occurred.  Results from hybridisation 
using the Sad1 3’ cDNA probe are identical to those of the Sad1 5’ cDNA probe 
which confirms that the Sad1 transcript is intact (Figure 3.6C).  This implies that 
intron inclusion has not occurred as if the intron adjacent to the splicing mutation 
had not been spliced and remained in the final transcript, a PTC would have been 
introduced.  As seen in the premature termination of translation mutants, 
introduction of a PTC into the transcript results in NMD and transcript levels are 
severely reduced.  As transcript is present in all of the splicing mutants, it can be 
concluded that intron inclusion has not occurred in any of the splicing error 
mutants and exon deletion is much more likely to have occurred. 
 As the RNA samples were separated by gel electrophoresis before being 
transferred to the membrane, this provided the opportunity to examine overall 
transcript size.  All transcripts appear to be of the same size and show no major 
size differences.  The minor size differences that are seen, specifically in S75, can 
be attributable to RNA loading, with samples containing more RNA migrating 
slightly further than those with less RNA.  If, as the Northern blot data suggests, 
the exon adjacent to each of the splicing mutants was deleted, this would result 
in size differences of 75-189 base pairs.  These small size differences may not be 
distinguishable on an agarose gel therefore further analysis is needed to 
determine whether exon deletion had occurred in any of the splicing error 
mutants. 
 
3.3.2.3 Further RT-PCR analysis of splicing error mutants 
 Previous Northern blot and RT-PCR analysis had shown that both the 5’ 
and 3’ ends of the Sad1 transcript were intact in all of the splicing mutants, and 
therefore ruled out intron inclusion being caused by the splice site mutations.  
This left exon deletion as the most likely effect of the splice site mutations, 
however Northern blotting had failed to reveal any obvious transcript size 
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differences, possibly because the expected size differences were too small to be 
resolved.  Therefore in order to determine whether transcript size had been 
reduced and hence exon deletion had occurred, RT-PCR was carried out to 
amplify the region surrounding each of the splicing error mutants to look for small 
size differences.  
  A region between 200 bp and 550 bp surrounding each of the splicing 
error mutations was amplified for each of the splicing mutants together with a 
wild type control.  The RT-PCR reaction products were run on a 1% TAE agarose 
gel and visualised using ethidium bromide staining (Figure 3.7).  The results 
clearly show that when compared to the wild-type, all of the splicing mutants 
have a smaller product in the region surrounding their corresponding splice site 
mutation.  Figure 3.7A shows the amplification of the 315 bp region surrounding 
exon 16, the location of the splice site mutation in mutant #110.  In the wild-type 
and mutants #225, #589 and #1001, a band just above the 300 bp marker 
Figure 3.7: RT-PCR to amplify regions surrounding splice site mutations. 
RT-PCR using various Sad1 primer combinations to determine transcript size in regions surrounding 
each of the splice site mutations in wild-type and Sad1 splicing error mutants.  Fragment sizes for 
each of the sad1 mutants were compared to the wild-type S75.  Each of the agarose gel photo images 
corresponds to the amplification of the region surrounding each of the splice site mutations. A.  
G6689A in mutant #110, 315bp. B. G3302A and G3914A in mutants #225 and #589 respectively, 
553bp.  C. G3914A in mutant #589, 203bp. D. G4365A in mutant #1001, 336bp.  
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corresponding to the expected size of the region is seen, however in mutant 
#110, the band seen is smaller, approximately 250 bp in size.  Figure 3.7B shows 
the amplification of the 553 bp region surrounding exons 7-9, the locations of the 
splice site mutations in mutants #225 and #589.  In the wild-type and mutants 
#110 and #1001, a band at approximately 550 bp is seen which corresponds to 
the expected size of the region, however in mutants #225 and #589, a smaller 
band is seen at 350 bp and 450 bp  respectively.  Figure 3.7C shows the 
amplification of the 203 bp region surrounding exon 9, the location of the splice 
site mutation in mutant #589.  In the wild-type and mutants #110, #225 and 
#1001, a band just above the 200 bp marker is seen which corresponds to the 
expected size of the region, however in mutant #589 a faint smaller band at 
approximately 100 bp is seen.  Figure 3.7D shows the amplification of the 435 bp 
region surrounding exon 11 which includes the splice site mutation in mutant 
#1001.  In the wild-type and mutants #110 and #225 a band just above the 
400bp marker is seen which corresponds to the expected size of the region, 
however in mutant #1001 a smaller band at approximately 350bp is seen.  No 
band is seen in mutant #589 as the forward primer is located in the exon that 
has been deleted. 
 All of the splicing mutants had a reduced size transcript in the region 
where their point mutation occurred.  This reduction in size corresponded to a 
deletion of the exon that each splicing mutation is associated with, therefore it 
can be concluded that errors at Sad1 splice sites, whether they be at the start or 
end of the exon, result in deletion of the exon.  This reduces the size of the 
transcript and may affect protein folding or protein function if important regions 
of the protein have been deleted.  It was then of interest to determine whether 
any of the splicing mutants had protein present. These results will be discussed in 
the following chapter. 
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Chapter 4 - Protein analysis of sad1 mutants 
4.1 Introduction 
4.1.1 Genetic analysis of sad1 mutants 
 The previous chapter describes the genetic analysis of the 17 sad1 
mutants by sequencing the genomic DNA to determine the location of the 
mutations and by RT-PCR and Northern blotting to determine whether sad1 
transcript was present.  At the gene level, genomic DNA sequencing showed that 
all mutants contained single point mutations in the Sad1 gene which introduced 
predicted premature termination of translation codons, splicing errors or amino 
acid substitutions into the Sad1 coding sequence.  RT-PCR showed that all of the 
predicted premature termination of translation mutants had a severe reduction in 
Sad1 transcript levels possibly due to degradation of the faulty transcripts by 
nonsense-mediated mRNA decay.  Both the splicing error mutants and the amino 
acid substitution mutants had Sad1 transcript, but Northern blotting and further 
RT-PCR experiments showed that the splicing error mutants contained a single 
exon deletion thereby shortening the transcript.  The amino acid substitution 
mutants were the only mutants to produce full-length sad1 transcript. 
 
4.1.2 Aims 
 Following on from the genetic characterisation of the 17 sad1 mutants in 
the previous chapter, the mutants will now be analysed at the protein level by 
Western blotting to determine whether full-length β-amyrin synthase protein 
(AsbAS1) is produced.  Western blotting requires a primary antibody specific to 
AsbAS1, therefore a polyclonal AsbAS1 antibody will be generated using an 
Escherichia coli expression system.  Once the Western blotting conditions have 
been optimised, oat root protein extracts from each of the mutants can be probed 
with the AsbAS1 antibody to determine which, if any, of the sad1 mutants 
produce full-length protein.  This will provide and insight into catalytic regions of 
the protein that play an important role in OSC function. 
 
4.2 Materials and Methods 
4.2.1 Cloning of Sad1 into pET-14B vector 
 The β-amyrin synthase cDNA was amplified by PCR using a full-length 
cDNA clone, AsbAS1-pYES2 (49) as a template.  The following primers were used 
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which contained NcoI and BamHI restriction sites for cloning into the pET-14B 
vector (NcoI site is shown in red, BamHI site is shown in blue): pET14-5’ = GGTA 
CGCCATGGGCAGGCTAACAATAGGTGAGGGCGGCG, and pET14b-3’ = CTATAT 
GGATCCTTAGCTCTTAATCGCAAGAAGTCGACG.  PCR was carried out using 
Phusion™ High Fidelity DNA polymerase (Finnzymes) using the following 
program: 98°C for 1 minute followed by 30 cycles of 98°C for 10 seconds, 60°C 
for 30 seconds, 72°C for 3 minutes and a final extension at 72°C for 5 minutes. 
The presence of a product of the correct size was confirmed by 1% TBE agarose 
gel electrophoresis with ethidium bromide staining, and the resulting DNA 
fragments were purified using a Wizard PCR Preps Kit (Promega).  Using the two 
new restriction sites, the amplified DNA fragments were cloned into the pET-14b 
vector (Invitrogen) and transformed by heat-shock into Escherichia coli DH5α 
cells (Invitrogen) and spread onto LB agar plates (1% tryptone, 1% NaCl, 0.5% 
yeast extract, 1.5% agar) containing 50 µg/ml ampicillin for growth overnight at 
37°C.  Plasmid DNA was purified by Wizard SV Minipreps Kit (Promega) and 
digested with EcoRI (Invitrogen) for 1 hour at 37°C to confirm the presence of 
the Sad1 coding sequence.  Those E. coli transformants containing the Sad1 
coding sequence were sequenced. 
 
4.2.2 Expression of pET-14b-Sad1 in Escherichia coli BL21(DE3) cells 
 Purified pET-14b-Sad1 plasmid DNA was transformed by heat-shock into 
competent E. coli BL21(DE3) cells and spread onto LB plates containing 100 
µg/ml ampicillin for growth overnight at 37°C.  For small scale expression trials, a 
single colony was grown in 10 ml of LB media (1% tryptone, 1% NaCl, 0.5% 
yeast extract) containing 50 µg/ml ampicillin overnight at 37°C.  Two ml of the 
culture was used to inoculate 50 ml of LB media containing 50 μg/ml ampicillin 
and grown at 37°C with shaking until the culture reached log phase growth 
(OD600 = 0.5).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a 
final concentration of 1 mM to induce protein expression, and the culture was 
grown at 37°C with shaking for 4 hours.  After 4 hours, 1 ml of the culture was 
taken for expression analysis. 
 For large scale expression, a single colony was grown in 10 ml of LB media 
containing 100 µg/ml ampicillin overnight at 37°C.  Two 500 ml flasks of LB 
media were each inoculated with 5ml of the culture and grown at 37°C with 
shaking until the culture reached log phase growth (OD600 = 0.5).  IPTG was 
added to a final concentration of 1 mM to induce protein expression and the 
culture was grown at 37°C with shaking for 3 hours.  After 3 hours 1 ml of the 
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culture was taken for analysis of expressed protein and the remainder of the 
culture was centrifuged at 5,000 xg for 5 minutes and stored at 4°C. 
 Samples were prepared for SDS-PAGE analysis by standardising the OD600 
after 3 hours of induction to the OD600 at 0 hours of induction in a 1 ml volume.  
Samples were centrifuged at 16,000 xg for 5 minutes and the pellet was 
resuspended in 20 μl of distilled water.  Five μl NuPAGE® LDS Sample Buffer 
(Invitrogen) and 13 μl distilled water were added to 2 μl of the resuspended 
culture.  The protein preparation was heated at 95°C for 30 minutes and then 
centrifuged at 16,000 xg for 5 minutes. 
 
4.2.3 Purifying AsbAS1 from inclusion bodies 
 Cells harvested from the 1 L culture were resuspended in 50 ml lysis 
buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 5% (v/v) glycerol, 1 mM DTT, 50 
mM NaCl, 0.2% (w/v) sodium deoxycholate (NaDOC), 200 μg/ml lysosyme) 
supplemented with 1 tablet of Complete protease inhibitor (Roche) per 50 ml and 
incubated on ice for 30 minutes.  The cell suspension was sonicated at 18 
microns, using a Soniprep 150 (MSE), for 3 sets of 30 second pulses with a pause 
of 30 seconds on ice between each pulse.  The cell lysates were centrifuged at 
15,000 xg for 20 minutes and the supernatant (S/N1) was decanted and stored at 
4°C for analysis.  The cell pellet was resuspended in 50 ml Wash buffer (50 mM 
Tris-HCl pH 8.0, 0.1 mM EDTA, 5% (v/v) glycerol, 50 mM NaCl, 2% (w/v) 
NaDOC, 0.1 mM DTT) and incubated at 4°C with slow stirring for 1 hour.  The 
sonication, centrifugation and resuspension steps were repeated twice and the 
supernatants (S/N2 and S/N3) were stored at 4°C for analysis.  The cell pellet 
was resuspended in 50 ml solubilisation buffer (50 mM Tris-HCl pH 8.0, 0.1 mM 
EDTA, 5% (v/v) glycerol, 50 mM NaCl, 0.25% sarkosyl (N-lauroylsarcosine), 0.1 
mM DTT) and incubated at 4°C with slow stirring for 1 hour.  The cell suspension 
was dialysed against 2 L dialysis buffer (50 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 
5% (v/v) glycerol, 50 mM NaCl, 0.1 mM DTT) at 4°C overnight, then centrifuged 
at 15,000 xg for 20 minutes.  The supernatant (S/N4) was decanted and 
concentrated using an Amicon Ultra-15 Centrifugal Filter Unit 30,000 MWCO 
(Millipore) then stored at 4°C. 
 
4.2.4 SDS-PAGE gel purification of AsbAS1 and antibody production 
 Concentrated S/N4 supernatant (1.5 ml) from inclusion body purification 
was added to 500 μl NuPAGE® LDS Sample Buffer (Invitrogen) and heated in a 
boiling water bath for 10 minutes then placed on ice for a further 5 minutes.  Two 
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ml of the sample was loaded onto an 10% SDS-PAGE gel placed in a PROTEAN® 
II xi Cell (Bio-Rad).  Both the upper and lower chambers were filled with Gel 
Running Buffer (0.25 M Tris, 1.92 M glycine, 1% (w/v) SDS) and the gel was 
electrophoresed at 50 mA through the stacking gel and 70 mA through the 
running the gel for 4½ hours.  The gel was stained in Coomassie Brilliant Blue 
(Bio-Rad) for 1 hour and destained overnight. 
 For electroelution of AsbAS1 from the SDS-PAGE gel, the band 
corresponding to the molecular weight of AsbAS1 was excised from the gel and 
placed into dialysis tubing filled with 0.5x Gel Running Buffer. The tubing was 
placed horizontally in a large gel tank and protein was electroeluted overnight at 
15 mA in 0.5x Gel Running Buffer.  Electroeluted protein was dialysed against 5 L 
water at 4°C overnight and then freeze-dried before storage at -20°C. 
 Freeze-dried electroeluted AsbAS1 (1 mg) was used as an antigen for 
antibody production in two rats (BioGenes). 
 
4.2.5   Protein analysis of sad1 mutants 
 Total protein was extracted from the terminal 0.5 cm of 3 day old oat root 
tips by grinding the roots in protein extraction buffer (50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 5 mM EDTA, 10% (v/v) glycerol, 1% (w/v) PVPP, 1% (v/v) Triton 
X-100 (Boehringer Mannheim), 1x Complete protease inhibitor (Roche)) for 1 
minute with a plastic pestle followed by incubation at 4°C for 2 hours.  Protein 
extract was obtained by centrifugation at 16,000 xg for 20 minutes and stored at 
-20°C in aliquots of 10 µl with 5 µl distilled H2O and 5 µl NuPAGE
® LDS Sample 
Buffer (Invitrogen). 
 For sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE), each 20 µl aliquot was heated at 95°C for 30 minutes then centrifuged at 
16,000 xg for 5 minutes.  Each sample (15 μl) was loaded onto a NuPAGE® Novex 
4-12% Bis-Tris Gel (Invitrogen) placed in an XCell SureLock™ Mini-Cell 
(Invitrogen).  Both the upper and lower chambers were filled with 1x MES SDS 
Running Buffer (Invitrogen) and 0.5 ml NuPAGE® Antioxidant (Invitrogen) was 
added to the upper buffer chamber.  The gel was electrophoresed at 200 V for 40 
minutes and stained by incubation with InstantBlue (Novexin) for 1 hour. 
 For Western blotting, samples were prepared and run on a NuPAGE® 
Novex 4-12% Bis-Tris Gel (Invitrogen) as described in section 4.2.4, then 
transferred to a nitrocellulose membrane using the XCell II™ Blot Module at 30V 
constant for 1 hour.  The membrane was washed in Tris-Buffered Saline (TBS) 
(20 mM Tris-HCl pH 7.5, 7.5 mM NaCl) and incubated for 1 hour/overnight in 
blocking solution (3% Bovine Serum Albumin, 10 mM Tris-HCl pH 7.5, 7.5 mM 
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NaCl).  The membrane was then washed with TBS with Tween-20 and Triton X-
100 (TBSTT) (20 mM Tris-HCl pH 7.5, 0.5 mM NaCl, 0.05% v/v Tween®-20, 0.2% 
v/v Triton X-100) and TBS and incubated with Sad1 polyclonal antibody diluted 
1:10,000 in blocking solution for 1 hour.  The membrane was washed again with 
TBSTT and TBS and incubated with Goat Anti-Rat IgG Horseradish peroxidase 
conjugate (Sigma) diluted 1:10,000 in blocking solution for 1 hour.  The 
membrane was thoroughly washed in TBSTT and incubated Supersignal® West 
Pico Chemiluminescent Substrate (Thermo Scientific) for 7 minutes at room 
temperature.  The membrane was then exposed to Super RX 18 x 24cm film 
(Fujifilm) and developed using a SRX-101A Film Processor (Konica Minolta). 
 
4.3 Results and Discussion 
4.3.1 Generation of AsbAS1 antibody 
 Transcript analysis of both the premature termination of translation 
mutants and the amino acid substitution mutants had the expected results, with 
the former having severely reduced transcript levels and the latter having wild-
type levels of transcript present.  Detailed analysis of the splicing error mutants 
revealed that transcript was present in all of the mutants, but at a reduced length 
due to deletion of the exon adjacent to the mutation in each mutant.  It was clear 
that both the splicing error and amino acid substitution mutants were affected at 
a post-transcriptional stage, so it was of interest to investigate the levels of SAD1 
(AsbAS1) protein present in each of the mutants.  If AsbAS1 protein was found in 
any of the mutants, this would provide valuable information about important 
residues or regions that are required for function in pentacyclic oxidosqualene 
cyclases, a class of enzymes that has previously not been studied in great detail. 
 Western blotting was used in order to study levels of AsbAS1 protein in 
each of the sad1 mutants, but this required a primary antibody specific to 
AsbAS1.  Antibodies were available for other proteins encoded by different genes 
in the avenacin pathway (Sad7, Sad9 and Sad10), but due to the membrane 
bound nature of AsbAS1, previous attempts to purify the protein for antibody 
generation had failed (62).  However without a specific antibody, accurate protein 
detection of AsbAS1 protein in all of the sad1 mutants would have been very 
difficult, therefore another attempt was made at generating an antibody for 
AsbAS1.  If this was successful then the antibody could be used to probe root 
extracts of sad1 mutants detect presence of AsbAS1 protein. 
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4.3.1.1 Sad1 antibody generation 
 Attempts to purify AsbAS1 in Pichia pastoris (see Chapter 5) and Nicotiana 
benthamiana (86) using immobilised metal affinity chromatography had been 
unsuccessful as too many impurities remained in the fractions eluted from the 
column.  Both the yeast and tobacco systems were originally selected as a means 
to generate functional protein for kinetic and structural studies, but as functional 
protein is not required for antibody generation, the Escherichia coli system could 
be used for protein purification.  This system had been successfully used to purify 
the Sad7 gene product, Avena strigosa serine carboxypeptidase-like 
acyltransferase (AsSCPL1) from inclusion bodies, which was then used to 
generate a highly specific antibody (62).  Therefore this method was used to 
purify AsbAS1 protein for antibody generation. 
 
4.3.1.1.1 Cloning of Sad1 into the pET-14b vector 
  The full-length Sad1 cDNA sequence was amplified by PCR using primers 
to add NcoI and BamHI restriction sites to the 5’ and 3’ ends of the coding 
sequence respectively.  The products were analysed by 1% TAE gel 
electrophoresis to confirm the presence of a correctly sized product at ~2.3kb.  
The DNA fragments were then digested with NcoI and BamHI and ligated into the 
pET-14b vector to generate the construct BAS-E1, and transformed into E. coli 
DH5α cells (Figure 4.1A).  Plasmid DNA was isolated from the transformed cells 
Figure 4.1: Cloning of Sad1 into the pET-14b vector 
A. Plasmid map of pET-14b (4.6kb).  ori – origin of replication; Ampicillin – bla gene for ampicillin 
resistance. Multiple cloning site is also shown and restriction sites used for Sad1 cloning are denoted 
by *. B. EcoRI digestion of plasmid DNA extracted from four BAS-E1 transformants to identify 
constructs containing the Sad1 gene.  Plasmids containing the Sad1 gene have bands at 4.2kb, 1.6kb 
and 1kb whereas undigested plasmids that do not contain the Sad1 gene have a single band at 3 kb.  
The digested plasmid DNA was run on a 1% TAE agarose gel and visualised with EtBr staining. 
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and digested with EcoRI to confirm presence of Sad1 cDNA.  The Sad1 coding 
sequence has two EcoRI sites 1kb apart and pET-14b has one EcoRI site situated 
512bp upstream of the NcoI restriction site, so successful integration of the Sad1 
cDNA into the pET-14b vector would generate fragments of 4.2kb, 1.6kb and 1kb 
(Figure 4.1B).  The BAS-E1-pET14b construct had a number of E. coli 
transformants which produced the desired fragment sizes after digestion with 
EcoRI.  Sequencing of the Sad1 gene in a selection of these E. coli transformants 
confirmed that the gene had been successfully cloned into the pET-14b vector. 
 
4.3.1.1.2 Expression of BAS-E1 in Escherichia coli BL21(DE3) cells 
 For small scale protein expression trials, the BAS-E1 construct was 
transformed into E. coli BL21(DE3) cells.  BL21(DE3) cells were chosen as they 
produce high levels of expression for T7 promoter-driven vectors such as pET-14b 
(244).  Expression trials in a 50ml culture volume were conducted on five E. coli 
BL21(DE3) transformants (BAS-E1.1:BL21(DE3) to  BAS-E1.5:BL21(DE3)) to 
identify a highly expressing transformant.  Protein expression was induced by 
addition of IPTG to a final concentration of 1mM and the culture was grown for 
four hours at 37°C with shaking.  After four hours, 1ml of the culture was taken 
for expression analysis.  Cell pellets were resuspended in distilled water and 
analysed by SDS-PAGE to detect protein expression. 
 SDS-PAGE analysis for each of the transformants was conducted by 
comparing a sample taken before protein induction to the sample taken after four 
hours of protein induction to look for the appearance of novel bands.  After 
InstantBlue staining all transformants had a novel band between the 62 and 
98kDa markers that was not seen in the uninduced sample.  This band 
corresponded to the expected molecular weight of AsbAS1, 86.8kDa.  There was 
no significant difference in the level of the novel protein produced by each of the 
transformants, so it did not matter which was chosen to carry forward to large 
scale expression.   
 
4.3.1.1.3 Inclusion body purification of AsbAS1 
 BAS-E1.4:BL21(DE3) was selected from small scale expression trials as 
the transformant to be used for large scale expression and purification of AsbAS1.  
For large scale expression the culture volume was scaled up to two 500ml 
cultures to give a total culture volume of one litre.  Protein expression was 
induced by addition of IPTG to a final concentration of 1mM and the cultures were 
grown for three hours at 37°C with shaking.  After three hours 1ml of each 
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culture was taken for expression analysis and the remainder of the cells were 
harvested by centrifugation and stored at -80°C.  The samples were analysed by 
SDS-PAGE to ensure that the novel band between the 62 and 98kDa markers that 
was seen in trial expression analysis was produced (Figure 4.2).  The SDS-PAGE 
gel showed that both 500ml cultures (culture 1 and culture 2) produced a novel 
band between the 62 and 98kDa markers after three hours of protein induction 
(Lanes 6 and 9) which corresponded to the novel band seen in the small scale 
expression trial (Lane 3) and the expected molecular weight of AsbAS1. 
 
Figure 4.2: Instant Blue stained SDS-PAGE gel of samples taken following large scale 
expression of AsbAS1. 
SDS-PAGE gel shows analysis of small and large scale BAS-E1.4:BL21(DE3) culture samples taken 
before and 3 hours after protein induction.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: myosin 
(188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic dehydrogenase (49kDa), 
alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), myoglobin red (17kDa), lysozyme 
(14kDa), aprotinin (6kDa).  Small scale expression of BAS-E1.4:BL21(DE3): Lane 2, uninduced culture 
(0 hours); Lane 3, induced culture (3 hours); Lane 4, blank.  Large scale expression of BAS-
E1.4:BL21(DE3): Lane 5, Culture 1 uninduced (0 hours); Lane 6, Culture 1 induced (3 hours); Lane 7, 
blank; Lane 8, Culture 2 uninduced (0 hours); Lane 9, Culture 2 induced (3 hours).  Expected 
molecular weight of AsbAS1 (shown by the arrow) is predicted to be 86.8kDa, which falls between the 
62 and 98kDa markers. 
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 For inclusion body purification, the cells harvested from protein induction 
were lysed by sonication in a buffer containing 0.2% (w/v) sodium deoxycholate, 
a mild detergent used to lyse cells and solubilise cellular and membrane 
components (245).  After centrifugation to remove soluble proteins, the pellet 
was then washed two times in a buffer containing 2% (w/v) sodium deoxycholate 
which involved sonication, incubation at 4°C with slow stirring for one hour 
followed by centrifugation.  At this stage the pellet appeared brown-white and 
had a chalky appearance.  The protein was solubilised from the inclusion bodies 
by resuspension and incubation at 4°C with slow stirring for one hour in a buffer 
containing sarkosyl, a detergent used to disrupt the interactions between 
inclusion bodies (246).  The solution was dialysed overnight to remove the 
detergent and underwent a final centrifugation step to remove insoluble 
fragments.  The final supernatant was then concentrated from a volume of 80 ml 
Figure 4.3: SDS-PAGE analysis of samples collected during inclusion body purification of AsbAS1. 
SDS-PAGE gel of samples collected during inclusion body purification of AsbAS1.  Lane 1, SeeBlue® 
Plus2 Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), bovine serum albumin 
(62kDa), glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase 
(28kDa), myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, BAS-E1,4:BL21(DE3) 
uninduced (culture 1); Lane 3, BAS-E1,4:BL21(DE3) induced (culture 1); Lane 4, Soluble protein 
isolated by centrifugation following lysis step; Lanes 5 and 6, Supernatant following wash steps; Lane 
7, Supernatant obtained following sarkosyl solubilisation and overnight dialysis; Lane 8, Pellet 
obtained following sarkosyl solubilisation and overnight dialysis; Lane 9, Supernatant obtained after 
final centrifugation step; Lane 10, Concentrated final supernatant.  Expected molecular weight of 
AsbAS1 (shown by the arrow) is predicted to be 86.8kDa, which falls between the 62 and 98kDa 
markers. 
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to 7 ml and stored at 4°C.  Samples taken at all stages of the purification process 
were then analysed by SDS-PAGE to determine whether the induced band from 
large scale expression had been successfully purified (Figure 4.3).  Lanes 2 and 3 
contain the samples from the trial expression (lanes 5 and 6 of Figure 4.2) which 
show a strong band produced at the expected molecular weight of AsbAS1 
following protein induction.  Lane 4 contains the soluble protein present after cell 
lysis and centrifugation steps to remove insoluble molecules and membrane 
fragments.  The strong band between the 62 and 98kDa markers is not present 
here indicating that this protein was present in the insoluble pellet fraction.  Both 
wash step fractions removed some minor impurities and after solubilisation and 
dialysis the large band was present in the supernatant which indicated that it had 
been successfully solubilised from the inclusion bodies.  The pellet remaining after 
solubilisation and dialysis still contained a large amount of the protein of interest, 
so more protein could have been recovered with a longer solubilisation period, 
but the amount of protein recovered was sufficient for antibody production.  In 
the final supernatant, the band of interest was clearly the most abundant protein 
in the sample and had been successfully solubilised from the inclusion bodies.  
Concentration of the protein showed that a lot of other lower molecular weight 
impurities were also present in the final sample, therefore another stage of 
purification was needed in order to obtain pure protein. 
 
4.3.1.1.4 Gel extraction and electroelution of AsbAS1 
 The protein of interest had been partially purified from inclusion bodies, 
but still contained a number of impurities.  As the protein was not expressed with 
any tags, column chromatography could not be used, therefore to obtain a pure 
protein sample gel extraction and electroelution were used.  To separate the 
proteins based on size, a large SDS-PAGE gel was used to allow a large sample 
volume to be loaded.  Two 10% SDS-PAGE gels were loaded with 1.5ml of the 
concentrated supernatant from inclusion body purification and 500µl of NuPAGE® 
loading dye.  A tris-glycine buffer was used as it provides better resolution for 
large proteins.  After electrophoresis and InstantBlue staining, a large thick band 
was seen approximately one third of the way down the gel which was likely to be 
the protein of interest.  The top and bottom halves of the band, sample 1 and 
sample 2 respectively, were excised separately from the gel and the protein was 
electroeluted into a 0.5x tris-glycine buffer overnight.  The electroeluted samples 
were dialysed overnight and then freeze-dried until the majority of the aqueous 
solution had been removed.   
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 The two freeze dried samples were then analysed by SDS-PAGE to assess 
the purity of the sample and to quantify the amount of protein present.  10 µl of 
each protein sample was analysed and a BSA dilution series was used to 
determine the concentration of the protein (Figure 4.4).  The freeze dried 
electroeluted protein samples from the top and bottom halves of the gel extracted 
band are shown in Figure 4.4, lanes 3 and 4 respectively.  Comparison with the 
partially purified sample in lane 2 shows that all of the lower molecular weight 
impurities have been removed and just a single band at the expected molecular 
weight of AsbAS1 is present.  Quantification using the BSA dilution series in lanes 
5-9 showed that the top and bottom halves of the excised band contained 1µg 
and 0.5 μg protein respectively.  This allowed the amount of protein in both of the 
Figure 4.4: SDS-PAGE gel to quantify the concentration and purity of AsbAS1 
SDS-PAGE gel to quantify the concentration of protein present in the freeze dried samples following 
gel extraction and electroelution of AsbAS1 from the large SDS-PAGE gel.  Purity of samples was 
assessed by comparison to the partially purified sample following inclusion body purification.  
Concentration of samples was calculated by comparison of the purified samples to a BSA dilution 
series.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), 
bovine serum albumin (62kDa), glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), 
carbonic anhydrase (28kDa), myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, 
Partially purified protein after inclusion body purification; Lane 3, Freeze-dried electroeluted protein 
excised from the top half of the gel extracted band (10µl); Lane 4; Freeze dried electroeluted protein 
excised from the bottom half of the gel extracted band (10µl); Lane 5, 0.5µg BSA standard; Lane 6, 
1µg BSA standard; Lane 7, 2µg BSA standard; Lane 8, 5µg BSA standard; Lane 9, 10µg BSA 
standard.  Expected molecular weight of AsbAS1 (shown by the arrow) is predicted to be 86.8kDa, 
which falls between the 62 and 98kDa markers. 
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samples to be calculated.  The total volumes of samples 1 and 2 were 7 ml and 
10 ml respectively therefore they contained 0.7 mg and 0.5 mg protein 
respectively.  The total amount of pure protein obtained was 1.2mg and as both 
samples had equal purity they were combined and freeze dried. 
 To confirm the identity of the purified protein, the band in lane 3 of Figure 
4.4 was excised and sent for Matrix Assisted Laser Desorption/Ionization – Time 
Of Flight – Mass Spectrometry (MALDI-TOF-MS fingerprinting).  This technique 
involves digesting the proteins contained in the band of interest with trypsin and 
dissolving them in a matrix solution which protects the protein and facilitates 
ionisation.  The peptide molecules are spotted onto a MALDI plate, then ionised 
using a laser which promotes the matrix molecules and peptides from a solid to a 
gaseous state.  These molecules are then accelerated in the electric field of the 
mass spectrometer and their mass is calculated by measuring the time of flight 
(TOF) over a specified distance (247).  The masses of the different peptide 
fragments are exported as peak lists which are then analysed by MASCOT, a 
search engine that uses the peak lists to search a number of databases containing 
protein sequence information to match the masses produced by tryptic digestion 
to known proteins.  The results are exported as a list of possible matches each 
with a mascot score value.  This score is calculated using the probability that the 
observed match between the MS data and the sequence database entry is a 
random event.  Probability is converted to a mascot score using -10log10(P), 
where P is the probability, therefore meaning that the best match has the highest 
score.  A significance level is determined for each data set, but usually matches 
with a score above 70 are significant (248-249).  Mascot analysis of the band 
confirmed the identity of the protein to be Avena strigosa β-amyrin synthase, 
with a mascot score of 235.  This confirmed that the protein purified from E. coli 
BL21(DE3) cells was AsbAS1. 
  
4.3.1.1.5 AsbAS1 antibody production and testing 
 The freeze dried protein was sent to BioGenes, Germany for polyclonal 
antibody production.  Antibodies were raised in two rats which were immunised 
with 0.5mg of purified AsbAS1 protein solution over a three month period.  Pre-
immune serum was taken from each rat before immunisation and 3ml of final 
bleed serum was obtained from each rat at the end of the immunisation protocol 
(serum numbers 13082 and 13803).  Each antibody was then tested against a 
number of different protein extracts to determine specificity of the antibody and 
to quantify the level of antibody dilution needed for Western blotting.  Pre-
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immune sera was also tested to determine whether any background signal was 
present in the rats before immunisation.  
 The protein extracts used to test the AsbAS1 antisera were Avena strigosa 
S75 root extract, Avena strigosa S75 leaf extract and E. coli expressed AsbAS1 
(BAS-E1.4:BL21(DE3)).  AsbAS1 is expressed in the roots of young oat seedlings 
but is not present in the leaves which provides a method of testing the specificity 
of the antibody (49).  The closest related protein to AsbAS1 that is present in oats 
is the Avena strigosa cycloartenol synthase.  This enzyme is expressed in all 
tissues and organs of oat, so if it is also detected by the AsbAS1 antibody then 
signal would be seen in both root and leaf extracts and the presence or absence 
of AsbAS1 protein would be masked (49).  However, if a signal is seen in the oat 
root extract but not in the leaf extract this will show that the enzyme is highly 
specific to AsbAS1.  The E. coli expressed AsbAS1 provides a positive control as it 
was used to raise the antisera, so should produce a strong signal.  To optimise 
the protocol, membranes were probed with varying concentrations of the two rat 
antiseras to find the concentration which produced the clearest signal with 
minimal background.  Optimal dilution ratios for serum 13082 and 13083 were 
found to be 1:10,000 and 1:5,000 respectively.   
 Analysis of the three protein extracts produced the same results for both 
antisera.  Western blots with the pre-immune sera were blank for both sets of 
sera at 30 seconds and 30 minutes of exposure.  This confirmed that before 
immunisation neither of the rats contained antibodies that cross-reacted with any 
of the proteins present in the oat or E. coli extracts.  Western blots with the final 
bleed sera had a clear signal at the expected molecular weight of AsbAS1 in the 
A. strigosa root extract and the E. coli expressed AsbAS1, but no signal was seen 
in the A. strigosa leaf extract (Figure 4.5).  In the samples that produced a signal, 
only a single band was seen even after 30 minutes of exposure indicating  
that the AsbAS1 antibody is highly specific to AsbAS1, and lack of signal in the 
leaf extract showed that no cross-reaction with A. strigosa cycloartenol synthase 
is present.  Therefore this highly specific, highly concentrated antibody could now 
be used to probe root extracts of the sad1 mutants to look for presence of the 
AsbAS1 protein in the three different mutant groups. 
Chapter 4 – Protein analysis of sad1 mutants 
 
 
100 
Figure 4.5: Testing of pre-immune and final bleed sera from AsbAS1 antibody production 
Western blot analysis of pre-immune and final bleed sera from AsbAS1 antibody production in two rats 
(13082 and 13083).  Lane 1, SeeBlue® Plus2 Pre-Stained Standard - phosphorylase (98kDa) and 
bovine serum albumin (62kDa) denoted by arrows; Lane 2, A. strigosa S75 root tip protein; Lane 3, A. 
strigosa S75 leaf protein; Lane 4, E. coli expressed AsbAS1 (BAS-E1.4:BL21(DE3) transformant).  A. 
Pre-immune sera testing of serum numbers 13082 and 13083.  Sera tested at 5x concentration of the 
final bleed sera.  B. Final bleed sera testing of serum numbers 13082 and 13083. 
 
4.3.2 Western blot analysis of sad1 mutants 
 None of the sad1 mutants had previously been analysed for presence of 
AsbAS1 protein, but it was expected that the premature termination of translation 
mutants would not contain AsbAS1 protein as the Sad1 transcript had been 
severely degraded in each of these mutants.  Transcript was present in the other 
the splicing error mutants but each mutant contains an exon deletion resulting in 
a shorter transcript so stable folded protein is unlikely to be produced.  All of the 
amino acid substitution mutants have full length transcript so all have the 
potential to produce fully folded protein, but if the point mutation affects protein 
stability, then the protein will be degraded.  However, those mutants that do 
contain full-length protein will provide valuable clues as to the amino acid 
residues and regions of the protein that are important for protein function. 
 AsbAS1 antibody generation had produced a highly specific, high titre 
antibody against AsbAS1 which could now be used to probe protein extracts of 
sad1 mutants to look for presence or absence of AsbAS1 protein.  Protein 
Serum 
number
13082
1:2,000
1 2 3 4 1 2 3 4
1 2 3 4 1 2 3 4
1 2 3 4 1 2 3 4
1 2 3 4 1 2 3 4
Pre-immune sera Final bleed sera
10 second 
exposure
30 minute 
exposure
10 second 
exposure
30 second 
exposure
Serum 
number
13083
1:1,000
Serum 
number
13082
1:10,000
Serum 
number
13083
1:5,000
A B
Chapter 4 – Protein analysis of sad1 mutants 
 
 
101 
extracted from the terminal 0.5cm of 3 day old root tips from each of the sad1 
mutants was run on an SDS-PAGE gel and transferred to a nitrocellulose 
membrane.  The membrane was then probed with the AsbAS1 antibody from 
serum 13083 followed by a horseradish peroxidase conjugate for 
chemiluminescent detection using X-ray film.  
 
4.3.2.1.1 Premature termination of translation mutants 
 As expected, when compared to the wild-type S75, none of the premature 
termination of translation mutants produced AsbAS1 protein (Appendix 8).  These 
mutants had all had a predicted premature termination of translation codon 
within the coding sequence that resulted in a substantial reduction in Sad1 
transcript levels.   
 
4.3.2.1.2 Splicing error mutants 
 Western blot analysis revealed that none of the splicing mutants had any 
AsbAS1 protein present (Figure 4.6).  The wild type S75 root protein clearly 
shows a single band between the 62 and 98 kDa markers at the expected size of 
AsbAS1, but none of the splicing mutants have any evidence of a signal at any 
size.  These mutants each had a point mutation at an intron-exon boundary which 
resulted in deletion of the exon adjacent to the mutation producing a shorter 
Sad1 transcript.  Although deletion of an exon does not alter the reading frame in 
any of the splicing mutants, relatively large regions of the coding sequence (110 
– 25 amino acids, 225 – 63 amino acids, 589 – 41 amino acids and 1001 – 33 
amino acids) would be deleted.  The majority of the tertiary structure of AsbAS1 
is formed of alpha helices, and all of the deleted regions would result in the 
removal of at least one helix which would seriously affect protein stability and 
folding.  Accumulation of misfolded proteins can be toxic to cells, so eukaryotic 
cells have evolved a quality control mechanism to detect misfolded and 
unassembled proteins and either retain them in the endoplasmic reticulum for re-
folding or transport them for degradation by a process known as ER-associated 
degradation (ERAD) (250-253).  It is currently understood that misfolded proteins 
are recognised by detection of features such as, abnormal hydrophobic regions, 
unpaired cysteine residues or immature glycans.  These misfolded proteins are 
then translocated to the cytoplasm where they are ubiquitinated and degraded by 
the 26S proteosome (254-255).  Since no AsbAS1 protein is observed in any of 
these mutants, it seems likely that the shortened sad1 transcripts produce 
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protein that is either unable to fold or is misfolded and is targeted for 
degradation. 
Figure 4.6: Western blot analysis of sad1 splicing error mutants using the AsbAS1 antibody 
Western blot analysis of the sad1 splicing mutants to look for the presence of AsbAS1 protein.  
Membrane was probed with the AsbAS1 antibody at 1:10,000 dilution (13083 serum) and 
chemiluminescent signal detected by exposure to X-ray film for 30 seconds.  Lane 1, SeeBlue® Plus2 
Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), 
glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), 
myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, Wild type S75 root tip protein; 
Lane 3-6, Root tip protein from mutant numbers 110, 225, 589 and 1001. A. SDS-PAGE gel to show 
even total protein loading. B. Western blot at 30 seconds exposure. 
 
4.3.2.1.3 Amino acid substitution mutants 
 Western blot analysis of the seven amino acid substitution mutants 
revealed that three of the mutants had full length AsbAS1 protein present (Figure 
4.7).  In the wild-type, a single band is seen between the 62 and 98 kDa markers 
corresponding to the expected molecular weight of AsbAS1.  This band is also 
seen in mutants #358, #384 and #1023 indicating that these mutants all 
produce full-length AsbAS1 protein, however the remaining four mutants, #297, 
#532, #599 and #1217 do not have any AsbAS1 protein as no signal is seen.  As 
transcript is present in these four mutants, lack of protein is likely to be caused 
by ERAD in the same way as for the splicing mutants.  Unlike the splicing 
mutants, these substitution mutants produce full-length protein, but the location 
of the mutations most likely destabilises the protein fold resulting in misfolded 
protein, which is then recognised by the cell and targeted for degradation.  The 
mutation in #1217 is located near to one of the QW motifs which are postulated 
to be involved in protein stability, adjacent to the stacked glutamine and 
tryptophan residues.  This mutation may therefore disrupt the stacking and 
destabilise the protein structure resulting in the protein being targeted for 
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Figure 4.7: Western blot analysis of sad1 amino acid substitution mutants using the AsbAS1 
antibody 
Western blot analysis of the sad1 amino acid substitution mutants to look for the presence of AsbAS1 
protein.  Membrane was probed with the AsbAS1 antibody at 1:10,000 dilution (13083 serum) and 
chemiluminescent signal detected by exposure to X-ray film for 1 minute.  Lane 1, SeeBlue® Plus2 
Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), 
glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), 
myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, Wild type S75 root tip protein; 
Lane 3-9, Root tip protein from mutant numbers 297, 358, 384, 532, 599, 1023, 1217. A. SDS-PAGE 
gel to show even total protein loading. B. Western blot at 1 minute exposure. 
 
degradation.  The mutation in #599 is found on the protein surface, and is the 
only substitution mutation not to be located near the active site or a region 
known to be important for stability.  If this residue was involved in protein-
protein interactions and mutation resulted in AsbAS1 being unable to interact with 
its binding partner, this could destabilise the protein or activate regulatory 
mechanisms leading to its degradation.   
 As for the three mutants which produce full-length AsbAS1 protein, the 
reason for their lack of function must come at a stage after protein folding as 
disruption to AsbAS1 protein folding would have resulted in protein degradation 
as seen for the other substitution mutants.  As none of these mutants produce 
the end product of the avenacin pathway despite having fully folded protein, it 
can only be concluded that the AsbAS1 protein is non-functional.  It was therefore 
of interest to examine the areas of the protein where the mutations were located 
in order to gain further insights into residues or regions of the protein that were 
important for protein function.   
 To ascertain what effect each of the three mutations would have on 
protein function, the location of the mutation and its proximity to residues 
predicted to be involved the enzyme mechanism were examined in detail on the 
homology model of AsbAS1.  The point mutation in mutant #358 was found to be 
in the active site close to the catalytic aspartate which is essential for function 
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and is conserved throughout all OSCs (Figure 4.8A) (52, 124, 210-211).  The 
mutation was found to be in one of the cysteine residues (Cys563) which 
coordinates the catalytic aspartate and increases its acidity to allow it to 
protonate the epoxide group of the substrate (144, 212).  Both cysteines are 
required for activity, as site-directed mutagenesis in Saccharomyces cerevisiae 
lanosterol synthase has shown.  The cysteine adjacent to the catalytic aspartate 
(not corresponding to the mutation in mutant #358) was mutated to a aspartate 
residue to form the catalytic motif DDTAE, as is seen in bacterial squalene hopene 
cyclases, and this resulted in a significant reduction in enzyme activity (256).  
The aspartate is of a similar size to the cysteine and is able to form a hydrogen 
bond with the catalytic aspartate which may explain why enzyme activity is not 
completely abolished.  In mutant #358, the non-adjacent cysteine to the catalytic 
aspartate is mutated to a tyrosine residue.  This residue is much bulkier than the 
original cysteine residue so the vital hydrogen bond required for reaction initiation 
is unlikely to be formed.  With the reaction unable to commence, the enzyme is 
rendered inactive and the avenacin pathway is terminated at this stage. This 
demonstrates that two cysteine hydrogen bonds are required for activation of the 
catalytic aspartate.   
Figure 4.8: Effect of mutations in mutants #358, #384 and #1023 on enzyme function 
Diagrams to illustrate the location of the residues affected by point mutations in mutants #358, #384 
and #1023 and their proximity to conserved and important amino acid residues involved in the 
enzyme mechanism.  The AsbAS1 tertiary structure is shown in purple.  A. The residue affected by the 
point mutation in mutant #358.  Mutation is found in a cysteine residue (shown in red) hydrogen 
bonded to the catalytic aspartate.  Hydrogen bonds are shown by grey dashed lines.  B.  The residue 
affected by the point mutation in mutants #384 and #1023.  Mutation is found in a serine residue 
(shown in red) which has close proximity to the three residues involved in allowing substrate access 
(shown in orange) and the Phe725 (shown in purple) which is involved in stabilisation of the D-ring 
during cyclisation.  Cation-π interactions are shown by grey dashed lines. 
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 Despite being independent from each other, mutants #384 and #1023 
contain the same point mutation, which was also found to be in the active site 
close to two mechanistic features that are vital for correct enzyme function 
(Figure 4.8B).  The mutation substitutes a serine residue (Ser728) for a 
phenylalanine.  Ser728 is found to be in close proximity to the three residues 
(Tyr264, Cys260 and Ile554) postulated to block the substrate access channel 
which then undergo a conformational change to allow substrate entry into the 
active site (144).  Substrate access is dependent on all of the residues being in 
the correct orientation so that when they change conformation the substrate can 
fit through the newly created opening.  The loop on which Ser728 is located is 
adjacent to the loop containing isoleucine 554 (Ile554) so the position of the loop 
could easily be shifted by mutation of a small serine residue to a large bulky 
phenylalanine.  If the orientation of Ile554 is altered then the substrate access 
may be permanently blocked resulting in a non-functional enzyme.  Ser728 is 
also located three residues along from a phenylalanine residue (Phe725) which is 
involved in stabilising the positive charge formed upon D-ring closure during 2,3-
oxidosqualene cyclisation to allow ring expansion to a 6-membered ring (144, 
165).  The positive charge is stabilised through cation-π interactions between the 
delocalised electrons of the phenylalanine and the positive charge formed on the 
newly cyclised ring of the intermediate (164).  Phe725 works together with 
Phe259 to stabilise the positive charge, and stabilisation is dependent on the 
correct orientation of the delocalised electrons on the aromatic residues.  AsbAS1 
mechanism analysis has demonstrated that at least two aromatic residues are 
required for ring stabilisation, therefore substitution of Ser728 with a 
phenylalanine residue may affect the orientation of Phe725.  If Phe725 is shifted 
to a position in which it is no longer able to stabilise the positive charge, Phe259 
will not be able to provide enough negative potential to stabilise the charge so the 
cyclisation will be terminated prematurely resulting in a truncated tetracyclic 
product.  This effect is seen in the sterol oxidosqualene cyclases which only have 
a single phenylalanine residue for D-ring stabilisation and as a result can only 
produce tetracyclic products as cyclisation is terminated at this stage (144).  Also, 
site-directed mutagenesis experiments on Panax ginseng β-amyrin synthase 
where one of the D-ring stabilising phenylalanine residues is mutated have also 
found that tetracyclic products were produced (176).  If this, rather than blocked 
substrate access, occurs in mutants #384 and #1023 then truncated tetracyclic 
products may be present in the root tips of these mutants, so this could be 
investigated in future experiments. 
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 All, except one, of the amino acid substitution mutants, whether they 
produced folded protein or not, were found in the active site or in a region known 
to be important for stability (Figure 4.9).  This pattern can be explained by the 
method used to select the mutants.  Mutant selection was done using a loss-of-
fluorescence screen, therefore only mutants which lacked the ability to express 
functional protein or produced folded proteins with mutations in critical regions 
would have been selected as they would not have produced a fluorescent product.  
There may have been mutants present in the mutagenised oat population that 
had single point mutations in the Sad1 gene that resulted in no effect on enzyme 
function, but these would not have been selected for as they would have 
displayed a wild-type phenotype.  This implies that OSC enzymes are very 
 
Figure 4.9: Location of amino acid substitution mutations on AsbAS1 homology model 
Location of amino acid residues affected by amino acid substitutions on the AsbAS1 homology model.  
The tertiary structure of AsbAS1 is shown in lilac with the four QW motifs shown in purple.  Detergent 
molecules are shown as grey spheres which represent the lipid bilayer and show how the enzyme is 
oriented in the membrane.  Amino acid residues directly involved in the catalytic mechanism 
(initiation, stabilisation, deprotonation and substrate access) are shown as green spheres.  Amino acid 
residues affected by the mutations are shown as red spheres and the mutations which produce full-
length AsbAS1 protein are indicated by asterisks (*). 
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tolerant of mutations in areas of the enzyme that are not critical for function, and 
only those mutations that seriously affect enzyme expression or function that 
result in premature termination of the pathway. 
  
108 
Chapter 5 - Expression and purification of AsbAS1 in    
Pichia pastoris 
5.1 Introduction 
 Plant terpene synthases synthesise a diverse range of secondary 
metabolites which have a wide range of functions in plants, for example, plant 
defence, pigmentation, scents, signalling and allelopathy.  Many of these 
compounds have been exploited commercially as drugs and medicines (taxol – an 
anticancer drug from the yew tree), flavourings (glycyrrhizin – an artificial 
sweetener from licorice root), fragrances (eucalyptol – from the eucalyptus tree) 
and agrochemicals (rotenone – an insecticide from the vine plant).  It is therefore 
of huge interest to both the scientific and commercial industries to characterise 
the enzymes involved in synthesising these compounds.  Oxidosqualene cyclases 
(OSCs) are found at the initial stage of triterpenoid secondary metabolite 
synthesis and cyclise 2,3-oxidosqualene to a number of cyclic products, for 
example cycloartenol and β-amyrin, which are the cyclic backbones for all 
steroids and triterpene secondary metabolites, respectively.   
 
5.1.1 Cloning and purification of oxidosqualene cyclases 
 As mentioned previously, a large number of sterol and triterpene OSCs 
have been cloned from mammalian, fungal and plant species.  The majority of 
these OSCs have been heterologously expressed in yeast, and in vitro or in vivo 
assays coupled with GC-MS, LC-MS or HPLC have been used to determine their 
function and product specificity.   
 Despite their importance to the commercial industry, very few OSCs have 
been purified and only one, the Homo sapiens lanosterol synthase (hOSC), has 
been subjected to in depth biochemical and structural studies.  Prior to the 
cloning of the OSCs, lanosterol synthase, cycloartenol synthase and β-amyrin 
synthase had been purified from their native organisms.  OSCs had proved 
difficult to purify due to their membrane-bound nature, their instability and their 
insolubility in the absence of detergents.  Lanosterol synthase from rat liver was 
the first OSC to be solubilised.  This was achieved by isolating liver microsomes 
by centrifugation then solubilising the enzyme from the membrane using 0.08 M 
deoxycholate.  The enzyme was partially purified by centrifugation and ether 
extraction and was found to be active, but it proved to be unstable and rapidly 
lost activity (257).  Subsequent experiments found that solubilisation using 1% 
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Triton X-100 greatly improved the solubility and stability of the enzyme, which 
could then be stored at 0°C for two weeks without significant loss of activity 
(258).  Lanosterol synthases have since been purified both partially and fully from 
Saccharomyces cerevisiae (211, 258-259), Rattus norvegicus (260) and Bos 
taurus (261).  Cycloartenol synthase and β-amyrin synthase have also been 
partially purified from pea seedlings (262).  All purification protocols involve 
solubilisation of the enzyme from microsomes using Triton X-100, followed by 
various purification steps that include ion-exchange chromatography, affinity 
chromatography, isoelectric focussing and gel filtration.  Most of the enzymes 
were purified to homogeneity and retained activity but yields were relatively low, 
typically approximately 2 mg (2-5% final yield from the crude homogenate) (211, 
260-261). 
 Heterologous overexpression of proteins in yeast or bacteria dramatically 
increases the amount of protein that can be produced in cultures and therefore 
increases yield.  However attempts to overexpress OSCs in a bacterial system 
proved unsuccessful as the proteins mainly formed inclusion bodies possibly due 
to insolubility, improper folding or lack of post-translational modification (211).  
Saccharomyces cerevisiae lanosterol synthase has also been successfully 
expressed in insect cells.  The majority of OSCs have been heterologously 
expressed in yeast, but despite the large number of OSCs cloned into a 
heterologous overexpression system, only hOSC has been successfully purified on 
a large scale and been subjected to kinetic analysis (151). 
 
5.1.2 Purification of hOSC in Pichia pastoris 
 hOSC was heterologously expressed in the methylotrophic yeast Pichia 
pastoris.  It was cloned into the pPICZB vector to give a construct with a C-
terminal 6-histidine tag attached to the OSC protein and the construct was 
transformed into Pichia pastoris GS115 cells.  Western blotting with an hOSC 
polyclonal antibody identified a single highly expressing clone that produced 3 mg 
hOSC per 1 g cell mass.  For large-scale purification, 0.2% Triton X-100 was used 
to solubilise hOSC from the membrane after cell disruption and the C-terminal 6-
histidine tag facilitated purification by metal-affinity chromatography.  Detergent 
exchange from Triton X-100 to 0.8% β-D-octylglucopyranoside (β-OG) was 
carried out before elution of hOSC from the column and the fractions containing 
hOSC were further purified by gel filtration.  The final yield of pure hOSC was 105 
mg and subsequent analysis showed that hOSC was monomeric with a molecular 
mass of 80 kDa (151). 
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 hOSC was successfully crystallised in a solution containing 2.4% β-OG and 
diffracted to a resolution of 2.1 Å.  The enzyme was crystallised with both the 
product, lanosterol, and an inhibitor, Ro 48-8071, bound in the active site.  The 
detergents used for solubilisation of the enzyme during the purification process 
were also visible in the final crystal structure and these detergent molecules 
identified a single amphipathic helix implicated in anchoring hOSC to the 
membrane (151). 
 
5.1.3 Challenges in purifying membrane proteins 
 Currently there are just over 600 membrane protein crystal structures in 
the Protein Data Bank, which represent just 1% of the total number of crystal 
structures in the database.  So why are structures of membrane proteins so 
scarce?  The main problems lie in the stages of protein expression, protein 
purification and crystal growth.  The first membrane protein crystals were grown 
using protein purified from natural sources rather than from heterologous 
expression.  Compared to soluble proteins, after ribosomal synthesis many 
membrane proteins undergo complex processes involved in targeting and 
inserting proteins into the membrane.  Over-expression of a membrane protein 
can overload the secretory pathways leading to formation of toxic intermediates 
or inclusion body formation (149, 263-265).  Eukaryotic membrane proteins 
present an additional challenge as bacterial hosts have a very different 
translocation mechanisms and membrane composition and also lack post 
translational machinery (266).  Other hosts, such as yeast, have been much more 
successful for eukaryotic membrane protein expression and purification.  The 
methylotrophic yeast Pichia pastoris has been successfully used for heterologous 
expression of a number of membrane proteins, such as hOSC (151); multidrug 
resistance transporters (267-268) and G-protein coupled receptors (269-270). 
 After successful expression in a host, protein purification presents the next 
challenge and selection of the right detergent for solubilisation of the membrane 
protein is key.  The detergent needs to stabilise the protein structure in an 
unaggregated state which may involve mixtures of detergents and non-detergent 
additives (271-272).  Crystal growth is the final hurdle and is unpredictable.  
Crystals have been grown using detergent:protein complexes or by reintroducing 
the protein to a lipid bilayer environment (although the former method is more 
commonly used).  Searching for the right conditions requires the correct choice of 
precipitant and must take into consideration the complex phase behaviour of the 
detergent as well as the protein (273).  New methods for crystallisation of 
membrane proteins such as lipidic cubic phase and bicelle techniques are being 
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developed which may improve the success rate for membrane protein 
crystallisation (274-275). 
 
5.1.4 Aims 
 To date no triterpene OSCs have been purified on a large scale from 
heterologous expression.  The aim of this part of the project was to develop 
methods for purification of AsbAS1.  As hOSC is currently the only OSC to be 
successfully purified from heterologous expression, the expression system and 
purification strategy were used as templates for AsbAS1 expression and 
purification.  This involved cloning and heterologous functional expression of 
tagged AsbAS1 in Pichia pastoris, followed by expression and purification using 
metal-affinity chromatography.  The ultimate aim was to generate sufficient pure 
protein to generate crystals and solve the structure of AsbAS1, which would 
provide important new insights into the mechanism of triterpene OSCs and enable 
the hypotheses made by the AsbAS1 homology model generated in Chapter 2 to 
be tested. 
 
5.2 Materials and Methods 
5.2.1 Cloning of Sad1 into pPICZB vector 
 β-amyrin synthase was amplified by PCR using a full-length cDNA clone, 
AsbAS1-pYES2 (49) as a template.  The following primers were used which 
contained PmlI and XbaI restriction sites for cloning into the pPICZB vector (PmlI 
site is shown in red, XbaI site is shown in blue, start and stop codons are shown 
in bold): pPICZB-5’-native = 5’GTACATCACGTGACCATGTGGAGGCTAACAATAGGT 
GAGG-3’, pPICZB-3’-native = 5’-CATGTATCTAGATTAGCTCTTAATCGCAAGAAGTCG 
ACGGC-3’, pPICZB-3’-6His = 5’CATGTATCTAGATTAGTGATGGTGATGGTGATGGCT 
CTTAATCGCAAGAAGTCGACG-3’, and pPICZB-5’-6His = 5’GTACATCACGTGACC 
ATGCATCACCATCACCATCACTGGAGGCTAACAATAGGTGAG-3’.  Three different 
primer combinations were used to generate the constructs: pPICZB-BAS1 (native 
protein) using pPICZB-5’-native and pPICZB-3’-native; pPICZB-BAS2 (C-
terminally 6-histidine tagged protein) using pPICZB-5’-native and pPICZB-3’-
6His; and pPICZB-BAS4 (N-terminally 6-histidine tagged protein) using pPICZB-
5’-6His and pPICZB-3’-native.  PCR was carried out using Pfu Ultra DNA 
polymerase (Stratagene Europe) for 30 cycles (program: 95°C, 0.5min, 50°C, 1 
min, 70°C, 3 min, and final extension at 72°C, 10 min).  The presence of a 
correctly sized product was confirmed by 1% TBE agarose gel electrophoresis 
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with ethidium bromide staining, and the resulting DNA fragments were purified 
using a Wizard PCR Preps Kit (Promega).  Using the two new restriction sites, the 
amplified DNA fragments were cloned into the pPICZB-vector (Invitrogen) and 
transformed by heat-shock into Escherichia coli DH5α cells (Invitrogen) and 
spread onto Low Salt LB pH 7.5 plates (1% tryptone, 0.5% NaCl, 0.5% yeast 
extract, 1.5% agar) containing 25 µg/µl zeocin for growth overnight at 37°C.  
Plasmid DNA was purified by Wizard SV Minipreps Kit (Promega) and digested 
with EcoRI (Invitrogen) for 1 hour at 37°C to confirm the presence of the Sad1 
coding sequence.  Those E. coli transformants containing the Sad1 coding 
sequence were sequenced. 
 
5.2.2 Transformation into Pichia pastoris 
 Competent cells were prepared from a 500 ml culture of Pichia pastoris (P. 
pastoris) X-33 or KM71H strain in Yeast Peptone Dextrose (YPD) medium (1% 
yeast extract, 2% peptone, 2% dextrose) grown at 30°C with shaking to an OD600 
= 1.3-1.5.  Cells were harvested by centrifugation at 1,500 xg for 5 minutes and 
resuspended in 500 ml ice-cold sterile water.  The resulting pellet was washed 
with 250 ml ice-cold sterile water, followed by 20 ml ice-cold 1 M sorbitol and 
finally 1 ml ice-cold 1 M sorbitol.   
 Plasmid DNA for each of the constructs was linearised with SacI, purified 
by phenol/chloroform extraction and ethanol precipitation and transformed into 
the competent P. pastoris cells by electroporation.  Increasing volumes (10, 25, 
50, 100, 200 µl) of the electroporated cells were grown on Yeast extract Peptone 
Dextrose+ (YPDS) medium (1% yeast extract, 2% peptone, 2% dextrose, 1 M 
sorbitol, 2% agar) plates containing 100 µg/ml zeocin at 30°C.  Up to ten colonies 
were purified on fresh YPDS plates containing 100 µg/ml zeocin at 30°C. 
 The Mut phenotype of the P. pastoris transformants was determined by 
growing up to 10 purified colonies on Minimal Dextrose (MD) (1.34% YNB, 4x10-
5% biotin, 2% dextrose) and Minimal Methanol (MM) (1.34% YNB, 4x10-5% 
biotin, 0.5% methanol) media agar plates at 30°C.   
 
5.2.3 Small scale expression trials of AsbAS1 P. pastoris X-33 transformants 
 A single Mut+ colony was grown in 25 ml of Buffered Glycerol-complex 
(1% yeast extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% 
YNB, 4x10-5% biotin, 1% glycerol) media (BMGY) at 30°C with shaking at 250 
rpm to an OD600 = 2-6.  The cells were harvested by centrifugation at 5,000 xg 
and resuspended to an OD600 = 1.0 in 100 ml Buffered Methanol-complex (1% 
Chapter 5 – Expression and purification of AsbAS1 in Pichia Pastoris 
 
 
113 
yeast extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 
4x10-5% biotin, 0.5% methanol) media (BMMY) to induce protein expression.  
The culture was grown at 30°C with shaking at 250 rpm.  Methanol was added to 
a final concentration of 0.5% every 24 hours to maintain protein induction.  On 
day 3 of protein induction, 1 ml of the culture was taken for expression analysis.  
Cells were pelleted by centrifugation at 16,000 xg for 2 minutes, the supernatant 
was decanted to a fresh 1.5 ml eppendorf tube and 150 µl 80% glycerol was 
added.  Both supernatant and pellet were frozen in liquid nitrogen and stored at -
80°C. 
 
5.2.4 SDS-PAGE analysis of protein expression 
 Cell pellets were resuspended in 300 µl Breaking buffer (50 mM sodium 
phosphate pH 7.4, 1 mM protease inhibitor, 1 mM EDTA, 5% glycerol) and lysed 
by sonication at 18 microns, using a Soniprep 150 (MSE), for 5 sets of 15 second 
pulses with a pause of 30 seconds on ice between each pulse.  Triton X-100 
(Boehringer Mannheim) was added to the cell lysates to a final concentration of 
1% and incubated for 1 hour at 4°C with inversion.  After centrifugation at 
16,000 xg for 15 minutes, the supernatant was collected.  For sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE), 7 µl of NuPAGE® LDS 
Sample Buffer (Invitrogen) was added to 20 µl of supernatant, incubated at 70°C 
for 10 minutes and placed on ice for a further 5 minutes.  20 µl of each sample 
was loaded onto a NuPAGE® Novex 4-12% Bis-Tris Gel (Invitrogen) placed in an 
XCell SureLock™ Mini-Cell (Invitrogen).  Both the upper and lower chambers were 
filled with 1x MES SDS Running Buffer (Invitrogen) and 0.5 ml NuPAGE® 
Antioxidant (Invitrogen) was added to the upper buffer chamber.  The gel was 
electrophoresed at 200 V for 40 minutes and stained by incubation with 
InstantBlue (Novexin) for 1 hour. 
 
5.2.5 Western blot analysis of protein expression 
 Samples were prepared and run on a NuPAGE® Novex 4-12% Bis-Tris Gel 
(Invitrogen) as described in section 4.2.4, then transferred to a nitrocellulose 
membrane using the XCell II™ Blot Module at 30V constant for 1 hour.  The 
membrane was washed in Tris-Buffered Saline (TBS) (20mM Tris-HCl pH 7.5, 7.5 
mM NaCl) and incubated for 1 hour/overnight in blocking solution (3% Bovine 
Serum Albumin, 10 mM Tris-HCl pH 7.5, 7.5 mM NaCl).  The membrane was 
washed with TBS with Tween-20 and Triton X-100 (TBSTT) (20 mM Tris-HCl pH 
7.5, 0.5 mM NaCl, 0.05% v/v Tween®-20, 0.2% v/v Triton X-100) and TBS and 
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incubated with His•Tag® Monoclonal Antibody (Novagen) diluted 1:1000 in 
blocking solution for 1 hour.  The membrane was washed again with TBSTT and 
TBS and incubated with Goat-Anti-Mouse IgG Alkaline Phosphatase conjugate 
(Novagen) diluted 1:5000 in blocking solution for 1 hour.  The membrane was 
thoroughly washed in TBSTT and incubated with the colourimetric reagent 
BCIP/NBT solution (50 mM Tris-HCl pH 8.8, 14 mM MgCl2, 0.1 mg/ml 4-nitro blue 
tetrazolium chloride (NBT), 0.05 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate 
(BCIP)).  The colourimetric reaction was stopped by washing the membrane 
thoroughly in deionised water. 
 
5.2.6 GC-MS analysis of in-vivo protein activity 
 P. pastoris transformants were grown under inducing conditions as 
described in 4.2.3.  On day 3 of protein induction the cells were harvested by 
centrifugation at 5,000 xg for 5 minutes.  Cells were disrupted and saponified by 
resuspension in 20 ml Extraction Buffer (80% ethanol, 10% w/v potassium 
hydroxide, 0.5 mg/ml butylated hydroxytoluene (Sigma)) and incubated at 65°C 
for 2 hours.  The mixture was diluted with 5 ml water and the products were 
extracted 3 times with 1 volume of hexane.  The hexane fraction was washed 
three times each with 1 volume of water and 3 M NaCl solution.  The hexane was 
then evaporated under reduced pressure and the resulting extract derivatised 
with Tri-Sil Z (Pierce) and analysed by gas-chromatography mass-spectrometry 
(GC-MS) on an Agilent 5973 MSD (Agilent, Stockport, UK) coupled to an Agilent 
6890 Gas Chromatograph.  The column used was a Phenomenex Zebron ZB-5 
column (0.25 mm ID x 30 m, 0.25 μm film) (Macclesfield, UK) with a built-in 5 m 
guard column.  The injector port, source and transfer line temperatures were set 
at 250°C and an oven temperature program from 170°C (2.0 min) to 340°C (3.0 
min) at 6°C /min was used, with helium as the carrier gas at 0.8 ml/min constant 
flow.  Splitless injections (1 μl) were made from the derivatised sample.  EI+ 
mass spectral data were acquired for the duration of the GC program from m/z 
50-800. 
 
5.2.7 Large scale expression of AsbAS1 
 A single Mut+ colony was grown in 25 ml of Buffered Glycerol-complex 
(1% yeast extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% 
YNB, 4x10-5% biotin, 1% glycerol) media (BMGY) at 30°C with shaking at 250 
rpm to an OD600 = 2-6.  The 25 ml culture was used to inoculate 500 ml of BMGY 
media and grown at 30°C with shaking at 250 rpm until the culture reached log 
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phase growth (OD600 = 2-6).  The cells were harvested by centrifugation at 5,000 
xg and resuspended to an OD600 = 1.0 in 5 litres Buffered Methanol-complex (1% 
yeast extract, 2% peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 
4x10-5% biotin, 0.5% methanol) media (BMMY) to induce protein expression.  
The culture was grown at 30°C with shaking at 250 rpm.  Methanol was added to 
a final concentration of 0.5% every 24 hours to maintain protein induction.  On 
day 3 of protein induction, 1 ml of the culture was taken for expression analysis.  
Cells were pelleted by centrifugation at 5,000 xg for 10 minutes and stored on at 
4°C or frozen at -80°C until required. 
 
5.2.8 Extraction and solubilisation of AsbAS1 protein 
 The following protocol was adapted from Ruf et al. (151).  Cells harvested 
from the 5 litre culture were resuspended in 250 ml Resuspension buffer (50 mM 
Tris-HCl pH 7.5, 5% glycerol (v/v), 2 mM DTT, 2 mM MgCl2) supplemented with 1 
tablet of Complete protease inhibitor (Roche) per 50 ml.  The cell suspension was 
disrupted with Pg = 1000 psi in a French pressure cell press (SLM Aminco) and 
then sonicated for 10 minutes at 18 microns on a Soniprep 150 (MSE).  Triton X-
100 (Boehringer Mannheim) was added to the crude extract to a final 
concentration of 0.2% (v/v) and incubated for 1 hour at 4°C with stirring.  
Unbroken cells and cell fragments were removed by centrifugation at 30,000 xg 
and the supernatant was stored at 4°C until required. 
 
5.2.9 Immobilised metal affinity chromatography 
 Purification was carried out using an AKTA Purifier (Amersham 
Biosciences).  The supernatant was loaded, using a 150 ml Superloop (GE 
Healthcare), onto a HiTrap™ Chelating HP 5ml column (GE Healthcare) 
equilibrated with Loading buffer (50 mM Tris-HCl pH 7.5, 5% glycerol (v/v), 2 mM 
DTT, 2 mM MgCl2, 0.2% Triton X-100 (v/v)).  The column was washed with 1 
column volume (CV) of loading buffer and 5 CVs of Wash buffer (50 mM Tris-HCl 
pH 7.5, 5% glycerol (v/v), 2 mM DTT, 2 mM MgCl2, 0.8% β-D-
octylglucopyranoside (β-OG) (w/v) (Sigma).  Bound protein was eluted with a 
linear gradient of Elution buffer (50 mM Tris-HCl pH 7.5, 5% glycerol (v/v), 2 mM 
DTT, 2 mM MgCl2, 0.5 M imidazole) and 5 ml fractions were collected on a Frac-
920 (Amersham Biosciences).  Fractions with an absorbance at 280 nm were 
analysed by SDS-PAGE and Western blotting.  Fractions containing AsbAS1 were 
pooled and concentrated using an Amicon Ultra-15 Centrifugal Filter Unit 30,000 
MWCO (Millipore) and stored at -80°C until required 
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5.2.10  Gel filtration 
 Gel filtration was carried out using an AKTA Purifier.  The IMAC purified 
concentrated protein solution was loaded at 0.5 ml/minute onto a Superdex 200 
16/60 120 ml column (GE Healthcare) equilibrated with Gel filtration buffer (50 
mM Tris-HCl pH 7.5, 5% glycerol (v/v), 2 mM DTT, 2 mM MgCl2, 0.15 M NaCl).  
The column was washed with 1 CV of Gel filtration buffer and 1 ml fractions were 
collected on a Frac-920.  Fractions were analysed by SDS-PAGE. 
 
5.2.11  Hydrophobic interaction chromatography 
 Hydrophobic interaction chromatography (HIC) was carried out using an 
AKTA purifier.  The IMAC purified concentrated protein solution was diluted with 1 
volume of Buffer C (0.1 M sodium phosphate buffer pH 7.6, 2 M (NH4)2SO4).  It 
was then loaded at 0.5 ml/minute onto a Phenyl Sepharose Fast Flow (low-sub) 
25 ml column (GE Healthcare) equilibrated with 5 CV of Buffer B (50 mM sodium 
phosphate buffer pH 7.6) followed by 5CV of Buffer A (0.1 M sodium phosphate 
buffer pH 7.6, 1 M (NH4)2SO4).  The column was washed with Buffer A until 
unbound protein had been eluted and then bound protein was eluted with a linear 
gradient of Buffer B over 5 CVs and 0.25 ml fractions were collected on a Frac-
920.  Fractions were analysed by SDS-PAGE. 
 
5.3 Results and Discussion 
5.3.1 Pichia pastoris expression system 
 Both prokaryotic and eukaryotic systems have been used for 
overexpression of oxidosqualene cyclases (OSCs) (151, 211).  Attempts to 
express Saccharomyces cerevisiae lanosterol synthase (ScLS) in Escherichia coli 
(E. coli) failed to produce active protein despite a large number of strain and 
vector combinations being used.  Prokaryotes do not contain the post-
translational modification machinery that is present in eukaryotes so this may 
explain why active enzyme was not produced.  Subsequent attempts to 
overexpress ScLS in its native organism did result in active protein, however the 
expression levels were very low (211). 
 The expression system chosen for heterologous expression of AsbAS1 was 
the yeast Pichia pastoris.  Pichia is an attractive system for heterologous protein 
expression as it maintains many of the properties seen in other higher eukaryotic 
expression systems, such as protein folding, protein processing and post-
translational modification, which are not found in prokaryotic expression systems 
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such as E. coli.  In addition to this, it has also been shown to produce higher 
expression levels than other yeast systems, with expression levels 10- to 100-fold 
higher than the Saccharomyces cerevisiae expression system.  The P. pastoris 
expression system has been successfully utilised for the functional expression of 
other plant OSCs for activity assays (123, 151), purification (151) and 
crystallisation (144).   
 P. pastoris is a methylotroph which gives it the ability to use methanol as 
its sole carbon source.  Methanol is oxidised to formaldehyde and hydrogen 
peroxide in the first step of the methanol utilisation pathway.  Hydrogen peroxide 
is highly toxic to cells, so the reaction takes place in peroxisomes where it is 
detoxified by catalase.  Methanol oxidation is catalysed by the enzyme alcohol 
oxidase (AOX) which has a very low affinity for oxygen, so AOX expression is 
upregulated to produce large quantities of the enzyme.  AOX is encoded by two 
genes, AOX1 and AOX2, although it is the gene product of the former that 
provides the majority (85%) of the AOX activity (276-278).  Expression of AOX is 
tightly regulated at the transcriptional level and the promoter is highly inducible 
by methanol (279).  This property has been exploited for expression of foreign 
proteins in P. pastoris, and a plasmid-borne version of the AOX1 promoter has 
been developed to drive heterologous protein expression in P. pastoris (279-281). 
 pPICZ vectors were used for heterologous expression of AsbAS1.  This set 
of vectors has three different sub-types (A, B and C) which contain different 
restriction sites to allow the target gene to be cloned in-frame with the C-terminal 
tags which are present in the vector.  The vectors have a C-terminal myc epitope 
tag and a C-terminal polyhistidine tag to enable detection purification and 
detection of the expressed protein.  For positive selection in both E. coli and P. 
pastoris, all vectors contain the Sh ble gene which confers resistance to the 
antibiotic Zeocin™.  Zeocin™ is a water-soluble copper-chelated glycopeptide 
antibiotic with a broad spectrum against bacteria and eukaryotes.  Copper-bound 
Zeocin™ is inactive, but upon cell entry it is activated by removal of the copper 
cation by sulfhydryl compounds.  It then causes cell death by binding and 
cleaving cellular DNA.  Zeocin™ is light sensitive and inactivated by high salt 
concentrations, so reduced salt media must be used in cultures and incubation 
and storage must be in dark conditions (282).  The Sh ble, Zeocin™ resistance, 
gene was isolated from Streptoalloteichus hindustanus and inhibits Zeocin™ by 
binding to it in a stoichiometric manner which prevents its DNA cleavage activity 
(283).   
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5.3.2 Design of expression constructs 
 Three constructs were designed for heterologous expression of oat β-
amyrin synthase (AsbAS1) in P. pastoris with the aim of producing large 
quantities of protein that could be easily purified, for use in kinetic and structural 
studies.  Constructs consisted of the full-length Sad1 cDNA sequence with no tag 
(BAS1), C-terminal 6-histidine tag (BAS2) or N-terminal 6-histidine tag (BAS4) 
(Figure 5.1).  6-histidine tags were chosen as a C-terminal 6-histidine tag had 
been successfully used to purify the human lanosterol synthase (hOSC) (151).  
None of the constructs utilised the C-terminal 6-histidine and myc epitope tags 
originally contained in the vector as the restriction sites chosen resulted in a 60bp 
gap between the C-terminus of the protein and the end of both tags.  The 
resulting size of the tag may have hindered crystallisation and as only a histidine 
tag was required for purification, 6-histidine tags were added directly at the end 
or start of the appropriate constructs by PCR.  pPICZB was chosen as the vector 
for heterologous expression of AsbAS1 as it contained the desired PmlI and XbaI 
restriction sites.   
Figure 5.1: Design of constructs for β-amyrin synthase expression  
A. Three constructs designed for expression of Sad1 in Pichia pastoris.  All constructs contain the full 
length Sad1 cDNA sequence with and without 6-histidine tags.  BAS1 does not have a tag, BAS2 and 
BAS4 have a 6-histidine tag at the C- and N-terminus respectively.  The restriction sites used for 
cloning into the pPICZB vector are shown. B. Plasmid map of pPICZB (3.3 kb).  5’AOX1 – AOX1 
promoter; AOX1 TT – AOX1 transcription termination and polyadenylation signal; PTEF1 – Transcription 
elongation factor 1 gene (for Sh ble expression); PEM7 – constitutive promoter which drives Sh ble 
expression; Zeocin – Sh ble gene for Zeocin™ resistance;  cyc1TT – 3’ end of Saccharomyces 
cerevisiae CYC1 gene for efficient 3’ processing of Sh ble gene; pUC ori – pUC origin.  Multiple cloning 
site is shown between 5’AOX1 and AOX1 TT and restriction sites used for Sad1 cloning are denoted by 
*. 
 
5.3.3 Cloning of Sad1 into the pPICZB vector 
 The full-length Sad1 cDNA sequence was amplified by PCR using the 
primers required to add the desired restriction sites and tags for each of the 3 
constructs.  The products were analysed by 1% TBE gel electrophoresis to 
A B
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BAS2
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Sad1 cDNA
Sad1 cDNA
Sad1 cDNA
HHHHHH
HHHHHH
PmlI XbaI
PmlI
PmlI XbaI
XbaI
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confirm the presence of a correctly sized DNA fragment (Figure 5.2A).  The gel 
showed a single band between the 2.0 and 3.0kb markers for all constructs which 
corresponded to the size of the Sad1 coding sequence, ~2.3kb.   
 The Sad1 DNA fragments were then digested with PmlI and XbaI and 
ligated into the pPICZB vector to generate the constructs pPICZB-BAS1, pPICZB-
BAS2 and pPICZB-BAS4, and transformed into E. coli DH5α cells.  Plasmid DNA 
was isolated from the transformed cells and digested with EcoRI to confirm 
presence of Sad1 cDNA.  The Sad1 coding sequence has two EcoRI sites 1kb 
apart and pPICZB has one EcoRI site situated ~200bp upstream of the XbaI 
restriction site, so successful integration of the Sad1 gene into the pPICZB vector 
would generate fragments of 4.4kb, 1kb and 0.2kb.  All three constructs had E. 
coli transformants which produced the desired fragment sizes after digestion with 
EcoRI (Figure 5.2B).  Sequencing of the Sad1 cDNA in each of these E. coli 
transformants confirmed that the gene had been successfully cloned into the 
pPICZB vector. 
Figure 5.2: Cloning of Sad1 into pPICZB vector  
A. PCR amplification of Sad1 from full-length cDNA clone using primers to add desired restriction sites 
and 6-histidine tags for the three constructs.  The amplified PCR products were run on a 1% TBE 
agarose gel and visualised with EtBr staining.  B. EcoRI digestion of plasmid DNA extracted from five 
pPICZB-BAS2 transformants to identify constructs containing the Sad1 gene.  Plasmids containing the 
Sad1 gene have bands at 4.5 kb and 1 kb (N.B the 0.2 kb band is not visible) whereas plasmids that 
do not contain the Sad1 gene have a single band at 3.3 kb.  The digested plasmid DNA was run on a 
1% TBE agarose gel and visualised with EtBr staining. 
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5.3.4 Expression of pPICZB-BAS1, BAS2 and BAS4 in Pichia pastoris X-33 
 For protein expression, the three pPICZB constructs were transformed into 
Pichia pastoris wild-type strain X-33 cells.  X-33 was chosen as it has good 
growth levels in large-scale cultures and has been used for heterologous 
expression of other plant proteins (284-286).   
 Linearised pPICZB-BAS1, pPICZB-BAS2 and pPICZB-BAS4 plasmid DNA 
were transformed into competent P. pastoris X-33 cells via electroporation.  Ten 
colonies were purified on fresh plates for each construct to select for single 
transformants.  The methanol utilisation (Mut) phenotype of each colony was 
then determined.  The linearised plasmid DNA is integrated into the Pichia 
genome via homologous recombination which can result in either gene insertion 
or gene replacement.  Constructs generated in pPICZB vectors integrate into the 
Pichia genome at the AOX1 locus by crossover events between the either of the 
two AOX1 regions on the pPICZB vector, 5’AOX1 or AOX1 TT (Figure 5.1).  Single 
crossover events result in insertion of the gene of interest upstream or 
downstream of the AOX1 gene.  These transformants maintain a functional copy 
of the AOX1 gene and therefore have a wild type Mut phenotype, designated 
Mut+.  Double crossover events result in replacement of the AOX1 gene by the 
gene of interest.  As the AOX1 gene has been replaced, these transformants have 
to rely solely on the weaker AOX2 gene for methanol metabolism and therefore 
consume methanol at a slower rate so have a Mut slow phenotype, designated 
MutS (277, 287-288).  Mut phenotype is tested by growth of the transformant on 
MD and MM media agar plates.  MD media agar plates have dextrose as the sole 
carbon source so both Mut+ and MutS transformants should grow well.  MM media 
agar plates have methanol as the sole carbon source, therefore Mut+ 
transformants should grow well on these plates, whereas MutS transformants, 
which can only utilise the AOX2 gene, will grow at a much slower rate (Figure 
5.3).  Each of the three constructs had nine independent P. pastoris X-33 
transformants.  Growth comparisons on MD and MM media agar showed all nine 
pPICZB-BAS1:X-33 transformants, five pPICZB-BAS2:X-33 transformants and 
eight pPICZB-BAS4:X-33 transformants had a Mut+ phenotype, whilst the 
remainder displayed a MutS phenotype. As Mut+ transformants are more desirable 
for protein expression, all Mut+ P. pastoris X-33 transformants were carried 
forward to small-scale expression trials.  
 Expression trials were conducted on all Mut+ P. pastoris X-33 
transformants for each of the three constructs.  Protein expression was induced 
by resuspension in 100 ml methanol growth media (BMMY) and a 1 ml sample 
 
Chapter 5 – Expression and purification of AsbAS1 in Pichia Pastoris 
 
 
121 
Figure 5.3: Determination of Mut phenotype of P. pastoris X-33 transformants 
P. Pastoris X-33 cells transformed with each of the three pPICZB constructs were grown on minimal 
dextrose (MD) and minimal methanol (MM) media agar to determine the methanol utilisation (Mut) 
phenotype of each colony.  Examples of the two phenotypes are shown.  Colony A has a MutS 
phenotype as it grows well on MD media but grows poorly on MM media.  Colony B has a Mut+ 
phenotype as it grown well on both MD and MM media.  
 
was taken from each culture after three days of protein induction.  Cell pellets 
were disrupted by sonication and the lysate was incubated with Triton X-100 
(1%).  Detergent addition was essential in order to release the membrane-bound 
AsbAS1 into the supernatant.  Triton X-100 had been used successfully during the 
purification of Homo sapiens lanosterol synthase (hOSC) and in in-vitro assays for 
many other plant and fungal OSC, so was selected as the detergent used for 
AsbAS1 solubilisation in pPICZB-BAS1, pPICZB-BAS2 and pPICZB-BAS4 lysates 
(52, 57, 94, 101-102, 104).  The cell-free extracts of pPICZB-BAS1, pPICZB-
BAS2 and pPICZB-BAS4 P. pastoris X-33 transformants were then analysed using 
SDS-PAGE to look for expression of AsbAS1 protein. 
 
5.3.4.1 pPICZB-BAS1:X-33 
 SDS-PAGE analysis showed no significant difference between the nine 
Mut+ pPICZB-BAS1:X-33 transformants and a pPICZB:X-33 vector only control.  
The predicted size of AsbAS1 is 86.8kDa so should be seen between the 62 and 
98kDa markers on the gel if it has been induced in any of the  pPICZB-BAS1:X-33 
transformants.  However, as all pPICZB-BAS1:X-33 transformants are Mut+ and 
under the control of the AOX1 promoter, Pichia pastoris alcohol oxidase (PpAOX1) 
MD MM
A AB B
Chapter 5 – Expression and purification of AsbAS1 in Pichia Pastoris 
 
 
122 
would be co-expressed with AsbAS1.  The molecular weight of PpAOX1 is 
approximately 75kDa which is approximately 12kDa smaller than AsbAS1.  The 
theoretical calculations imply that AsbAS1 and PpAOX1 could be separated on an 
SDS-PAGE gel, however SDS-PAGE analysis of hOSC, which is predicted to have a 
molecular weight of 85.6 kDa, showed that it migrates at a distance of 80 kDa, 6 
kDa lower than predicted (151).  If AsbAS1 travels in a similar way to hOSC on 
an SDS-PAGE gel it may migrate a similar distance on an SDS-PAGE gel to 
PpAOX1 which may obscure the AsbAS1 band.  At the time, the AsbAS1 antibody 
was not available, and as this construct did not have a tag, presence of AsbAS1 
protein could not be detected by SDS-PAGE analysis alone. 
 The nine pPICZB-BAS1:X-33 transformants were analysed for production 
of AsbAS1 protein by function expression assays which are described in a later 
section. 
 
5.3.4.2 pPICZB-BAS2:X-33 and pPICZB-BAS4:X-33 
 Analysis of the five pPICZB-BAS2:X-33 and eight pPICZB-BAS4:X-33 Mut+ 
transformants was more conclusive as both constructs contained 6-histidine tags 
at the C- and N-terminus respectively, so cell-free extracts could be analysed by 
Western blotting as well as SDS-PAGE.   
 One out of the five pPICZB-BAS2:X-33 transformants (pPICZB-BAS2.1:X-
33) had a strong band present between the 62 and 98kDa markers that was not 
seen in the pPICZB:X-33 vector only control (Figure 5.4).  As mentioned 
previously, due to the co-expression and similar molecular weight of AsbAS1 and 
PpAOX1, it was possible that the band observed was alcohol oxidase, therefore a 
Western blot using the His•Tag® monoclonal antibody was carried out to detect 
whether C-terminally tagged AsbAS1 was present.  The Western blot detected a 
very faint signal which corresponded to the location of the band seen on the SDS-
PAGE gel which confirms that AsbAS1 has been expressed from pPICZB-
BAS2.1:X-33 (data not shown).  The faint signal seen on the Western blot does 
not correspond to the intensity of the band seen on the SDS-PAGE gel, therefore 
it is likely that this band also contains the co-expressed PpAOX1 which appears to 
be expressed at much higher levels than AsbAS1.   
 Two out of the eight pPICZB-BAS4:X-33 transformants (pPICZB-BAS4.4:X-
33 and pPICZB-BAS4.5:X-33) had a band present between the 62 and 98kDa 
markers that was not seen in the pPICZB:X-33 vector only control (Figure 5.5).  A 
Western blot using the His•Tag® monoclonal antibody detected a faint signal 
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Figure 5.4: InstantBlue stained SDS-PAGE gel of cell-free extracts from trial expression of  
pPICZB-BAS2:X-33 Mut+ transformants. 
SDS-PAGE gel of Triton X-100 treated cell-free extracts from Day 3 of the trial expression of pPICZB-
BAS2:X-33 Mut+ transformants.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: myosin (188kDa), 
phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic dehydrogenase (49kDa), alcohol 
dehydrogenase (38kDa), carbonic anhydrase (28kDa), myoglobin red (17kDa), lysozyme (14kDa), 
aprotinin (6kDa); Lane 2, pPICZB:X-33 vector only control cell-free extract; Lanes 3-7, pPICZB-
BAS2:X-33 Mut+ transformants cell-free extracts.  Expected molecular weight of AsbAS1 (shown by 
the arrow) is predicted to be 86.8kDa, which falls between the 62 and 98kDa markers. 
 
corresponding to the location of the band seen on the SDS-PAGE gel for pPICZB-
BAS4.4:X-33 but not for pPICZB-BAS4.5:X-33 (data not shown).  As for pPICZB-
BAS2.1:X-33, the signal from the Western blot did not correspond to the intensity 
of the band on the gel, so the band is also likely to contain the co-expressed 
PpAOX1.  The lack of signal for pPICZB-BAS4.5:X-33 may be a result of 
insufficient AsbAS1 protein loaded onto the gel rather than lack of AsbAS1 
expression as the band seen on the SDS-PAGE gel is much weaker than that of 
pPICZB-BAS4.4:X-33. 
 From these preliminary protein expression results, it seems that both 
pPICZB-BAS2:X-33 and pPICZB-BAS4:X-33 constructs have a single transformant 
which produced AsbAS1 protein to detectable levels on a Western blot.  Both 
transformants were then analysed to determine whether the expressed protein in 
each of the transformants was active. 
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Figure 5.5: InstantBlue stained SDS-PAGE gel of cell-free extracts from trial expression of  
pPICZB-BAS4:X-33 Mut+ transformants. 
SDS-PAGE gel of Triton X-100 treated cell-free extracts from Day 3 of the trial expression of pPICZB-
BAS4:X-33 Mut+ transformants.  Lane 1, pPICZB:X-33 vector only control cell-free extract; Lane 2-5, 
pPICZB-BAS2:X-33 Mut+ transformants cell-free extracts; Lane 6-7, SeeBlue® Plus2 Pre-Stained 
Standard: myosin (188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic 
dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), myoglobin red 
(17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 8, pPICZB:X-33 vector only control cell-free 
extract; Lane 9-12, pPICZB-BAS2:X-33 Mut+ transformants cell-free extracts.  Expected molecular 
weight of AsbAS1 (shown by the arrow) is predicted to be 86.8kDa, which falls between the 62 and 
98kDa markers. 
 
5.3.5 In-vivo functional assay of AsbAS1 activity in Pichia X-33 transformants 
 Protein expression analysis in P. pastoris X-33 transformants with 6-
histidine tagged constructs had identified two transformants (pPICZB-BAS2.1:X-
33 and pPICZB-BAS4.4:X-33) expressing AsbAS1 protein.  These two 
transformants were then tested using an in-vivo assay to determine whether the 
expressed protein was active.  All nine Mut+ pPICZB-BAS1:X-33 constructs were 
also analysed using the in-vivo assay as protein could not be detected via SDS-
PAGE analysis. 
 Pichia pastoris cells produce the membrane sterol ergosterol as their major 
sterol product by cyclisation of 2,3-oxidosqualene to lanosterol, which is catalysed 
by lanosterol synthase.  They do not, however, produce any secondary metabolite 
triterpenes such as β-amyrin, therefore any β-amyrin detected in the 
transformants would be a direct result of the heterologously expressed AsbAS1 
activity.  The enzyme can use the endogenous 2,3-oxidosqualene as a substrate 
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so the enzyme activity of AsbAS1 can be assayed in-vivo without feeding a 
substrate (123, 289). 
 Each transformant was grown using the same protocol as for the small-
scale expression trials.  After disruption and saponification of the cell pellets, 
triterpenes were extracted using hexane and analysed by GC-MS.  Raw GC-MS 
data was analysed using the AMDIS software package which removes background 
noise from the raw data, extracts individual component spectra and compares 
them to a library of common triterpenes (290).  The total ion chromatogram 
(TIC) of each clone was compared to the TIC of the pPICZB:X-33 vector only 
control to identify novel peaks.  The spectra of any novel peaks were compared to 
the library of common triterpenes to identify the product(s) that had been 
produced.   
 The nine pPICZB-BAS1:X-33 Mut+ transformants together with the 
pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-33 transformants selected from 
small scale expression trials were then tested for enzyme function using the in 
vivo assay. 
 
5.3.5.1 pPICZB-BAS1:X-33 
 Of the nine pPICZB-BAS1:X-33 Mut+ transformants analysed, all produced 
a novel peak which had a fragmentation pattern identical to that of β-amyrin.  
Figure 5.6A shows the AMDIS analysis of one of the transformants pPICZB-
BAS1.6:X-33 compared to the pPICZB:X-33 vector only control.  Both TICs have 
a peak at a retention time of 26.6 minutes and a fragmentation pattern corresponding 
to that of ergosterol, the primary sterol in Pichia pastoris.  pPICZB-BAS1.6:X-33 
contains a novel peak with a retention time of 27.7 minutes that is not observed 
in the pPICZB:X-33 vector only control.  The extracted spectrum of this novel 
peak is shown in Figure 5.6B and displays the characteristic fragmentation 
pattern of β-amyrin, with the molecular ion at m/z 426, and ions at m/z 393, 218 
and 203, thereby confirming that the compound in the novel peak to be β-amyrin.  
As stated previously, Pichia pastoris cells do not make secondary metabolite 
triterpenes, therefore the production of β-amyrin is a direct result of 
heterologously expressed AsbAS1 activity (123, 289).  The same analysis was 
conducted for the other eight pPICZB-BAS1:X-33 transformants (data not shown) 
and all had a novel peak corresponding to β-amyrin, thereby confirming that all 
transformants contained active AsbAS1 protein. 
 In order to determine which transformant had the highest levels of 
expressed protein, and could therefore be carried forward to large-scale 
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Figure 5.6: GC-MS analysis of pPICZB-BAS1:X-33 
A. TIC chromatogram of hexane extracts from Pichia transformants with (i) pPICZB:X-33 as an empty 
vector control and (ii) pPICZB-BAS1.6.  pPICZB-X-33 control shows only presence of the primary 
membrane sterol, ergosterol (1), whereas in pPICZB-BAS1.6:X-33, a novel peak at 27.7 min is 
detected. B. Mass spectra of the extracted spectrum of (i) the novel peak (2) from pPICZB-BAS1.6:X-
33 and (ii) a β-amyrin standard. 
 
expression trials, the levels of β-amyrin production were compared between all 
pPICZB-BAS1:X-33 transformants.  Although this method would not give 
quantitative data on the amounts of AsbAS1 protein present, measuring the 
amounts of β-amyrin synthesised in each of the transformants would allow 
indirect quantification of protein levels on the assumption that the transformant 
with the highest product levels produced more functional AsbAS1 protein. 
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Figure 5.7: Comparison of β-amyrin levels in pPICZB-BAS1:X-33 transformants 
Peak area of β-amyrin produced by each transformant is expressed as a percentage of total peak area 
of ergosterol.  The vector only control pPICZB:X-33 produces no β-amyrin and all transformants show 
some degree of AsbAS1 activity. 
 
Comparisons were made between the nine pPICZB-BAS1:X-33 transformants by 
expressing β-amyrin levels as a percentage of the total ergosterol level.  
Ergosterol levels remained at a similar level to the pPICZB:X-33 vector only 
control in all transformants so did not appear to be affected by pPICZB-BAS1 
expression.  The peak area of the β-amyrin peak was expressed as a percentage 
of the peak area of the ergosterol peak for each of the transformants and the 
data was displayed on a graph (Figure 5.7).  The highest levels of β-amyrin 
production was observed in pPICZB-BAS1.6 which had 30% peak area compared 
to ergosterol levels, and twice the ratio of β-amyrin:ergosterol seen in any other 
transformant.  This high ratio indicated that pPICZB-BAS1.6:X-33 had high levels 
of functional AsbAS1 protein, possibly as a result of multiple gene insertion 
events at the AOX1 locus during transformation of the pPICZB-BAS1 construct 
into Pichia pastoris X-33.  This data indicated that pPICZB-BAS1.6:X-33 is likely 
to be a highly expressing transformant. 
 
5.3.5.2 pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-33 
 The two transformants selected from the small scale expression trials as 
producing the highest AsbAS1 protein levels, pPICZB-BAS2.1:X-33 and pPICZB-
BAS4.4:X-33, both produced a novel peak which had a fragmentation pattern 
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identical to β-amyrin.  Figure 5.8 shows the AMDIS analysis of both transformants 
compared to the pPICZB:X-33 vector only control.  All TICs had a peak at 26 
minutes which corresponded to the primary membrane sterol ergosterol.  The 
TICs of the transformants also had a novel peak at 27.7 minutes that is not 
observed in the vector only control with a fragmentation pattern identical to that 
of β-amyrin.  The extracted ion chromatogram at m/z 218, a characteristic 
fragmentation size of β-amyrin, showed a single peak thereby further confirming 
the identity of the novel peak to be β-amyrin. 
 Estimates for β-amyrin production were calculated in the same way as the 
pPICZB-BAS1:X-33 transformants by expressing the peak area of the β-amyrin 
peak as a percentage of ergosterol peak area.  β-amyrin production was 8% and 
2% of the total ergosterol levels for pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-
33 respectively.  If it is assumed that β-amyrin levels are a direct reflection of 
AsbAS1 protein levels then pPICZB-BAS1.6:X-33, which had 30% of total 
ergosterol levels, contains 4-fold and 15-fold more functional AsbAS1 protein than 
pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-33 respectively.  This implied that 
the untagged Sad1 construct had much higher functional protein levels than both 
the C- and N-terminally 6-histidine tagged constructs.  This could be a result of 
higher expression levels for the untagged construct, or that the untagged 
construct is more active than both of the tagged constructs which implies that the 
Figure 5.8: GC-MS analysis of pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-33 
TIC and EIC (m/z 218) chromatograms of hexane extracts from Pichia transformants with A. 
pPICZB:X-33 as an empty vector control, B. pPICZB-BAS2.1 and C. pPICZB-BAS4.4.  pPICZB-X-33 
control shows only presence of the primary membrane sterol, ergosterol (1), whereas in pPICZB2.1 
and pPICZB4.4 a novel peak (2) at 27.7 min is detected. EIC at m/z 218 shows both of these 
transformants have the characteristic fragmentation ion of β-amyrin. 
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6-histidine tag may interfere with enzyme function.  However, the presence of a 
tag on both of these constructs enables the protein to be purified on a large scale 
by immobilised metal affinity chromatography (IMAC), so despite their reduced 
expression levels compared to the untagged transformant, pPICZB-BAS1.6:X-33, 
both tagged constructs would be much easier to purify.  Therefore both tagged 
transformants, pPICZB-BAS2.1:X-33 and pPICZB-BAS4.4:X-33 were carried 
forward for large scale expression trials. 
 
5.3.6 Large scale expression of pPICZB-BAS2.1:X-33 
 Small scale expression trials identified a single highly expressing 
transformant for each of the three different constructs designed for AsbAS1 
expression in Pichia pastoris X-33.  pPICZB-BAS1.6:X-33 was selected as the 
transformant for the untagged construct, pPICZB-BAS2.1:X-33 for the C-
terminally 6-histidine tagged construct and pPICZB-BAS4.4:X-33 for the N-
terminally 6-histidine tagged construct.  All transformants produced functional 
protein and GC-MS analysis allowed indirect quantification of protein levels 
through comparison of β-amyrin product levels produced by each of the 
transformants (on the assumption that the transformant with the highest product 
levels produced more functional AsbAS1 protein).  pPICZB-BAS1.6:X-33 was 
shown to produce the most functional protein followed by pPICZB-BAS2.1:X-33 
(4-fold less) and finally pPICZB-BAS4.4:X-33 (15-fold less).  pPICZB-BAS1.6:X-
33 was therefore the first choice for large scale expression as it produced the 
most functional protein.  However, as this construct lacked a tag and at the time, 
no antibody against the AsbAS1 protein was available, purification of this 
construct would have been very difficult.  The other two transformants contained 
constructs with 6-histidine tags, so would allow for purification of the protein via 
IMAC followed by gel filtration, therefore the highest expressing of these two 
transformants, pPICZB-BAS2.1:X-33 was the first to be chosen for large scale 
expression of AsbAS1. 
 For large scale expression of pPICZB-BAS2.1:X-33, the culture volume was 
scaled up to five litres.  Protein expression was induced by resuspension in five 
litres of methanol growth media (BMMY) and the cells were harvested by 
centrifugation after three days of protein induction and stored at -80°C. 
 
5.3.7 Immobilised metal affinity chromatography of pPICZB-BAS2.1:X-33 
 Purification of Homo sapiens lanosterol synthase (hOSC) was carried out 
using IMAC, which utilised the 6-histidine tag on the expressed protein followed  
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Figure 5.9: IMAC purification of pPICZB-BAS2.1:X-33 and SDS-PAGE analysis of eluted fractions 
A. Linear elution profile of AsbAS1 from a nickel charged metal affinity column using a 0.5M imidazole 
gradient.  Absorbance at 280nm of eluate from the column is represented by the blue line (left axis), 
conductivity is shown by the brown line and concentration of imidazole in the elution buffer is shown 
by the green line (right axis).  Sample injection at the start of the purification is shown by the red line 
and fraction numbers are also shown in red.  Fraction A1 was collected during the 1CV Triton X-100 
wash, Fractions A2-A6 were collected during the 5CV β-OG wash and the remaining fractions A7-B4 
were collected during elution with an imidazole gradient.  The fractions labelled with a star denote 
those chosen for SDS-PAGE and Western blot analysis. B. SDS-PAGE gel of fractions eluted from the 
column.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), 
bovine serum albumin (62kDa), glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), 
carbonic anhydrase (28kDa), myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, 
Cell free extract from Day3 pPICZB-BAS2.1:X33 culture; Lane 3, Unbound protein; Lane 4, Fraction 
A3 – β-OG detergent exchange wash; Lane 5-9, Fractions A8-A11 - 1st elution peak; Lane 10, Fraction 
B3 – 2nd elution peak.  Expected molecular weight of AsbAS1 (shown by the arrow) is predicted to be 
86.8kDa, which falls between the 62 and 98kDa markers. 
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by gel filtration (151).  Homology modelling predicted hOSC and AsbAS1 to have 
highly similar structures (see Chapter 2) and both proteins have an almost 
identical molecular weight, therefore the conditions used for hOSC purification 
could be applied to AsbAS1 purification.   
 The cells harvested from protein induction were lysed and incubated with 
Triton X-100 to solubilise the protein from the membrane.  After centrifugation 
the cell-free extract was loaded onto a nickel-charged metal affinity column and 
washed to remove unbound protein.  Detergent exchange was carried out by first 
washing the column with Wash buffer containing Triton X-100 (0.2% v/v) 
followed by Wash buffer containing β-OG (0.8% w/v).  Detergent exchange was 
performed to prepare the protein for further crystallisation trials, as the optimal 
conditions for hOSC crystallisation were achieved using β-OG (144, 151).  Bound 
protein was eluted with a linear gradient of 0.5 M imidazole and as all fractions 
were eluted, their absorbance was measured at 280 nm and the data displayed in 
graphical form.  The elution profile showed two peaks, one large peak at the start 
of the imidazole gradient and a much smaller peak towards the end (Figure 5.9A).  
The fractions containing these eluted peaks together with fractions collected from 
each of the wash steps were analysed by SDS-PAGE and Western blotting (Figure 
5.9B and 5.10). 
 The InstantBlue stained SDS-PAGE gel showed presence of a large band 
which corresponded to the expected molecular weight of AsbAS1 in fractions 
containing the cell-free extract, unbound protein and elution fractions A8-A11 
(Figure 5.9B).  Upon Western blotting using an antibody against the 6-histidine 
tag, the band observed in fractions A8-A11 gave a strong signal, but no signal 
was observed for the band seen in the cell-free extract and unbound protein 
fractions (Figure 5.10).  This indicated that the band observed in these fractions 
is likely to be Pichia pastoris AOX1 as it is co-expressed with AsbAS1 and has an 
almost identical molecular weight.  As PpAOX1 does not have a 6-histidine tag, it 
would not bind to the column so would be present in the unbound fraction as is 
observed on the SDS-PAGE gel.  The intensity of the signal seen on the Western 
blot corresponds with the size of the band on the SDS-PAGE gel which implied 
that AsbAS1 was a major constituent of this band.   
 To confirm the identity of this band, it was excised from the gel, from 
fractions A8 and A11 and sent for MALDI-TOF-MS fingerprinting.  Mascot analysis 
of the bands from fraction A8 and A11 confirmed the identity of protein to be 
Avena strigosa β-amyrin synthase, with mascot scores of 137 and 250 
respectively.  This provided convincing evidence that the large band seen in the 
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Figure 5.10: Western blot of fractions from IMAC purification of pPICZB-BAS2.1:X-33. 
Colorimetric detection of fractions eluted from the metal affinity column with an antibody directed 
against the 6-histidine tag.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: myosin (188kDa), 
phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic dehydrogenase (49kDa), alcohol 
dehydrogenase (38kDa), carbonic anhydrase (28kDa), lysozyme (14kDa); Lane 2, Cell free extract 
from Day3 pPICZB-BAS2.1:X33 culture; Lane 3, Unbound protein; Lane 4, Fraction A3 – β-OG 
detergent exchange wash; Lane 5-9, Fractions A8-A11 - 1st elution peak; Lane 10, Fraction B3 – 2nd 
elution peak.  Expected molecular weight of AsbAS1 (shown by the arrow) is predicted to be 86.8kDa, 
which falls between the 62 and 98kDa markers. 
 
fractions eluted from the IMAC column was AsbAS1.  Therefore fractions A8-A11 
were pooled and concentrated from 20 ml to 3 ml and stored in 1 ml aliquots at -
80°C. 
 Comparisons between the crude extract and the fractions eluted from the 
column demonstrated that IMAC purification had been successful in partially 
purifying AsbAS1.  Western blotting and MALDI-TOF-MS analysis showed that 
AsbAS1 was the major protein observed in the eluted fractions A8-A11, however 
there was still a large number of contaminating proteins present in these 
fractions.  It is unlikely that all of the contaminating proteins were histidine-rich, 
so there must be another explanation for the presence of impurities.  One cause 
could be protein aggregation as a result of detergent addition to the cell lysate.  
Although necessary for AsbAS1 solubilisation from the membrane, Triton X-100 
may have bound to other proteins thereby causing aggregation with AsbAS1 and 
resulting in aggregated protein binding to the IMAC column via the AsbAS1 6-
histidine tag.  Another reason for the eluted impurities could be that the 
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detergent exchange wash step was too short, so weakly bound protein may have 
remained on the column and been eluted in the final elution step and 
contaminating the fractions.  In an attempt to solve this problem, the IMAC 
purification was repeated using a fresh pPICZB-BAS2.1:X-33 culture and the 
purification protocol was modified to include longer wash steps with 5CV and 
10CV of Triton X-100 wash buffer and β-OG wash buffer respectively.  However, 
these elongated steps resulted in AsbAS1 being washed off the column indicating 
that it is only weakly bound.  Weak binding could be as a result of protein 
aggregation or due to the 6-histidine tag not being fully exposed. 
 
5.3.8 Secondary purification of pPICZB-BAS2.1:X-33 
 Despite the large number of impurities present in the pooled fractions from 
IMAC purified AsbAS1, two different secondary purification steps, gel filtration and 
hydrophobic interaction chromatography, were carried out.  The aim was to 
remove some of the major impurities and to determine which method would be 
most successful for subsequent purifications. 
 Gel filtration separates proteins based on the relative size of the protein 
molecules.  The gel filtration matrix contains porous beads which allow small 
molecules to diffuse into them, but large molecules cannot enter as they are too 
large.  The column is pre-equilibrated with a buffer which fills both the area inside 
and outside the beads.  Once the protein sample is applied to the column, it 
moves through the bead matrix.  Large molecules cannot enter the beads, so 
pass through the column and are eluted first whereas small molecules are able to 
migrate into the matrix so spend longer in the column and are eluted later (291). 
 For secondary purification of AsbAS1, 1 ml of the concentrated pooled 
fractions from IMAC was loaded onto the gel filtration column.  The column was 
washed with 1 CV of gel filtration buffer and 1 ml fractions were collected which 
were monitored at an absorbance of 280 nm as they were eluted from the 
column.  AsbAS1 has a high molecular weight and was one of the largest proteins 
present in the IMAC purified sample, so was expected to be eluted in one of the 
early peaks.  The elution profile showed five peaks, none of which were clearly 
defined indicating that complete protein separation was not achieved.  SDS-PAGE 
analysis of fractions eluted at the maxima of each peak showed all fractions 
contained multiple proteins but there was some evidence of size separation as 
fractions eluted earlier contained the largest proteins and fractions eluted later 
contained smaller proteins (Figure 5.11).  A band corresponding to the expected 
molecular weight of AsbAS1 was observed most strongly in the second eluted 
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Figure 5.11: SDS-PAGE analysis of fractions eluted from gel filtration of IMAC purified AsbAS1 
SDS-PAGE gel of fractions eluted from the column.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: 
myosin (188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic dehydrogenase 
(49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), myoglobin red (17kDa), 
lysozyme (14kDa), aprotinin (6kDa); Lane 2, Concentrated protein from pooled IMAC fractions A8-
A11; Lane 3, Fraction 51 – 1st elution peak; Lane 4, Fraction 64 – 2nd elution peak; Lane 5, Fraction 
68 – 3rd elution peak; Lane 6, Fraction 69 – 3rd elution peak; Lane 7, Fraction 74 – 4th elution peak; 
Lane 8, Fraction 76 – 4th elution peak; Lane 9, Fraction 78 – 4th elution peak; Lane 10, Fraction 89 – 
5th elution peak.  Expected molecular weight of AsbAS1 (shown by the arrow) is predicted to be 
86.8kDa, which falls between the 62 and 98kDa markers. 
 
peak and contained three lower molecular weight contaminating proteins.  
Evidence of the band was also seen at lower levels in peaks three and four 
however these fractions contained much higher levels of lower molecular weight 
contaminating proteins. 
 This result indicates that gel filtration would be a suitable method for 
secondary purification of AsbAS1 as clear size separation was seen for the IMAC 
purified sample which removed a number of the lower molecular weight 
contaminants.  Had the purity of the IMAC purified sample been higher, gel 
filtration would have been much more successful, therefore once the IMAC 
purification step has been optimised, gel filtration can be utilised as the final 
polishing step to remove minor impurities. 
 
 Hydrophobic interaction chromatography (HIC) separates proteins based 
on the strength of hydrophobic interactions to hydrophobic ligands immobilised 
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on an uncharged matrix.  The sample is loaded onto the column in high salt 
conditions as hydrophobic interactions are enhanced in these conditions enabling 
hydrophobic regions of the protein to bind to the column.  Proteins are then 
eluted by a linear decrease in salt concentration, allowing weakly hydrophobic 
proteins to elute first followed by strongly hydrophobic proteins (292-294).  
AsbAS1 has hydrophobic helix on the protein surface that facilitates membrane 
attachment.  It was thought that this slight increase in hydrophobicity might 
enable it to bind more strongly to the hydrophobic column than the soluble 
proteins present in the IMAC purified sample. 
 For secondary purification of AsbAS1, 1 ml of the concentrated pooled 
fractions from IMAC was loaded onto the HIC column.  Non-bound proteins were 
eluted with a high salt wash and bound proteins were eluted with a linear 
gradient of low salt buffer and 0.25 ml fractions were collected which were 
monitored at an absorbance of 280 nm.  The elution profile showed one major 
peak which eluted at the end of the low salt gradient.  SDS-PAGE analysis of 
alternate fractions from the peak showed that sample purity had not been 
improved, as the majority of the major impurities were still present in the eluted 
fractions (Figure 5.12).  This indicated that protein aggregation had occurred 
which may have been caused by high salt concentrations.  However despite the 
possibility of protein aggregation, there was no evidence that the purity of the 
Figure 5.12: SDS-PAGE analysis of fractions eluted from hydrophobic interaction 
chromatography of IMAC purified AsbAS1 
SDS-PAGE gel of fractions eluted from the column.  Lane 1, SeeBlue® Plus2 Pre-Stained Standard: 
myosin (188kDa), phosphorylase (98kDa), bovine serum albumin (62kDa), glutamic dehydrogenase 
(49kDa), alcohol dehydrogenase (38kDa), carbonic anhydrase (28kDa), myoglobin red (17kDa), 
lysozyme (14kDa), aprotinin (6kDa); Lanes 2-9, Even fractions 16-39; Lane 10, SeeBlue® Plus2 Pre-
Stained Standard; Lanes 11-19, Even fractions 31-48.  Expected molecular weight of AsbAS1 (shown 
by the arrow) is predicted to be 86.8kDa, which falls between the 62 and 98kDa markers. 
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sample had been improved, therefore HIC is unlikely to be a beneficial step 
should the IMAC purification step be optimised. 
  
5.3.9 Repeat purification problems of pPICZB-BAS2.1:X-33 
 Subsequent attempts to purify AsbAS1 using IMAC were significantly less 
successful than the first attempt (see 4.3.7).  After extending the wash steps to 
ensure all unbound protein was eluted proved to be unsuccessful as AsbAS1 was 
washed off the column, IMAC was repeated several times using the original 
protocol which had been so successful for hOSC.  However the peak seen at the 
start of the imidazole elution gradient never appeared at the same magnitude and 
although SDS-PAGE analysis revealed a band was seen at the expected molecular 
weight of AsbAS1, MALDI analysis repeatedly found this to be PpAOX1.  This 
implied that the yeast transformant was no longer making AsbAS1.  However in 
vivo functional analysis carried out on each of the cultures used for large scale 
expression showed that all the cultures produced β-amyrin at similar levels to 
those seen in the original functional assay of pPICZB-BAS2.1:X-33 activity.  This 
indicated that AsbAS1 was being produced at similar levels. 
 The subcellular localisation of OSCs in mammalian and yeast cells has 
been shown to be both in microsomes and in lipid particles.  Partial purification of 
native OSCs in mammals and yeast has been achieved by detergent solubilisation 
of the microsomal fraction (258-260).  Therefore microsomes were isolated from 
induced cultures of pPICZB-BAS2.1:X-33 in order to increase the purity of the 
crude extract before IMAC.  The microsome fraction was obtained and a number 
of different detergents were used to solubilise pPICZB-BAS2.1:X-33 from the 
microsomes.  SDS-PAGE analysis showed a single band at the expected molecular 
weight of AsbAS1 but this band was also found to be PpAOX1 by MALDI analysis 
(data not shown). 
 The problems encountered with AsbAS1 purification seemed to be as a 
result of PpAOX1 contamination which produced ambiguous results.  As the AOX1 
promoter is used to drive heterologous protein expression of AsbAS1 in Pichia 
pastoris and pPICZB-BAS2.1:X-33 has the Mut+ phenotype, PpAOX1 is co-
expressed with AsbAS1.  Unfortunately as PpAOX1 has a similar molecular weight 
to AsbAS1, they both migrate to the same point on an SDS-PAGE gel and cannot 
be separated by gel filtration.  Presence of a histidine tag on the expressed 
AsbAS1 should have facilitated separation by IMAC as AsbAS1 is able to bind to 
the column whereas PpAOX1 is not.  However, although this was seen on the first 
purification attempt, subsequent attempts indicated that PpAOX1 also bound to 
the column as it was seen in the eluted fractions.   
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 If PpAOX1 was not expressed, this would solve the problem of PpAOX1 
contamination leading to ambiguous results.  Therefore the three pPICZB 
constructs, pPICZB-BAS1, pPICZB-BAS2 and pPICZB-BAS4, were transformed 
into the Pichia pastoris KM71H strain.  This strain contains a non-functional AOX1 
gene and relies on the secondary AOX gene in Pichia pastoris, AOX2, for 
production of the alcohol oxidase enzyme.  AOX2 has the same activity as AOX1 
but due to a weaker promoter has a much lower expression level (277, 279).  
pPICZB constructs expressed in KM71H will not be co-expressed with AOX1 so 
this should prevent the ambiguous results seen with the Mut+ transformants.  
Although AOX2 also has the same molecular weight as AOX1, due to its much 
lower expression levels, it should not interfere with AsbAS1 detection. 
 
5.3.10  Expression of pPICZB-BAS1, BAS2 and BAS4 in Pichia pastoris KM71H 
 Linearised pPICZB-BAS1, pPICZB-BAS2 and pPICZB-BAS4 plasmid DNA 
were transformed into competent P. pastoris KM71H cells via electroporation.  
Colonies were purified on fresh plates for each construct to select for single 
transformants.  As all P. pastoris KM71H transformants are MutS, there is no need 
for selection on MM and MD media. After purifying selection, pPICZB-
BAS1:KM71H had seven transformants, pPICZB-BAS2:KM71H had six 
transformants, and pPICZB-BAS4:KM71H had ten transformants.  Previously, P. 
pastoris X-33 transformants were tested for expression of AsbAS1 by SDS-PAGE 
analysis.  However this technique was not suitable for the pPICZB-BAS1 
constructs as they did not have a tag and no AsbAS1 antibody was available at 
the time.  Tagged constructs were tested using Western blotting against the 
His•Tag® monoclonal antibody but these proved to be unclear due to the low 
amounts of AsbAS1 protein loaded onto the SDS-PAGE gel.  Testing the 
transformants for functional expression proved a much more conclusive technique 
as product levels could be detected even if present at very low levels.  If it was 
assumed that product levels mirrored protein levels, transformants which 
expressed the highest levels of functional protein could be easily identified and 
carried forward to large scale purification. 
 For in-vivo functional analysis of all P. pastoris KM71H transformants, each 
transformant was grown and analysed using the same protocol as for pPICZB:X-
33 transformants (see 4.3.4 and 4.3.5). 
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5.3.10.1 pPICZB-BAS1:KM71H 
  Of the seven pPICZB-BAS1:KM71H MutS transformants analysed, all 
produced a novel peak which has a fragmentation pattern identical to that of β-
amyrin which confirmed that all transformants produced active AsbAS1 protein.  
To identify a candidate for large scale expression, the β-amyrin level in each of 
the transformants was analysed as a percentage of ergosterol level for an indirect 
quantification of AsbAS1 protein levels.  The peak area of the β-amyrin peak was 
expressed as a percentage of the peak area of the ergosterol peak for each of the 
transformants and the data was displayed on a graph (Figure 5.13).  The highest 
level of β-amyrin production was observed in pPICZB-BAS1.4:KM71H which had 
5.8% peak area compared to ergosterol levels.  However this level of β-amyrin 
production was significantly lower than that seen for the highest expressing 
pPICZB-BAS1:KM71H transformant which produced β-amyrin to 30% of 
ergosterol levels.  This low production of β-amyrin may be linked to the slow 
growth levels of the Pichia KM71H strain.  The growth of the yeast depends on 
supply of carbon for use as an energy source, which Pichia KM71H can obtain 
Figure 5.13: Comparison of β-amyrin levels in pPICZB-BAS1:KM71H transformants 
Peak area of β-amyrin produced by each transformant is expressed as a percentage of total peak area 
of ergosterol.  The vector only control pPICZB:KM71H produces no β-amyrin and all transformants 
show some degree of AsbAS1 activity. 
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from methanol should glycerol not be available.  In wild-type Pichia, both the 
AOX1 and AOX2 genes can be used to metabolise methanol but Pichia KM71H 
lacks a functional AOX1 gene so can only use the much lower expressed AOX2 
gene for methanol metabolism and as a result grows at a slower rate.  Both the 
KM71H and the X-33 transformants were grown using the same conditions and 
protein was induced over the same number of days, so the slower growing 
KM71H would have had a lower final cell density therefore would produce lower 
amounts of AsbAS1 protein overall.  However, as AsbAS1 levels were measured 
as a percentage of ergosterol levels rather than quantitative amounts, this implies 
that the KM71H cells were expressing AsbAS1 protein at lower levels than X-33 
cells.  Therefore, optimisation of the growth and induction conditions is needed to 
maximise the density of the cell culture and the amount of AsbAS1 protein 
expressed.  This could be done via finding the optimum concentration of methanol 
required for induction, increasing length of protein induction, using a fermentation 
system and increasing shaking speed to maximise aeration of the culture.  Pichia 
transformation could also be repeated to try to generate a high copy number 
transformant with multiple integration events. 
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Chapter 6 - Conclusion 
  
 This work describes the detailed characterisation of β-amyrin synthase 
from the diploid oat Avena strigosa (AsbAS1). AsbAS1 catalyses the first 
committed step in biosynthesis of avenacin A-1, an antimicrobial triterpene 
glycoside localised in oat roots that confers broad spectrum disease resistance.   
  
 Chapter 2 discusses the characterisation of AsbAS1 on a structural level to 
explore the mechanism of enzyme action and identify residues and regions of the 
protein that are likely to be catalytically important.  In the absence of a crystal 
structure for the enzyme, a homology model was generated using the human 
lanosterol synthase crystal structure as a template.  Validation of the AsbAS1 
model showed that the indicators calculated from the model were indeed similar 
to those calculated from known protein structures of a similar size – a necessary 
condition for a reliable model.  The AsbAS1 model, together with information 
gathered from a comprehensive sequence alignment and phylogenetic tree of all 
cloned plant OSCs, was used to explore AsbAS1 mechanism and the mechanistic 
differences between the sterol and triterpene OSC classes. 
 During the first stage of the OSC mechanism, when the substrate is 
prefolded in the active site, clear differences between sterol and triterpene OSCs, 
and monocot and dicot triterpene OSCs are observed.  Triterpene OSCs fold the 
B-ring into the chair conformation, whereas sterol OSCs form the energetically 
unfavourable boat conformation.  This is mediated by Tyr98 (hOSC numbering) 
which forces the C10 carbon of 2,3-oxidosqualene below the molecular plane 
thereby enforcing the boat confirmation (144).  Triterpene OSCs, have a smaller 
residue at the equivalent position thereby removing the steric pressure on C10 
and allowing the chair conformation to form.  However, this was found to be 
restricted to dicot triterpene OSCs only. Monocot triterpene OSCs have retained a 
bulky aromatic residue at the equivalent Tyr98 position, so to allow the 
favourable chair conformation to be formed, have reversed the residues that 
position the tyrosine. This elevates the position of the tyrosine with respect to the 
C10 of the substrate and no longer causes steric hindrance.  Phylogenetic evidence 
indicates that monocot and dicot triterpene OSCs have evolved separately, with 
monocot triterpene OSCs being more closely related to sterol OSCs.  Therefore it 
seems that monocot triterpene OSCs have retained many of the features of sterol 
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OSCs, but these have been modified to allow the enzyme to function as a 
triterpene OSC. 
 After the substrate has been positioned in the active site, very few 
differences were found between sterol and triterpene OSCs during cyclisation of 
the first three rings.  A number of amino acid residues were compared which had 
previously been identified using site-directed mutagenesis or inhibitor studies.  All 
amino acid residues involved in reaction initiation and stabilisation of the first 
three rings were highly conserved in AsbAS1 and hOSC as well as in all other 
plant OSCs indicating that despite the different evolutionary paths of monocot 
and dicot OSCs, they have maintained a very similar catalytic mechanism.  The 
major difference between sterol and triterpene OSC mechanism occurs at 
cyclisation of the D-ring.  It is here that the two mechanisms diverge, with D-ring 
formation signalling the end of sterol OSC cyclisation, whereas triterpene OSC 
cyclisation continues.  In sterol OSCs, D-ring stabilisation is coordinated by 
His232 and Phe696, which do not provide enough negative potential to stabilise 
the positive charge, so deprotonation takes place and a tetracyclic product is 
formed (144).  However in AsbAS1 and other triterpene OSCs, His232 is replaced 
by a aromatic residue (Phe or Tyr) therefore the positive charge is coordinated by 
two aromatic residues which provide sufficient negative potential to stabilise the 
positive charge and allow the formation of the 5th E-ring.  This single residue 
change has been shown to differentiate between tetracyclic and pentacyclic 
products and the multiple sequence alignment clearly shows all sterol OSCs 
contain a His232 residue whereas all pentacyclic triterpene OSCs have an 
aromatic residue (Phe or Tyr) at the equivalent position (176). 
 E-ring stabilisation occurs only in pentacyclic triterpene OSCs and in 
AsbAS1 stabilisation appears to be mediated by Trp257 and Phe259 which allow 
the E-ring to be expanded to a 6-membered carbon ring.  Both of these residues 
are conserved in one class of pentacyclic triterpene OSC, β-amyrin synthases, but 
not in lupeol synthases where the tryptophan is replaced by a leucine residue.  
This reduction in stabilising negative potential results in lupeol synthases being 
unable to expand the E-ring resulting in a product, lupeol, with a 5-membered E-
ring.  Deprotonation at the end of the cyclisation cascade still remains unclear as 
due to the non-polar nature of the active site cavity, there are currently no 
candidate basic residues in the vicinity of the product cation to facilitate 
deprotonation.  
 The predictions from the AsbAS1 model and the multiple sequence 
alignment indicate that a very small subset of active site residues are responsible 
for defining product identity for plant OSCs.  Just a single residue change can 
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completely alter the product produced by the enzyme and presumably over time, 
it is these single base changes that have facilitated the diversification of the 
pentacyclic triterpene OSCs.  It is also important to note that the two AsbAS1 
residues Trp257 and Phe 259, appear only to be a requirement for defining β-
amyrin/lupeol product identity and pentacyclic products in triterpene OSCs that 
produce single products (i.e. solely β-amyrin or lupeol).  There are multifunctional 
triterpene OSCs from Pisum sativum (54), Arabidopsis thaliana (52, 132, 139), 
Lotus japonicus (134) and Rhizospora stylosa (56) that synthesise more than one 
product, often including both β-amyrin and lupeol, that contain different 
combinations of these apparent defining residues.  It therefore seems that the 
active site environment as well as the conserved active site residues are also 
important for dictating product identity which adds another level of complexity to 
the OSC mechanism. 
  
 Chapters 3 and 4 discuss the characterisation of 17 AsbAS1 (sad1) 
mutants at the gene, transcript and protein level.  The 17 sad1 mutants were 
sequenced and found to contain single point mutations resulting in three types of 
predicted mutations: premature termination of translation, splicing errors and 
amino acid substitution.  Two groups of mutants (#A1, #B1 and #610; and #384 
and #1023) were found to have identical point mutations.  Diversity array 
analysis (DArT) showed that the majority of the sad1 mutants were independent. 
Mutants #A1 and #B1 were genetically the most similar, but there was no 
conclusive proof that they were identical, so were treated as independent 
mutants in the analysis.  Further DArT analysis using more replicates for each 
mutant will be needed to confirm whether these mutants are truly independent. 
 RT-PCR analysis of the sad1 mutants at the transcript level revealed that 
all of the predicted premature termination of translation mutants had severely 
reduced transcript levels compared to the wild type S75.  Nonsense mediated 
mRNA decay is thought to be the cause for transcript reduction and occurs post-
transcriptionally as a result of mRNA instability (236).  All of the splicing error 
mutants had transcript present and further analysis by Northern blotting and RT-
PCR showed that each of the splicing mutants had a reduced transcript size.  This 
reduction in size corresponded to a deletion of the exon that each splicing 
mutation is associated with.  Finally, all of the amino acid substitution mutants 
had full-length transcript present which was expected as nonsynonymous 
mutations were not anticipated to affect transcript stability. 
 To analyse the sad1 mutants at the protein level, a highly specific AsbAS1 
polyclonal antibody was generated from AsbAS1 protein purified from inclusion 
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bodies.  Western blotting showed that both the premature termination of 
translation and splicing error mutants had no AsbAS1 protein present.  As the 
splicing mutants produce shortened sad1 transcripts, it seems likely that the 
protein produced is unable to fold or misfolded and is hence targeted for 
degradation.  Three out of the seven amino acid substitution mutants produced 
full length AsbAS1 protein which indicates that the protein is able to fold but is 
non-functional.  The location of these mutations were visualised on the AsbAS1 
homology model to ascertain what effect the mutations might have on protein 
function.  Mutant #358 contained a mutation in one of the cysteine residues that 
coordinates the catalytic aspartate.  The cysteine is essential for activation of the 
aspartate and therefore reaction initiation is likely to be affected.  Mutants #384 
and #1023 both contained the same mutation in a serine residue close to the 
substrate access channel, and Phe725 which is involved in stabilising the D-ring.  
These mutants could therefore have blocked substrate access or product exit 
from the active site or be unable to stabilise the D-ring leading to deprotonation 
and formation of a tetracyclic product.  If the latter occurs then truncated 
tetracyclic products may be present in the root tips of mutants #384 and #1023.   
 The location of all the amino acid substitution mutants on the AsbAS1 
structure gives an insight into the stability of OSC enzymes.  As the majority of 
the AsbAS1 secondary structure is helical, it is assumed that in the original 
mutagenised oat population there were other sad1 mutants that contained amino 
acid substitutions in other areas of the protein.  However, if these had no effect 
on enzyme function then they would not have been selected for in the loss of 
function screen. This therefore implies that OSC enzymes are very tolerant of 
mutations in areas of the protein that are not critical for function, and only those 
mutations that seriously affect enzyme expression or function result in premature 
termination of the pathway. 
 
 Chapter 5 describes the cloning and heterologous expression of AsbAS1 
(Sad1 cDNA) using the Pichia pastoris expression system with the aim of 
developing a purification strategy for AsbAS1.  Three constructs were designed 
for heterologous expression and consisted of the full-length Sad1 cDNA sequence 
with no tag (BAS1), C-terminal 6-histidine tag (BAS2) or N-terminal 6-histidine 
tag (BAS4).  All three constructs were transformed into wild-type Pichia pastoris 
X-33 and Western blotting and an in vitro functional assay was used to identify 
the highest expressing functional transformant for each construct.   
 The construct with a C-terminal tag was used for large scale expression to 
develop a purification strategy for AsbAS1.  The purification protocol was based 
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on the conditions used for purification of human lanosterol synthase (hOSC) and 
a combination of IMAC and gel filtration enabled partial purification of AsbAS1.  
The partially purified sample still contained a number of contaminants and 
subsequent purification attempts were hindered by the presence of the 
expression host enzyme PpAOX1, which is co-expressed with AsbAS1 and has a 
similar molecular weight.  Therefore to prevent PpAOX1 contamination, the three 
AsbAS1 constructs were transformed into a Pichia strain lacking the AOX1 gene 
(KM71H) and a highly expressing functional transformant was identified for the 
un-tagged protein.  In future, highly expressing functional tagged constructs in 
the KM71H strain can be identified and used to further develop the purification 
protocol to obtain pure AsbAS1 which can then be used for kinetic and structural 
studies. 
  
 This work has raised interesting questions about the evolution of the plant 
oxidosqualene cyclase family, in particular, how triterpene OSCs have evolved 
from ancestral sterol OSCs and how monocot and dicot triterpene OSCs have 
evolved separately.  This study can be extended to look at the evolution of OSCs 
from their bacterial ancestors across all kingdoms of life.  Evolutionary analysis 
can be combined with product profiles and known conserved residues of OSCs to 
generate a catalytic landscape of the OSC family.  This landscape together with 
the continuing discovery of novel OSCs and structural information from homology 
modelling or crystal structures is expected to give clues as to the direction of  
OSC evolution.  This will facilitate the design of novel OSCs which synthesise new 
secondary metabolites not previously seen in nature that may have applications 
in the medical or commercial industries. 
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Chapter 7 - Future work 
 
 The characterisation of β-amyrin synthase from Avena strigosa has 
provided an insight into the structure and function of the enzyme, but has also 
raised a number of questions and hypotheses that can be explored through 
further studies. 
 
 Chapter 2 described the structural characterisation of AsbAS1 via 
homology modelling.  Docking of some of the reaction intermediates and the β-
amyrin product into the active site identified residues and regions of the enzyme 
that were likely to be catalytically important.  Homology modelling allows 
hypotheses to be made regarding enzyme structure and mechanism, but alone it 
cannot provide experimental evidence for the involvement of specific residues or 
regions of the enzyme in catalysis.  Also, as the enzyme is modelled on a 
template structure there is a possibility that errors may be introduced into the 
homology model.  Therefore, the involvement of these residues in catalysis and 
ring stabilisation should be examined experimentally, and this can be done using 
site directed mutagenesis.  The effect of the mutations would be ascertained by 
heterologous expression in yeast, followed by GC-MS of metabolite extracts to 
look for novel cyclisation products.  Experiments could be conducted in Pichia 
pastoris or Saccharomyces cerevisiae as neither produce secondary metabolites 
so accumulation of a novel product can be detected.   
  Residues that are targets for mutagenesis include Tyr119 which is 
implicated in prefolding of the B-ring of the substrate prior to catalysis.  Tyr119 
could be mutagenised to asparagine or isoleucine which are seen in the dicot β-
amyrin synthases to see if β-amyrin is still produced.  Alternatively the two 
residues (Phe731 and Leu473) that position Tyr119 could be reversed to 
determine whether a chair-boat-chair conformation of the A-B-C rings can be 
achieved.  This residue reversal mirrors what is seen in sterol OSCs which prefold 
the B-ring into the boat conformation.  A number of aromatic residues have been 
implicated in ring stabilisation (letters in brackets denote which ring(s) each 
residue is implicated in stabilising); Trp611 (A, B), Phe731 (A, B, C), Phe725 (C, 
D, E), Phe259 (C, D, E).  Each of these candidate residues could be mutagenised 
to non-aromatic residues and GC-MS could be used to detect novel cyclisation 
products.  The ring structure of any truncated cyclisation products will provide 
valuable information as to which stage of the cyclisation each residue is involved 
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in.  Product specificity of the enzyme could also be investigated using site 
directed mutagenesis.  Mutagenesis of Phe259, which is implicated in defining 
pentacyclic products in dicot triterpene OSCs, to a histidine as is seen sterol OSCs 
will determine whether Phe259 has a similar role in monocot triterpene OSCs.  If 
this is the case, it would be expected that tetracyclic dammarenyl products would 
be produced.  The role of Trp257 in defining β-amyrin or lupeol product identity 
could be investigated by mutagenising this residue to a leucine as is seen in 
lupeol synthases and see if lupenyl based products are produced. 
 
 In addition to targeting individual residues, mutagenesis could also be 
used to investigate the role of specific regions of the enzyme.  Sequence analysis 
shows that all plant OSCs have an insertion at the N-terminus of approximately 
30 amino acids when compared to animal and fungal OSCs.  Homology modelling 
of AsbAS1 showed that this inserted region was modelled as an unordered loop 
that extended away from the protein surface.  The role of this loop region in 
plants is unclear as it secondary structure cannot be assigned, but it may be 
involved in protein-protein interactions or (add other reason here).  To ascertain 
whether the loop is essential for protein function, it could be removed by 
mutagenesis and the truncated protein expressed in the Pichia pastoris 
expression system.  AsbAS1 protein could then be detected using the AsbAS1 
antibody and protein function could be assayed by GC-MS. 
 Mutagenesis could also be used to make point mutations in the 
amphipathic membrane-binding helix in order to solubilise the protein.  Due to 
the membrane bound nature of the enzyme, purification currently requires the 
application of detergents which hinder the subsequent column purification steps.  
If the protein was able to be solubilised, purification may be more successful 
which would enable crystallisation trials to be done. 
 Chapter 2 also discussed the phylogenetic analysis of all cloned plant 
OSCs.  This study could be extended to include animal and fungal OSCs as well as 
bacterial squalene hopene cyclases (SHCs).  This will provide insights into how 
each of the kingdoms evolved, whether each evolved separately from a common 
ancient ancestor or whether the eukaryotic cyclases evolved from bacterial SHCs.  
The current plant OSC multiple sequence alignment could also be examined in 
more detail to study the sequence homology of inserted N-terminal loop region 
that is seen in plant OSCs. 
 
 Chapters 3 and 4 described the characterisation of the 17 sad1 mutants at 
the gene, transcript and protein level.  Protein analysis using the AsbAS1 
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antibody showed that three of the amino acid substitution mutants, #384, #532 
and #1023, had full length AsbAS1 protein present.  Mapping the point mutations 
to the AsbAS1 homology model indicated that #532 was likely to be affected in 
reaction initiation, and #384 and #1023 (which have identical mutations) could 
be affected in substrate entry or ring stabilisation.  Studying the metabolite 
profiles of these three mutants by GC-MS to look for accumulation of novel 
cyclisation products may provide further insights into the cyclisation mechanism. 
  Further applications of the AsbAS1 antibody could be to look for the 
presence of β-amyrin synthase in other oat species as well as other cereals and 
grasses.  The AsbAS1 antibody could also be used to determine the subcellular 
localisation of AsbAS1.  Currently studies on yeast have shown that OSCs could 
be associated with lipid particles, but the subcellular localisation of OSCs in plants 
is currently unclear.  Immunolocalisation of oat root sections with the AsbAS1 
antibody could determine whether AsbAS1 is localised to the endoplasmic 
reticulum or a subcellular organelle. 
 
 Chapter 5 described the cloning and expression of AsbAS1 in Pichia 
pastoris.  AsbAS1 was successfully expressed and resulted in production of 
transformants that expressed functional AsbAS1.  Partial purification of C-
terminally 6-histidine tagged AsbAS1 protein has been achieved in wild-type 
Pichia cells but contamination with the Pichia AOX1 led the AsbAS1 constructs to 
be expressed in an AOX1 deficient strain.  It is clear that AsbAS1 expression 
levels in both the wild-type and AOX1 deficient strains need to be optimised and 
following the identification of highly expressing functional tagged transformants 
(pPICZB-BAS2 and pPICZB-BAS4) in the AOX1 deficient strain, large scale 
purification can be repeated.  The availability of a highly specific AsbAS1 antibody 
will allow for accurate detection of AsbAS1 in induced cultures.  If expression of 
AsbAS1 in the AOX1 deficient strain removes the AOX1 protein contamination, 
then the purification protocol can be optimised to obtain pure AsbAS1 protein that 
can be used for kinetic and structural studies. 
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Appendices 
Appendix 1: BLAST search of AsbAS1 against the UniProt database 
Results table for BLAST search carried out against the UniProt Knowledge database using the AsbAS1 
cDNA sequence as a query.   
 
UNIPROT:ID Source 
Length 
(AA) 
Score 
Identity 
% 
Positives 
% 
E value 
Q93WU1_9POAL Beta-amyrin synthase Avena strigosa 757 4059 98 98 0.0 
Q6IWA0_9POAL 
Beta-amyrin synthase Avena 
longiglumis 
757 4055 98 98 0.0 
Q6IW99_9POAL 
Beta-amyrin synthase Avena 
prostrata 
757 4041 97 98 0.0 
Q6IWA1_9POAL 
Beta-amyrin synthase Avena 
longiglumis 
757 4031 97 98 0.0 
Q6IWA2_9POAL Beta-amyrin synthase Avena clauda 757 3859 92 96 0.0 
Q6IW97_9POAL 
Beta-amyrin synthase Avena 
ventricosa 
757 3852 92 95 0.0 
C5YJE0_SORBI 
Putative uncharacterized protein 
Sorghum bicolor 
753 2845 66 80 7.9e-295 
Q2R712_ORYSJ 
Cycloartenol synthase, putative, 
expressed Oryza sativa subsp. 
japonica 
760 2789 66 78 6.8e-289 
B6SVP8_MAIZE Cycloartenol synthase Zea mays 760 2680 63 78 2.4e-277 
C0PGA6_MAIZE 
Putative uncharacterized protein Zea 
mays 
762 2677 62 78 5.0e-277 
Q0IT98_ORYSJ 
Os11g0286800 protein Oryza sativa 
subsp. japonica 
756 2662 62 77 2.0e-275 
B6U7M4_MAIZE Cycloartenol synthase Zea mays 762 2661 62 78 2.5e-275 
B9GB84_ORYSJ 
Putative uncharacterized protein 
Oryza sativa subsp. japonica 
762 2593 61 78 4.0e-268 
Q0IS49_ORYSJ 
Os11g0562100 protein Oryza sativa 
subsp. japonica 
762 2593 61 78 4.0e-268 
C5YRX4_SORBI 
Putative uncharacterized protein 
Sb08g021260 Sorghum bicolor 
733 2211 59 75 1.9e-251 
C5Y5B0_SORBI 
Putative uncharacterized protein 
Sb05g022745 (Fragment) Sorghum 
bicolor 
627 2410 68 82 9.9e-249 
A4VB63_9LILI 
Cycloartenol synthase Dioscorea 
zingiberensis 
759 2376 54 74 4.0e-245 
Q8VWY4_COSSP 
Cycloartenol synthase Costus 
speciosus 
759 2376 55 73 4.0e-245 
C7U323_9LILI 
Cycloartenol synthase Dioscorea 
zingiberensis 
759 2374 54 74 6.5e-245 
Q6Z2X6_ORYSJ 
Os02g0139700 protein Oryza sativa 
subsp. japonica 
759 2365 55 73 5.8e-244 
A7BJ36_9ROSI 
Cycloartenol synthase Kandelia 
candel 
758 2364 54 74 7.4e-244 
Q2WGL6_LOTJA 
Cycloartenol synthase Lotus 
japonicus 
757 2360 54 73 2.0e-243 
Q2XPU6_RICCO 
Cycloartenol synthase Ricinus 
communis 
759 2358 54 74 3.2e-243 
B0FPA2_9APIA 
Cycloartenol synthase Panax 
notoginseng 
758 2357 54 73 4.1e-243 
Q9SXV6_GLYGL 
Cycloartenol synthase Glycyrrhiza 
glabra 
757 2357 55 73 4.1e-243 
O82139_PANGI Cycloartenol Synthase Panax ginseng 758 2355 54 73 6.7e-243 
Q9SPJ0_ORYSA 
Putative cycloartenol synthase 
(Fragment) 
757 2349 54 73 2.9e-242 
A7BJ35_RHISY 
Cycloartenol synthase Rhizophora 
stylosa 
758 2347 54 73 4.7e-242 
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Q941S0_9POAL Cycloartenol synthase Avena strigosa 759 2347 54 73 4.7e-242 
Q6IWA6_9POAL 
Cycloartenol synthase Avena 
longiglumis 
759 2346 54 73 6.0e-242 
Q6IWA5_9POAL 
Cycloartenol synthase Avena 
prostrata  
759 2343 54 73 1.2e-241 
B9HBB8_POPTR Predicted protein Populus trichocarpa 761 2340 54 72 2.6e-241 
Q6IWA7_9POAL 
Cycloartenol synthase Avena 
longiglumis 
759 2340 54 72 2.6e-241 
Q8W3Z3_9ROSI 
Cycloartenol synthase Betula 
platyphylla 
757 2337 53 73 5.4e-241 
Q6IWA4_9POAL Cycloartenol synthase Avena strigosa 759 2335 53 73 8.8e-241 
C5Z987_SORBI 
Putative uncharacterized protein 
Sb10g029175 (Fragment) Sorghum 
bicolor 
649 1349 71 84 5.2e-240 
C5XUJ6_SORBI 
Putative uncharacterized protein 
Sb04g003200 Sorghum bicolor 
757 2325 54 72 1.0e-239 
Q6IWA3_9POAL 
Cycloartenol synthase Avena 
ventricosa 
759 2317 53 72 7.1e-239 
Q6IWA8_9POAL Cycloartenol synthase Avena clauda 759 2316 53 72 9.1e-239 
CAS1_ARATH 
Cycloartenol synthase Arabidopsis 
thaliana 
759 2314 53 72 1.5e-238 
Q6QZW7_9APIA 
Cycloartenol synthase Centella 
asiatica 
757 2312 53 72 2.4e-238 
A9QW75_9FABA 
Cycloartenol synthase 1 Polygala 
tenuifolia 
761 2306 54 72 1.0e-237 
Q8W3Z4_9ROSI 
Cycloartenol synthase Betula 
platyphylla 
767 2299 53 71 5.7e-237 
Q2TU69_9APIA 
Cycloartenol synthase Bupleurum 
kaoi 
757 2296 52 72 1.2e-236 
C0P7K9_MAIZE 
Putative uncharacterized protein Zea 
mays 
759 2295 53 72 1.5e-236 
D3WI27_CIMRA 
Putative 2,3 oxidosqualene cyclase 
Cimicifuga racemosa 
757 2295 53 72 1.5e-236 
O23909_PEA Cycloartenol synthase Pisum sativum 756 2290 53 71 5.2e-236 
Q6BE25_CUCPE Cycloartenol synthase Cucurbita pepo 766 2287 52 72 1.1e-235 
Q9SLP9_LUFCY Cycloartenol synthase Luffa cylindrica 765 2282 52 72 3.6e-235 
B1PLH3_SOLLC 
Cycloartenol synthase Solanum 
lycopersicum 
757 2280 51 73 5.9e-235 
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Appendix 2: BLAST search of AsbAS1 against the Protein Data Bank 
Results table for BLAST search carried out against the RCSB Protein Data Bank (PDB) using the 
AsbAS1 cDNA sequence as a query. 
 
PDB ID Source Length Score 
Identity 
(%) 
Positives 
(%) 
E 
value 
1W6K_A LANOSTEROL SYNTHASE 732 1310 40 56 e-144 
1W6J_A LANOSTEROL SYNTHASE 732 1309 40 56 e-144 
2SQC_B SQUALENE-HOPENE CYCLASE 631 316 23 40 7e-29 
2SQC_A SQUALENE-HOPENE CYCLASE 631 316 23 40 7e-29 
3SQC_C SQUALENE--HOPENE CYCLASE 631 312 23 40 2e-28 
3SQC_B SQUALENE--HOPENE CYCLASE 631 312 23 40 2e-28 
3SQC_A SQUALENE--HOPENE CYCLASE 631 312 23 40 2e-28 
1UMP_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1UMP_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1UMP_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1SQC_ SQUALENE-HOPENE CYCLASE 631 309 23 40 5e-28 
1O79_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O79_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O79_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6R_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6R_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6R_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6Q_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6Q_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6Q_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6H_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6H_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1O6H_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3C_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3C_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3C_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3B_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3B_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3B_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3A_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3A_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H3A_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H39_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H39_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H39_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H37_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H37_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H37_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H36_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H36_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H36_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H35_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H35_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1H35_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1GSZ_C SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1GSZ_B SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
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1GSZ_A SQUALENE--HOPENE CYCLASE 631 309 23 40 5e-28 
1LTX_B GERANYLGERANLTRANSFERASE  331 81 30 51 0.12 
1DCE_D GERANYLGERANYLTRANSFERASE  331 81 30 51 0.12 
1DCE_B GERANYLGERANYLTRANSFERASE  331 81 30 51 0.12 
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Appendix 3: Structure of original AsbAS1 model 
Superimposed image of hOSC crystal structure (green) and the original AsbAS1 model (lilac) with the 
33 amino acid unordered loop shown in orange.  The product of hOSC catalysis – lanosterol (red 
sticks) is shown bound in the active site.  Detergent molecules (purple spheres) used for solubilisation  
and crystallisation of hOSC show the orientation of the enzyme at the membrane.  A detergent 
molecule is also bound in the substrate access channel.  The unordered loop extends away from the 
protein surface and no secondary structure could be assigned to this region.  It did not appear to 
interact with any of the structural or mechanistic features of the enzyme, hence was removed from 
the final model. 
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Appendix 4: Table of characterised plant oxidosqualene cyclases 
Table of all currently characterised plant OSCs used to construct the phylogenetic tree in Figure 2.7.  The OSCs are grouped according to their enzyme classification and are 
shaded using the colours of the corresponding clade on the phylogenetic tree.  A total of 101 sequences were analysed and consisted of 81 sequences from cloned and 
functionally characterised plant OSCs and 20 sequences for predicted OSCs from a variety of plant species. 
 
 
Enzyme name Organism 
Abbreviation in 
phylogenetic tree 
Common 
abbreviation 
Cloned 
Functionally 
expressed 
GenBank Accession 
number 
 
 
    
 
Cycloartenol synthase Cucurbita pepo CP-CAS CPX Yes Yes BAD34644 
Cycloartenol synthase Luffa cylindrica LC-CAS1 - Yes Yes BAA85266 
Cycloartenol synthase Betula platyphylla BP-CAS1 BPX Yes Yes BAB83085 
Cycloartenol synthase Solanum lycopersicum SL-CAS1 - Yes No ACA28830 
Cycloartenol synthase Olea europaea OE-CAS OEX Yes No BAA86931 
Cycloartenol synthase Kandelia candel KC-CAS KcCAS Yes Yes BAF73930 
Cycloartenol synthase Rhizophora stylosa RS-CAS RsCAS Yes Yes BAF73929 
Cycloartenol synthase Ricinus communis RC-CAS RcCAS Yes Yes ABB76767 
Cycloartenol synthase Arabidopsis thaliana AT-CAS1 - Yes Yes AAC04931 
Cycloartenol synthase Betula platyphylla BP-CAS2 BPX2 Yes Yes BAB83086 
Cycloartenol synthase Polygala tenuifolia PT-CAS1 - Yes No ABX75046 
Cycloartenol synthase Bupleurum kaoi BK-CAS - Yes No AAS83469 
Cycloartenol synthase Centella asiatica CA-CAS - Yes No AAS01524 
Cycloartenol synthase Glycyrrhiza glabra GG-CAS GgCAS1 Yes Yes BAA76902 
Cycloartenol synthase Lotus japonicus LJ-CAS OSC1 Yes Yes BAE53431 
Cycloartenol synthase Panax ginseng PG-CAS pMM31 Yes Yes BAA33460 
Cycloartenol synthase Pisum sativum PS-CAS PNX Yes Yes BAA23533 
 
 
    
 
Cycloartenol synthase Allium macrostemon AM-OSC - Yes No BAA84603 
Cycloartenol synthase Avena strigosa AS-CAS AsCS1 Yes Yes AAT38891 
Cycloartenol synthase Costus speciosus CS-CAS CSOCS1 Yes Yes BAB83253 
Cycloartenol synthase Dioscorea zingiberensis DZ-CAS - Yes ? CAM91422 
Putative cycloartenol synthase Sorghum bicolor SB-OSC3 - No No XP_002453283 
Putative cycloartenol synthase Sorghum bicolor SB-OSC4 - No No XP_002453282 
Putative cycloartenol synthase Oryza sativa OS-OSC1 - No No - 
Putative cycloartenol synthase Oryza sativa OS-OSC2 - No No - 
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Cycloartenol synthase Dictyostelium discoideum DD-CAS - Yes Yes AAF80384 
Putative cycloartenol synthase 
Chlamydomonas 
reinhardtii 
CR-CAS1 - No ? XP_001689874 
Predicted oxidosqualene cyclase Physcomitrella patens PP-OSC - No No XP_001758555 
Cycloartenol synthase Abies magnifica AbM-CAS1 - Yes ? AAG44096 
Cycloartenol synthase Adiantum capillus-veneris AC-CAS ACX Yes Yes BAF93208 
Cycloartenol synthase Stigmatella aurantiaca SA-CAS - Yes Yes AJ494839 
Cucurbitadienol synthase Cucurbita pepo CP-CuS CPQ Yes Yes BAD34645 
Lanosterol synthase Arabidopsis thaliana AT-LAS LSS Yes Yes NP_190099 
Putative lanosterol synthase Cucurbita pepo CP-OSC CPR Yes No BAD34646 
Lanosterol synthase Lotus japonicus LJ-LAS OSC7 Yes Yes BAE95410 
Putative lanosterol synthase Luffa cylindrica LC-OSC Lc-OSC2 Yes No BAA85267 
Lanosterol synthase Panax ginseng PG-LAS PNZ Yes Yes BAA33462 
Putative lanosterol synthase Taraxacum officinale TO-OSC TRV Yes Non-functional BAA86933 
 
 
    
 
Multifunctional triterpene synthase Costus speciosus CS-MTS CSOSC2 Yes Yes BAB83254 
 
 
    
 
Putative triterpene synthase Oryza sativa OS-OSC5 - No No - 
Putative triterpene synthase Oryza sativa OS-OSC6 - No No - 
Putative pentacyclic triterpene synthase Triticum aestivum TA-OSC - No No AX382063 
Triterpene synthase Sorghum bicolor SB-OSC1 - No No XP_002445263 
β-amyrin synthase Avena strigosa AS-bAS AsbAS1 Yes Yes CAC84558 
putative β-amyrin synthase Oryza sativa OS-OSC8 - No No - 
cycloartenol synthase Zea Mays ZM-CAS - No No ACG28931 
Putative triterpene synthase Oryza sativa OS-OSC10 - No No - 
Putative triterpene synthase Sorghum bicolor SB-OSC2 - No No XP_002442519 
Putative triterpene synthase Oryza sativa OS-OSC11 - No No - 
 
 
    
 
Putative triterpene synthase Oryza sativa OS-OSC7 - No No - 
Putative triterpene synthase Oryza sativa OS-OSC12 - No No - 
 
 
    
 
Lupeol synthase Betula platyphylla BP-LUS BPW Yes Yes BAB83087 
Lupeol synthase Glycyrrhiza glabra GG-LUS1 GgLUS1 Yes Yes BAD08587 
Lupeol synthase Lotus japonicus LJ-LUS OSC3 Yes Yes BAE53430 
Lupeol synthase Olea europaea OE-LUS OEW Yes Yes BAA86930 
Lupeol synthase Taraxacum officinale TO-LUS TRW Yes Yes BAA86932 
 
 
    
 
putative β-amyrin synthase Centella asiatica CA-DAS CaDDS Yes Yes AAS01523 
Appendix 4 
 
 
Multifunctional triterpene synthase Olea europaea OE-MTS OEA Yes Yes BAF63702 
Dammarenediol-II-synthase Panax ginseng PG-DAS PNA Yes Yes BAF33291 
 
 
    
 
Arabidiol synthase Arabidopsis thaliana AT-ARS At4g15340 Yes Yes BAF33292 
Baurol synthase Arabidopsis thaliana AT-BARS1 BARS1 Yes Yes NP_193272 
Thalianol synthase Arabidopsis thaliana AT-THAS At5g48010 Yes Yes BAB11065 
Marneral synthase Arabidopsis thaliana AT-MARS MRN1 Yes Yes NP_199074 
Multifunctional triterpene synthase Arabidopsis thaliana AT-MTS T30F21.16 Yes Yes NP_177971 
Predicted lupeol synthase Arabidopsis thaliana AT-PEN3 - No No NP_198464 
 
 
    
 
Multifunctional triterpene synthase Rhizophora stylosa RS-MTS2 RsM2 Yes Yes BAF80442 
 
 
    
 
Lupeol synthase Bruguiera gymnorrhiza BG-LUS BgLUS Yes Yes BAF80444 
putative oxidosqualene cyclase Euphorbia tirucalli ET-OSC EtOSC Yes No BAE43643 
Multifunctional triterpene synthase Kandelia candel KC-MTS KcMS Yes Yes BAF35580 
Lupeol synthase Ricinus communis RC-LUS RcLUS Yes Yes ABB76766 
Isomultiflorenol synthase Luffa cylindrica LC-IMS LcIMS1 Yes Yes BAB68529 
 
 
    
 
Lupeol synthase Arabidopsis thaliana AT-LUP1 LUP1 Yes Yes NP_178018 
Multifunctional triterpene synthase Arabidopsis thaliana AT-LUP2 LUP2 Yes Yes NP_178017 
Multifunctional triterpene synthase Arabidopsis thaliana AT-LUP3 F1019.4 Yes Yes NP_176868 
Camelliol synthase Arabidopsis thaliana AT-CamS CAMS1 Yes Yes NP_683508 
β-amyrin synthase Arabidopsis thaliana AT-bAS AtBAS Yes Yes AB374428 
 
 
    
 
Baccharis oxide synthase Stevia rebaudiana SR-BOS StrBOS Yes Yes BAH23676 
β-amyrin synthase Gentiana straminea GS-bAS GSAs1 Yes Yes ACO24697 
β-amyrin synthase Nigella sativa NS-bAS Ns-bAS1 Yes Yes ACH88048 
 
 
    
 
β-amyrin synthase Bupleurum kaoi BK-bAS - Yes No AAS83468 
β-amyrin synthase Panax ginseng PG-bAS1 PNY Yes Yes BAA33461 
β-amyrin synthase Saponaria vaccaria VH-bAS SvBS Yes Yes ABK76265 
β-amyrin synthase Gypsophila paniculata GP-bAS - ? ? ABC33922 
β-amyrin synthase Euphorbia tirucalli ET-bAS EtAS Yes Yes BAE43642 
β-amyrin synthase Betula platyphylla BP-bAS BPY Yes Yes BAB83088 
Multifunctional triterpene synthase Rhizophora stylosa RS-MTS1 RsM1 Yes Yes BAF80441 
β-amyrin synthase Bruguiera gymnorrhiza BG-bAS BgbAS Yes Yes BAF80443 
β-amyrin synthase (isogene) Panax ginseng PG-bAS2 - Yes ? BAA33722 
β-amyrin synthase Artemisia annua AA-bAS AaBAS Yes Yes ACB87531 
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β-amyrin synthase Aster sedifolius AstS-bAS AsOXA1 Yes ? AAX14716 
Mixed amyrin synthase Pisum sativum PS-MTS PSM Yes Yes BAA97559 
Multifunctional triterpene synthase Lotus japonicus LJ-MTS LjAMY2 Yes Yes AAO33580 
β-amyrin synthase Polygala tenuifolia PT-bAS - Yes Yes ABL07607 
β-amyrin synthase Medicago truncatula MT-bAS1 - Yes Yes CAD23247 
β-amyrin synthase Pisum sativum PS-bAS PSY Yes Yes BAA97558 
β-amyrin synthase Glycine max GM-bAS - Yes No AAM23264 
β-amyrin synthase Glycyrrhiza glabra GG-bAS1 GgbAS1 Yes Yes BAA89815 
β-amyrin synthase Lotus japonicus LJ-bAS LjAMY1 Yes Yes BAE53429 
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Appendix 5: Multiple sequence alignment of characterised plant OSCs 
Multiple sequence alignment of all characterised plant OSCs shown in Appendix 4.  The alignment was generated in MUSCLE and viewed and edited using Jalview.  The 
OSCs are grouped in the alignment according to their enzyme classification and are shaded using the colours of the corresponding clade on the phylogenetic tree 
(Horizontal key).  Important conserved structural features and amino acids involved in the enzyme mechanism are also annotated (Vertical key).  Both the horizontal and 
vertical keys are shown below.  The OSCs are named according to their abbreviations in the phylogenetic tree (Figure 2.7). 
 
DICOT β-amyrin synthases
Arabidopsis triterpene synthases
DICOT multifunctional triterpene synthases
DICOT lupeol synthases
MONOCOT triterpene synthases
DICOT lanosterol synthases
MONOCOT cycloartenol synthases
DICOT cycloartenol synthases
Substrate access
Pre-folding of the B-ring
Catalytic initiation
Ring stabilisation (letter(s) denote(s) which ring residue is 
involved in stabilising)
QW motif
• Except monocot triterpene OSCs
 Only in monocot triterpene OSCs
DCTAE catalytic motif
AsbAS
HORIZONTAL KEY VERTICAL KEY
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Appendix 6: Genomic DNA sequence of Sad1 
 
Genomic DNA sequence of the Sad1 gene showing the positions of the primers used for gDNA 
sequencing of the sad1 mutants.  Exons and introns are shown in uppercase and lowercase 
respectively.  Locations of the forward and reverse primers identified in table 3.1 are shown in green 
and pink respectively.  The start (ATG) and STOP codon (TGA) are shaded in grey. 
 
ATGTGGAGGCTAACAATAGGTGAGGGCGGCGGTCCGTGGCTGAAGTCGAACAATGGCTTCCTTGGCCGCCAAGTGT
GGGAGTACGACGCCGATGCCGGCACGCCGGAAGAGCGTGCCGAGGTTGAGAGGGTGCGTGCGGAATTCACAAAGAA
CAGGTTCCAGAGGAAGGAGTCACAGGACCTTCTTCTACGCTTGCAGgtacatgcgtcttctttcccctacttccat
atacacccagtagtatatgttgccactgccgttagctctagctttaggactgagaaaagggctctcagataatcca
tatctctctttagatggagggtttgcttttatttattattacatattgttcaatccttgctgtgtatatcatcaac
tgcagTACGCAAAAGACAACCCTCTTCCGGCGAATATTCCGACAGAAGCCAAGCTTGAAAAGAGTACAGAGGTCAC
TCACGAGACTATCTACGAATCATTGATGCGAGCTTTACATCAATATTCCTCTCTACAAGCAGACGATGGGCATTGG
CCTGGTGATTACAGTGGGATTCTCTTCATTATGCCTATCATTgtaagtattttactattattttatgatacagcaa
tttggcaattaatatatgcatacgaggtttcttatttcgtaaatactcaagacaatatagcatgtggaatcttata
atttctataatgaatatgtaccgtcttgtgtgcgcaatacgtatactatattattccgctatgcatatagtattac
ataccaatattgatagatgttcaaaccaattatgaagagtttaactacaagatttaatatagtagtttctgttatt
ctagcagcaagttacctccattaggttccggaagttctactcttaccacctatatatatgtattattgcttatact
accttcgtctcaaagtttaagacttttttttaaagtcaatttatggaaagtttgaactaacttttataaaactatc
aagaactatgatattatatttgccatgtgaaaatatgttttattatgtatcaaagggtatggatttcgtaccgtaa
atataatattgttgtctaaaatcttggttgaactttacttagtttgacttttggaaagtatataagccttaaactt
taaaatagacgtagtaattcagatgcacttcactgatatcccgacaaaagtacaaaatacatttatggaatgtcaa
atttatttgaaaacaacacatttggtttagcttcaatatttcggaaaagaaaatatgaggagtgatttaaataagt
tcttaaggttttcatgaaaaacaaatctgttatggggactttatgcaaagagaacaagattggctcttagaaattt
ctttagatatgattaaattaaaatacagtgtttgcactaaaaccacatttggtttgatttgaatatttgaaagaga
tagaaaatcttgaacatttatttttagggaatataggctttattactaccatcctatgtatcatcgatggtggctc
atcacattgatcacaactctgaaaactaagaagtctccaacatttagacaatgatattggtttttcaaatttcagt
aacacttacaagaattccgttgattttattctccatccgagaactcatttctcctctcctaataatgatgcacata
tatgatgggatcttttctttatgttgcagATATTCTCTTTATATGTTACTAGATCACTTGACACCTTTTTATCTCC
GGAACATCGTCATGAGATATGTCGCTACATTTACAATCAACAGgcatgggattaaacctaacacatatttccatat
ttgttttctatatgtttgtgattttgtgaccaaaataaaaacagtacttaatgcaacatatattgagcagAATGAA
GATGGTGGTTGGGGAAAAATGGTTCTTGGCCCAAGTACCATGTTTGGATCGTGTATGAATTATGCAACCTTAATGA
TTCTTGGCGAGAAGCGAAATGGTGATCATAAGGATGCATTGGAAAAAGGGCGTTCTTGGATTTTATCTCATGGAAC
TGCAACTGCAATACCACAGTGGGGAAAAATATGGTTGTCGgtatgttaaataacacaagatatcaatgctcatata
tgttctcttctgaactaacgttaaatcaacctactatttgataacatcatagATAATTGGCGTTTACGAATGGTCA
16F 
26R 
10F 
25R 
18F 
610F 
610R 
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GGAAACAATCCTATTATACCTGAATTGTGGTTGGTTCCACATTTTCTTCCGATTCACCCAGgtatttctatctagc
ttgcatatataacaaaattgttgtagaacgcatgcttagaccatcattctgtggaattattctgtgcaatttgttg
cttgtggaagcaatttaaccatatatcaaacaaggaatattgaggcatggtacctgaaatagttttttgaaaaata
catgccgaaaaggaaatcaatgtttcaattaggcatgtttgcacgtagattccacaagattctcttgtatatgttt
tgatcttggagatacatgtatatatttatgtatctttcatattatctcaaaaaaataacatgttactaccccctct
atccataataagtgtcggtcacttagtacaaactttatactagcttagtacaaaatggacgactcttattatggat
tgcagggagtactaaatattatgaagttgaaccttatcattcacaagtaatttattggaaaataatccttcatatg
tagGTCGTTTTTGGTGTTTTACCCGGTTGATATACATGTCAATGGCATATCTCTATGGTAAGAAATTTGTTGGGCC
TATTAGTCCTACAATATTAGCTCTGCGACAAGACCTCTATAGTATACCTTACTGCAACATTAATTGGGACAAGGCG
CGTGATTATTGTGCAAAGgttagttagttaatcaatcactatatatatgtattcagtttgttagaatatattaatt
tagcccatgtcactacataatattttcatggattcaagattaagaacatcacgtagaataatgaagtacatcattt
cagtacttggtatctcagaaaaaatatagactaagaaagctagtgttcttcaaaaattttatgttgtttcagGAGG
ACCTTCATTACCCACGCTCACGGGCACAAGATCTTATATCTGGTTGCCTAACGAAAATTGTGGAGCCAATTTTGAA
TTGGTGGCCAGCAAACAAGCTAAGAGATAGAGCTTTAACTAACCTCATGGAGCATATCCATTATGACGACGAATCA
ACCAAATATGTGGGCATTTGCCCTATTAACAAGgtgaaattattttcaaattgatttgcaccttttactttaataa
tgacggatgttattccattctaatgttttaacatgtttattgtaattagGCATTGAACATGATTTGTTGTTGGGTA
GAAAACCCAAATTCGCCTGAATTCCAACAACATCTTCCACGATTCCATGACTATTTGTGGATGGCGGAGGATGGAA
TGAAGGCACAGgttggtatagagctcttgtcagatattttgccaatttaactacgtgccaattcttcacaaccatt
aacctttttcatgaatatatatttcctcaaacaaaatgtgagaatcttttgggttacaaggattttttattttcat
ctatatctaggttgcattcaataagcatgtttgtgcatgtccgagttctcctgaaccaaactaaaatgcatattct
ctttagctgcacatagtgtatatgaaataaaattatggtaataatatttttactttagttaattctaatgacgaaa
tagttgatatgcctatatcgtttcgaatatataaatcagaggtagttagaaaaattattggacttacatcaaatgc
aaactgtgaatgtataagtaatatgtatacaatcgcagGTATATGATGGATGTCATAGCTGGGAACTAGCGTTCAT
AATTCATGCCTATTGTTCCACGGATCTTACTAGCGAGTTTATCCCGACTCTAAAAAAGGCGCACGAGTTCATGAAG
AACTCACAGgtttgttgttctccatattatattattgctcaaattctgaaaagatctaacattaattgtctaccct
tgaagGTTCTTTTCAACCACCCAAATCATGAAAGCTATTATCGCCACAGATCAAAAGGCTCATGGACCCTTTCAAG
TGTAGATAATGGTTGGTCTGTATCTGATTGTACTGCGGAAGCTGTTAAGgttaacataagaaccatgtcttccaat
tgtacatatataagtacatatgtgaatacatgacgggttaccctgtataagttgaaatgaactattcatgaatata
ttgaatctacattaatattcattattttttcagGCATTGCTACTATTATCAAAGATATCCGCTGACCTTGTTGGCG
ATCCAATAAAACAAGACAGGTTGTATGATGCCATTGATTGCATCCTATCTTTCATGgtatgagaatctaaattgga
tcaattaacaaacgtacattactaaacaagggaaactatgcagacccattactaaagaaatgtgagcccacctagc
tagataattttatctaaaagtattaaattatattttgcacaacatacaaaagttaaatttgttgtacaatgcatat
tattttctaaaaaaaatgcaaaaataatttggagaaattttataaggtagtccacggtaatttaatccatttctat
aatgcaaatagagtctcactaatagcaggtctccttttctcgttttgaagAATACAGATGGAACATTTTCTACCTA
11F 24R 
109F 
109R 
05F 
17R 
06F 
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CGAATGCAAACGGACATTCGCTTGGTTAGAGgttagtgatattcctttaaagttttataacatggtacaattaaga
tgaaatatcatttttgtattgtatgacttgtccatgagaacaaggtattgggattgaataagaagtcaaaagaaaa
ccaaatacaacaatgatatattaattgtaattcttatggtcattttgcatttctctttcatacccaagaaattttt
tctcctgaacaataagtttggataaccctatcccctttaacaaaatatctcttctacgagctagGTTCTCAACCCT
TCTGAGAGTTTTCGGAACATTGTCGTGGACTATCCgtaagacaaaaaacacctacttcataaattatctttacttc
tatattcaaatattcattttcgcgaactgacttgatatacataataatggtcagATCTGTTGAATGCACATCATCT
GTGGTTGATGCTCTCATATTATTTAAAGAGACGAATCCACGATATCGAAGAGCAGAGATAGATAAATGCATTGAAG
AAGCTGTTGTATTTATTGAGAACAGTCAAAATAAGGATGGTTCATGgtaagtgacatgatataaattatgcgttac
aataacttttacttttgattaaatttgaaaatttattacttcttgtatctcatagGTATGGCTCATGGGGTATATG
TTTCGCATATGGATGCATGTTTGCAGTAAGGGCGTTGGTTGCTACAGGAAAAACCTACGACAATTGTGCTTCTATC
AGGAAATCATGCAAATTTGTCTTATCAAAGCAACAAACAACAGGTGGATGGGGTGAAGACTATCTTTCTAGTGACA
ATGGGgtaatataacaaactactttacccctataacattttactaatggtaaatcaaatccatcatgattattcat
agatttaagtcatacatgatatagtaaacatagaaattgatactagttgagagttttgttgttctataaatatact
agttgagagttcagtagttctataagccatgcatggaattacgaaacattataaactcaacgcaagatgatatagt
tgacaaattttaaaaatatcatatgtcttgttaaaaaaaagatcctagttatattttgagcatgaatatcttcaaa
tattgtgtatatgtgagaaaggtgatgtttaattgcacaaggtacactaaataaaatggttaatttgtgtatgccc
aaaaaagagagatatagaaagagctaaagtaaacttttaattgacacatcttgttcttaacatttattttttatga
aagtctcagtacattcacgatacctagcaatatgaaaattcattgattagacagaagataaaattgccattccaca
attattaaatcatatatgttaatttttgcctttttgcttatttttgtcatgataatggatgcataacaccatgttt
tccaatggtctcatctactaatctcagatatcttaatacagcttggtctacaactgttacaccccagttttgatga
ccgtgtccacaaatacattataaactactactaatgacctaacacaaaaaaatgacgacaaagacaaatatccaat
agaaggatcttttgtactgaacaaatgaagaaaattgtacatatatattgtgtaatatttaatttgttttccttta
gtgtactccatccatgaaaatgatattaaatcaatatttgcaatcatgcggtcaaatctgttcttctagatgcgta
agctaaagtcattatatgtatatatatattttcaagaacacataggcatgttgtgttttctaatcacgttttgtac
agGAATATATTGATAGCGGTAGGCCTAATGCTGTGACCACCTCATGGGCAATGTTGGCTTTAATTTATGCTGGACA
Ggtttgtcaaatatttttccttgtttgtctagaatatgaattttttattaaaaaggaaaagttctcactattcttg
aatagtcgagttatctaacagaataatttatattttgtttttttaataagGTTGAACGTGACCCAGTACCACTGTA
TAATGCTGCAAGACAGCTAATGAATATGCAGCTAGAAACAGGTGACTTCCCCCAACAGgtaatatgtttccgtcct
acatgttttcaaacaaaaatgcaaagtaatcttaagtttaattgaaactgatcttttgttaatgaaactcaatgta
gaccttaagggaacaaccagtagaaataaaatacttgtgaattgataactctggaaagtgtatgcattaatgttgg
tgtgaatgtggtaaatgttggcattgcgtcataatttttgcatcggtacttacaaagtttaattaacactaatctc
ttgtcagattcaatgatcattaaaaattaagatataacctccatctagcttcttacttacagtttcaccttggtaa
tagGAACACATGGGTTGCTTCAACTCCTCCTTGAACTTCAACTACGCCAACTACCGCAATCTATACCCGATTATGG
CTCTTGGGGAACTTCGCCGTCGACTTCTTGCGATTAAGAGCTGA 
08F 
22R 
19F 
12F 
23R 
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Appendix 7: Original data from DArT analysis of sad1 mutants 
 
Table A: DArT binary data.  The binary data for the 35 genetic markers found to be polymorphic between all of the 17 sad1 mutants.  
Presence of absence of the marker was scored using ―1‖ and ―0‖ respectively and missing data is shown by a dash (-).  Mutants that 
show high levels of variability between replicate samples are highlighted in red. E/eric/7-10-09/002E/er c/7-10-09/002E/eric/7-1 -09/002E eric/7-1 -09/002E/ ric/7-1 -09/002E/eric/7-10-09/002E/eric/7-1 -09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric 7-10-09/002E/eric 7-10-09/002E/eric 7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002
A C B D C E D F E G H B B D E G F H C
1 3 1 3 1 3 1 3 2 4 2 5 3 5 1 3 1 3 2
CloneID CloneName MarkerName P Q Reproducibility Call Rate PIC Discordance S75-1 S75-2 A1-1 A1-2 B1-1 B1-2 109-1 109-2 610-1 610-2 1146-1 1146-2 1293-1 1293-2 110-1 110-2 225-1 225-2 589-1
415701 802106272005_N_24 oPt-8320 88.438 87.571 100 96.078 0.48 0 1 1 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0
468690 802107109015_N_15 oPt-17991 83.785 82.964 100 94.118 0.5 0 0 1 1 1 1 1 - 1 0 0 1 1 1 1 1 1 0 0 0
415431 802106272005_C_18 oPt-3946 82.194 81.388 100 88.235 0.495 0 0 1 1 1 1 1 1 1 0 0 1 1 - 1 1 1 0 0 0
468690 802107109015_N_15 oPt-17991 81.915 81.112 100 90.196 0.499 0 0 1 1 1 1 1 1 1 0 0 1 1 - 1 1 1 0 0 0
466873 802107109011_B_22 oPt-16174 81.404 80.605 100 100 0.109 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0
464253 802107109004_E_18 oPt-13554 79.327 78.549 100 86.275 0.498 0 0 1 1 1 1 1 - 1 0 0 1 1 - 1 - 1 0 0 0
467153 802107109011_N_14 oPt-16454 78.949 78.175 100 92.157 0.219 0 - 0 1 1 1 1 0 0 - - 0 0 0 0 0 0 0 0 0
465310 802107109007_A_19 oPt-14611 77.514 76.671 100 90.196 0.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
455550 800907094014_K_3 oPt-11379 76.888 76.134 100 93.137 0.245 0 1 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 1
451487 800907094004_A_20 oPt-2489 73.515 73.625 100 89.216 0.252 0 - 1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 - 1
450979 800907094002_L_16 oPt-7377 73.474 72.754 100 91.176 0.292 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0
468422 802107109015_C_11 oPt-17723 72.307 71.598 100 93.137 0.285 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0
467089 802107109011_K_22 oPt-16390 72.225 71.551 100 87.255 0.266 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
451823 800907094004_O_20 oPt-7303 70.929 71.036 100 92.157 0.225 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 1 1 0
464996 802107109006_D_17 oPt-14297 67.635 67.164 100 88.235 0.252 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 - 0
466143 802107109009_D_12 oPt-15444 66.243 65.594 100 93.137 0.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0
397225 802106198003_M_4 oPt-9687 65.35 64.703 100 89.216 0.228 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 0
794668 804909173005_A_1 oPt-794668 64.406 63.774 100 95.098 0.117 0 0 0 0 0 0 0 1 1 0 0 - 0 0 0 0 0 0 0 0
393089 802106192010_P_20 oPt-2374 63.354 62.733 100 94.118 0.192 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1
793423 804909173001_M_4 oPt-793423 60.718 60.152 100 97.059 0.058 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
412054 802106271006_G_1 oPt-6715 64.346 63.786 96.97 82.353 0.215 0.022 - 0 0 0 0 0 0 0 1 - 0 0 0 0 - - 0 0 0
467187 802107109011_O_24 oPt-16488 66.992 66.673 96.97 80.392 0.337 0.022 1 - 1 1 1 - 1 1 1 1 - 1 1 - - - 0 0 0
454314 800907094011_G_15 oPt-10143 71.103 70.986 96.97 83.333 0.27 0.022 1 0 - 0 0 - 1 1 0 - - - 0 0 0 0 0 0 0
794493 804909173004_I_18 oPt-794493 70.015 69.682 96.97 87.255 0.299 0.019 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 - 0 0
390960 802106192005_H_3 oPt-1586 69.409 68.729 96.97 84.314 0.483 0.021 0 0 0 0 0 0 1 1 1 1 0 0 0 0 1 - 1 1 0
454390 800907094011_J_19 oPt-10219 67.033 68.164 96.97 87.255 0.18 0.021 - 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1
465377 802107109007_D_14 oPt-14678 73.056 72.597 96.97 85.294 0.452 0.022 0 0 0 0 1 1 0 0 - 1 0 0 - 1 0 0 0 0 0
415431 802106272005_C_18 oPt-3946 83.566 83.02 96.97 91.176 0.5 0.018 0 1 1 1 1 1 1 1 0 0 1 1 - 1 1 1 0 0 0
467633 802107109013_B_14 oPt-16934 74.16 73.588 96.97 84.314 0.456 0.022 0 0 0 0 1 1 0 0 1 1 0 0 0 0 0 0 0 0 1
467672 802107109013_D_5 oPt-16973 74.233 73.506 96.97 84.314 0.481 0.022 - 1 0 0 0 - - 1 1 1 0 0 0 0 1 1 0 0 1
467633 802107109013_B_14 oPt-16934 74.122 73.395 96.97 82.353 0.492 0.021 0 0 - - 1 1 0 0 1 1 0 0 0 0 - 0 0 0 -
453764 800907094009_P_17 oPt-9106 73.829 73.105 96.97 83.333 0.492 0.024 0 0 0 0 1 1 0 0 1 1 0 0 1 1 0 0 - 0 0
464962 802107109006_C_7 oPt-14263 75.059 74.323 96.97 94.118 0.242 0.017 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
794975 804909173005_M_20 oPt-794975 74.558 73.827 96.97 86.275 0.488 0.021 0 0 - 0 - 1 0 0 1 1 0 0 1 1 0 0 0 0 0
392831 802106192010_F_2 oPt-9413 83.599 82.779 96.97 95.098 0.488 0.018 1 1 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0
74.029 73.393 100 92.0098 0.273 0 0.278 0.55 0.42 0.4 0.4 0.4 0.278 0.35 0.211 0.211 0.4444 0.4 0.4375 0.45 0.353 0.421 0.2 0.188 0.25
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E/eric/7-10-09/002E/eric 7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric/7-10-09/002E/eric 7-10-09/002E/eric 7-10-09/002E/eric 7-10-09/002
F H G A H B A C B D D F G A A C
2 4 1 4 1 4 2 4 2 4 2 4 2 5 3 5
CloneID CloneName MarkerName P Q Reproducibility Call Rate PIC Discordance 1001-1 1001-2 297-1 297-2 358-1 358-2 384-1 384-2 532-1 532-2 599-1 599-2 1023-1 1023-2 1217-1 1217-2
415701 802106272005_N_24 oPt-8320 88.438 87.571 100 96.078 0.48 0 1 1 0 0 1 1 0 0 0 0 0 0 1 - 0 0
468690 802107109015_N_15 oPt-17991 83.785 82.964 100 94.118 0.5 0 0 0 0 0 1 0 0 0 0 0 1 1 1 1 0 0
415431 802106272005_C_18 oPt-3946 82.194 81.388 100 88.235 0.495 0 0 0 0 0 1 0 - 0 0 0 1 1 1 1 0 0
468690 802107109015_N_15 oPt-17991 81.915 81.112 100 90.196 0.499 0 0 0 0 0 1 0 - 0 0 0 1 1 1 1 0 0
466873 802107109011_B_22 oPt-16174 81.404 80.605 100 100 0.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
464253 802107109004_E_18 oPt-13554 79.327 78.549 100 86.275 0.498 0 0 0 0 0 - 0 0 0 0 0 1 1 1 1 0 0
467153 802107109011_N_14 oPt-16454 78.949 78.175 100 92.157 0.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
465310 802107109007_A_19 oPt-14611 77.514 76.671 100 90.196 0.065 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0
455550 800907094014_K_3 oPt-11379 76.888 76.134 100 93.137 0.245 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
451487 800907094004_A_20 oPt-2489 73.515 73.625 100 89.216 0.252 0 - 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1
450979 800907094002_L_16 oPt-7377 73.474 72.754 100 91.176 0.292 0 - 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1
468422 802107109015_C_11 oPt-17723 72.307 71.598 100 93.137 0.285 0 - 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1
467089 802107109011_K_22 oPt-16390 72.225 71.551 100 87.255 0.266 0 1 1 0 0 0 0 0 0 0 0 0 0 - 0 0 0
451823 800907094004_O_20 oPt-7303 70.929 71.036 100 92.157 0.225 0 - 1 0 0 0 0 1 0 0 0 0 0 0 0 - 0
464996 802107109006_D_17 oPt-14297 67.635 67.164 100 88.235 0.252 0 - - 0 0 0 0 0 0 0 0 1 1 0 0 1 1
466143 802107109009_D_12 oPt-15444 66.243 65.594 100 93.137 0.175 0 1 1 0 0 0 0 0 0 0 0 0 0 0 - 0 0
397225 802106198003_M_4 oPt-9687 65.35 64.703 100 89.216 0.228 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 - 1
794668 804909173005_A_1 oPt-794668 64.406 63.774 100 95.098 0.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0
393089 802106192010_P_20 oPt-2374 63.354 62.733 100 94.118 0.192 0 1 - 1 1 1 1 1 1 1 1 1 1 - 1 0 0
793423 804909173001_M_4 oPt-793423 60.718 60.152 100 97.059 0.058 0 1 1 1 1 1 1 1 1 1 1 0 - 1 1 1 1
412054 802106271006_G_1 oPt-6715 64.346 63.786 96.97 82.353 0.215 0.022 0 0 - 0 0 0 - 1 0 0 0 0 0 0 1 1
467187 802107109011_O_24 oPt-16488 66.992 66.673 96.97 80.392 0.337 0.022 1 1 - 0 1 1 1 1 1 1 1 - 1 1 1 1
454314 800907094011_G_15 oPt-10143 71.103 70.986 96.97 83.333 0.27 0.022 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
794493 804909173004_I_18 oPt-794493 70.015 69.682 96.97 87.255 0.299 0.019 0 0 1 0 0 - 1 - 0 0 - 0 0 0 1 1
390960 802106192005_H_3 oPt-1586 69.409 68.729 96.97 84.314 0.483 0.021 - - 1 - 0 0 0 0 1 0 1 1 - 1 1 -
454390 800907094011_J_19 oPt-10219 67.033 68.164 96.97 87.255 0.18 0.021 1 - 1 - - 1 0 0 1 1 1 1 1 1 1 1
465377 802107109007_D_14 oPt-14678 73.056 72.597 96.97 85.294 0.452 0.022 1 1 - 0 0 0 0 1 1 1 0 0 - 1 1 1
415431 802106272005_C_18 oPt-3946 83.566 83.02 96.97 91.176 0.5 0.018 0 0 0 0 - 0 0 0 0 0 1 1 1 1 0 0
467633 802107109013_B_14 oPt-16934 74.16 73.588 96.97 84.314 0.456 0.022 1 1 0 0 0 - 1 - 1 1 0 0 - 0 1 1
467672 802107109013_D_5 oPt-16973 74.233 73.506 96.97 84.314 0.481 0.022 1 1 1 1 0 0 - 0 1 1 1 1 1 1 - 0
467633 802107109013_B_14 oPt-16934 74.122 73.395 96.97 82.353 0.492 0.021 1 1 0 0 0 0 1 1 1 1 0 0 - - - 1
453764 800907094009_P_17 oPt-9106 73.829 73.105 96.97 83.333 0.492 0.024 1 1 - 0 0 - 0 1 1 1 - 0 - 1 1 1
464962 802107109006_C_7 oPt-14263 75.059 74.323 96.97 94.118 0.242 0.017 - 0 0 0 0 0 0 0 0 0 1 1 0 0 - 1
794975 804909173005_M_20 oPt-794975 74.558 73.827 96.97 86.275 0.488 0.021 1 1 - 0 0 0 - 1 1 1 0 0 1 1 1 1
392831 802106192010_F_2 oPt-9413 83.599 82.779 96.97 95.098 0.488 0.018 1 1 0 0 1 1 0 0 0 0 0 0 1 1 0 0
74.029 73.393 100 92.0098 0.273 0 0.4 0.5 0.1 0.2 0.421 0.2 0.222 0.1 0.15 0.15 0.5 0.526 0.3889 0.3889 0.2941 0.3
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Table B: Humming matrix analysis of binary data.  The binary data was analysed using a Humming matrix which gives a numerical 
score of the similarity between each of the mutant samples.  The samples are scored at distances between 0 and 100, with identical 
samples being at a distance of 0 from each other.  The two groups of mutants with identical point mutations are highlighted in red and 
blue. 
 
 
Clone A1-1 A1-2 1001-1 1001-2 1023-1 1023-2 109-1 109-2 110-1 110-2 1146-1 1146-2 1217-1 1217-2 1293-1 1293-2 225-1 225-2 297-1 297-2 358-1 358-2 384-1 384-2 532-1 532-2 589-1 589-2 599-1 599-2 610-1 610-2 B1-1 B1-2 S75-1 S75-2
A1-1 0 0 63 67 16 21 14 16 22 14 11 10 59 53 24 20 41 44 37 31 14 29 30 38 36 32 36 23 28 24 45 45 10 10 35 27
A1-2 0 0 59 63 18 22 16 18 21 13 10 9 59 55 25 21 38 40 35 28 16 29 28 38 35 32 32 21 28 25 44 45 9 13 35 24
1001-1 63 59 0 0 32 32 60 61 48 52 56 52 33 36 27 44 46 46 35 44 56 32 39 31 18 18 26 32 62 62 19 16 44 44 29 48
1001-2 67 63 0 0 39 39 68 68 58 57 59 57 28 36 36 50 41 39 46 48 59 39 39 38 26 26 33 40 62 62 28 25 50 50 37 50
1023-1 16 18 32 39 0 0 24 21 9 4 8 7 52 54 9 7 48 54 36 37 16 30 35 41 25 25 36 25 33 31 26 24 15 12 35 19
1023-2 21 22 32 39 0 0 24 22 15 11 18 16 48 52 15 10 43 50 30 37 24 35 41 37 22 25 44 33 30 30 27 24 16 14 44 26
109-1 14 16 60 68 24 24 0 0 15 18 14 16 56 61 37 32 37 36 22 27 20 28 36 40 34 38 36 26 30 27 47 45 29 30 32 32
109-2 16 18 61 68 21 22 0 0 14 16 16 18 59 65 38 32 42 42 27 30 22 34 40 46 37 40 38 28 27 24 49 47 29 28 37 29
110-1 22 21 48 58 9 15 15 14 0 4 12 11 60 61 29 24 44 42 27 30 19 31 40 44 38 41 38 28 26 21 33 37 32 33 32 17
110-2 14 13 52 57 4 11 18 16 4 0 4 3 62 61 20 16 41 44 32 27 11 25 37 48 39 39 33 20 24 20 35 38 27 28 30 13
1146-1 11 10 56 59 8 18 14 16 12 4 0 0 67 67 16 13 38 41 41 31 4 18 35 48 45 42 37 24 35 30 45 45 23 27 27 16
1146-2 10 9 52 57 7 16 16 18 11 3 0 0 64 61 14 12 41 43 38 31 3 16 35 44 41 38 36 25 31 28 41 41 21 25 24 15
1217-1 59 59 33 28 52 48 56 59 60 62 67 64 0 0 57 57 37 36 25 44 69 42 32 26 21 24 45 54 41 44 22 23 46 48 60 54
1217-2 53 55 36 36 54 52 61 65 61 61 67 61 0 0 54 55 44 43 35 49 65 42 35 25 27 27 46 54 41 44 28 29 42 45 59 52
1293-1 24 25 27 36 9 15 37 38 29 20 16 14 57 54 0 4 44 52 36 37 21 19 42 33 31 28 32 30 48 48 32 31 25 27 21 32
1293-2 20 21 44 50 7 10 32 32 24 16 13 12 57 55 4 0 47 53 40 41 19 29 45 38 35 32 46 36 41 39 38 36 18 19 41 27
225-1 41 38 46 41 48 43 37 42 44 41 38 41 37 44 44 47 0 0 21 16 40 28 21 31 30 33 28 30 52 48 39 40 47 50 36 53
225-2 44 40 46 39 54 50 36 42 42 44 41 43 36 43 52 53 0 0 23 17 43 32 27 35 36 39 30 32 48 41 48 50 53 57 37 47
297-1 37 35 35 46 36 30 22 27 27 32 41 38 25 35 36 40 21 23 0 11 41 21 22 14 13 17 21 21 41 41 17 18 40 39 27 47
297-2 31 28 44 48 37 37 27 30 30 27 31 31 44 49 37 41 16 17 11 0 26 20 21 29 21 21 13 11 42 36 32 33 41 40 24 38
358-1 14 16 56 59 16 24 20 22 19 11 4 3 69 65 21 19 40 43 41 26 0 14 33 43 44 41 39 32 40 37 43 41 29 31 21 23
358-2 29 29 32 39 30 35 28 34 31 25 18 16 42 42 19 29 28 32 21 20 14 0 22 28 25 22 23 26 50 50 20 17 36 38 7 36
384-1 30 28 39 39 35 41 36 40 40 37 35 35 32 35 42 45 21 27 22 21 33 22 0 14 20 17 21 23 50 50 21 25 30 32 33 48
384-2 38 38 31 38 41 37 40 46 44 48 48 44 26 25 33 38 31 35 14 29 43 28 14 0 15 12 31 36 59 61 19 20 28 30 32 59
532-1 36 35 18 26 25 22 34 37 38 39 45 41 21 27 31 35 30 36 13 21 44 25 20 15 0 3 21 24 46 46 12 9 24 22 37 50
532-2 32 32 18 26 25 25 38 40 41 39 42 38 24 27 28 32 33 39 17 21 41 22 17 12 3 0 18 21 49 49 15 13 21 19 33 47
589-1 36 32 26 33 36 44 36 38 38 33 37 36 45 46 32 46 28 30 21 13 39 23 21 31 21 18 0 0 50 44 31 32 36 36 17 42
589-2 23 21 32 40 25 33 26 28 28 20 24 25 54 54 30 36 30 32 21 11 32 26 23 36 24 21 0 0 41 33 37 39 29 27 17 32
599-1 28 28 62 62 33 30 30 27 26 24 35 31 41 41 48 41 52 48 41 42 40 50 50 59 46 49 50 41 0 0 55 57 38 40 61 16
599-2 24 25 62 62 31 30 27 24 21 20 30 28 44 44 48 39 48 41 41 36 37 50 50 61 46 49 44 33 0 0 58 60 38 39 57 12
610-1 45 44 19 28 26 27 47 49 33 35 45 41 22 28 32 38 39 48 17 32 43 20 21 19 12 15 31 37 55 58 0 0 34 33 31 50
610-2 45 45 16 25 24 24 45 47 37 38 45 41 23 29 31 36 40 50 18 33 41 17 25 20 9 13 32 39 57 60 0 0 32 30 31 52
B1-1 10 9 44 50 15 16 29 29 32 27 23 21 46 42 25 18 47 53 40 41 29 36 30 28 24 21 36 29 38 38 34 32 0 0 48 36
B1-2 10 13 44 50 12 14 30 28 33 28 27 25 48 45 27 19 50 57 39 40 31 38 32 30 22 19 36 27 40 39 33 30 0 0 50 38
S75-1 35 35 29 37 35 44 32 37 32 30 27 24 60 59 21 41 36 37 27 24 21 7 33 32 37 33 17 17 61 57 31 31 48 50 0 41
S75-2 27 24 48 50 19 26 32 29 17 13 16 15 54 52 32 27 53 47 47 38 23 36 48 59 50 47 42 32 16 12 50 52 36 38 41 0
Clone A1-1 A1-2 1001-1 1001-2 1023-1 1023-2 109-1 109-2 110-1 110-2 1146-1 1146-2 1217-1 1217-2 1293-1 1293-2 225-1 225-2 297-1 297-2 358-1 358-2 384-1 384-2 532-1 532-2 589-1 589-2 599-1 599-2 610-1 610-2 B1-1 B1-2 S75-1 S75-2
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Appendix 8: Western blot analysis of sad1 PTC mutants 
 
Western blot analysis of the sad1 premature termination of translation mutants to look for the 
presence of AsbAS1 protein.  Membrane was probed with the AsbAS1 antibody at 1:10,000 dilution 
(13083 serum) and chemiluminescent signal detected by exposure to X-ray film for 30 seconds.  Lane 
1, SeeBlue® Plus2 Pre-Stained Standard: myosin (188kDa), phosphorylase (98kDa), bovine serum 
albumin (62kDa), glutamic dehydrogenase (49kDa), alcohol dehydrogenase (38kDa), carbonic 
anhydrase (28kDa), myoglobin red (17kDa), lysozyme (14kDa), aprotinin (6kDa); Lane 2, Wild type 
S75 root tip protein; Lane 3-8, Root tip protein from mutants #A1, #B1, #109, #610, #1146, #1293. 
A. SDS-PAGE gel to show even total protein loading. B. Western blot at 30 seconds exposure. 
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